---

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended June 30, 2009

Commission File Number: 33-17598-NY

THE TIREX CORPORATION
(Exact name of registrant as specified in its charter)

Delaware	22-3282985
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

1771 Post Road East Westport, CT 06880
(Address of Principal Executive Offices)

(203)292-6922
(Registrant's Telephone Number, including Area Code)

Securities registered under Section 12(b) of the Exchange Act: NONE

Securities registered pursuant to Section 12(g) of the Exchange Act: Common Stock

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes [  ]         No [X]

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act.

Yes [  ]         No [X]

Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)has been subject to such filing requirements for the past 90 days.

Yes [X]         No [  ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (of for such shorter period that the registrant was required to submit and post such files).

Yes [X]         No [  ]

Indicate by check mark if disclosure of delinquent filers in response to Item 405 of Regulation S-K (section 229.405 of this chapter) is not contained herein, and will not be contained, to the best of the registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [X]

Indicate by check mark whether the registrant is a large accelerated filer,an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer[  ]        Accelerated filer [  ]         Non-accelerated [  ]         Small reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [ ]         No [X]

As of June 30, 2009, the aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant computed by reference to the average bid and asked price of such common equity as of such date, was $0.

2,233,499,756 (as of March 1, 2011)
Number of shares outstanding of the Registrant's common stock)

---

TABLE OF CONTENTS

PART I	F-1
Item 1 Business	F-1
Item 1A Risk Factors	F-5
Item 1B Unresolved Staff Comments	F-5
Item 2 Properties	F-5
Item 3 Legal Proceedings	F-5
Item 4 Submission of Matters to a Vote of Security Holders	F-6
PART II	F-7
Item 5 Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	F-7
Item 6 Selected Financial Data	F-7
Item 7 Management’s Discussion and Analysis of Financial Condition and Results of Operations	F-7
Item 7A Quantitative and Qualitative Disclosures about Market Risk	F-12
Item 8 Financial Statements and Supplementary Data	F-12
Item 9 Changes In and Disagreements with Accountants on Accounting and Financial Disclosure	F-12
Item 9A Controls and Procedures	F-12
Item 9B Other Information	F-13
PART III	F-13
Item 10 Directors, Executive Officers and Corporate Governance	F-13
Item 11 Executive Compensation	F-16
Item 12 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	F-18
Item 13 Certain Relationships and Related Transactions, and Director Independence	F-20
Item 14 Principal Accountant Fees and Services	F-21
PART IV	F-22
Item 15 Report of Independent Registered Public Accounting Firm, Consolidated Financial Statements, Reports Filed on Form 8-K, Financial Statement Schedules, Exhibits	F-22

---

PART I

ITEM 1. BUSINESS

FORWARD LOOKING STATEMENTS

This Annual Report contains forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including “could”, “many”, “will”, “should”, “expect”, “plan”, “anticipate” “believe”, “estimate”, “predict”, “potential” and the negative of these terms or other comparable terminology. These statements are only predictions. Actual events or results may differ materially.

While these forward-looking statements, and any assumptions upon which theu are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results,will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested in this report.

As used in this Annual Report, the terms “we”, “us” and “our” mean The Tirex Corporation, unless otherwise indicated.

All dollar amounts in this Annual Report refer to U.S. dollars, unless otherwise indicated.

BUSINESS OVERVIEW

The Company
The Tirex Corporation (hereinafter referred to as "we", "us", “Tirex” or the "Company") is engaged in the business of developing for sale, license or lease an environmentally safe patented "turn key" cryogenic tire recycling system, known as the "TCS System" The TCS System was designed and developed by Tirex and separates tires into clean and saleable rubber crumb, steel wire, and fiber. The Company was incorporated in Delaware on August 19, 1987 under the name "Concord Enterprises, Inc." The Company's name was changed to "Stopwatch Inc." on June 20, 1989 and to "Tirex America Inc." on March 10, 1993. On July 11, 1997, the Company's name was changed to "The Tirex Corporation" in order to better reflect our business.

Since 1993, our core business has been to develop and to initiate marketing efforts by sale or license of an environmentally friendly semi- cryogenic tire recycling system, which we intend to sell to recycling companies and governmental agencies to enable them to recycle tires. We devoted much of our earlier efforts to completing the design and development of the TCS Prototype and raising the financing required to do so but during the last nine years, our efforts have turned to marketing the first commercial facility. Tirex is in the development stage, seeking to commercialize its TCS Technology and produce revenues sufficient to sustain its operations.

The TCS-System
Our TCS-System comprises a complete, turn-key, environmentally safe, semi-cryogenic tire recycling system designed to: (i) disintegrate scrap tires with its patented ‘fracturing mill’ integrated with its proprietary rubber freezing process which uses less energy than is required by existing, ambient methods (which shred and/or chop tires at "ambient" or normal room temperatures) or other currently available, cryogenic methods (which freezes the rubber with the use of liquid nitrogen) and (ii) produce commercially exploitable, high quality, clean rubber crumb and marketable, intact steel and fiber strands.

The TCS System is a “semi” cryogenic system in that the precise, scientific definition of cryogenics describes temperatures much colder than what is actually required to freeze tire pieces to the point where they can be mechanically disintegrated. Liquid nitrogen systems are truly cryogenic in that the temperature of liquid nitrogen qualifies under the cryogenic definition. The operating cost of truly cryogenic systems, however, is significantly higher than that of a semi-cryogenic system, because the incremental cost of attaining cryogenic temperatures, which are not necessary, imposes a substantial “cost of cold” premium to the process of tire chip freezing. At issue is that the incremental cost of attaining each additional, lower degree of cold temperature costs a little more than obtaining the previous, lower degree. While not an exponential relationship, neither is it a linear relationship. The semi-cryogenic process, on the other hand, avoids the incremental cost of acquiring these additional and unnecessary degrees of cold.

The beta-version freezing chamber of the TCS Prototype, previously located in Montreal, was a large tank through which the tire chips were circulated having temperatures of approximately 170 degrees below zero, Fahrenheit. The current, proposed commercial version of the TCS has been re-designed to run approximately 20 degrees colder than the beta-version of the TCS

F-1

---

Prototype to ensure that no pieces of rubber can warm up from the "glass point" before being entirely processed by our patented fracturing mill.

During the process, the frozen tire parts are passed through a fracturing mill that separates the recycled tires into their component parts, including rubber powder, clean steel wire and twine. The rubber “mesh” is then physically separated from the metal and twine and is finally subjected to other steps to achieve the desired mesh size. The configuration of the back end of the system can be modified, as required, to produce proportions of mesh sizes appropriate to local crumb rubber customers, such as 100% -30 mesh or even finer.

The functions and mechanisms of the TCS System were originally designed for the purpose of disintegrating automobile tires, although relatively minor modifications could be introduced to accept other kinds of tires as well. Such modifications would focus on the front-end tire chip operation, which is not part of the Tirex technology, and which is widely available.

The TCS System has been designed to operate continuously (with minimum amounts of scheduled downtime for maintenance) and to require less energy than is used, to the best of the Company's knowledge, by other existing tire recycling systems.

Step-by-Step Operations
The step-by step operations of the TCS-System comprise the following:

Tire Feedstock Preparation

The TCS System is not designed to accept whole tires; whole tires must undergo preliminary preparation to produce pieces of tire having dimensions which permit their introduction into the patented fracturing mill. Feedstock preparation can be accomplished in a number of ways including chipping, shredding and removal of sidewalls followed by die cutting. None of these techniques form part of the TCS System technology and the tire feedstock preparation technique ultimately chosen by the tire recycling entrepreneur will depend upon capital and operating costs as well as possible issues of transportation costs respecting whole tires.

Freezing the Tire Pieces

The prepared tire pieces are deposited on a conveyor belt that brings a continuous stream of tire pieces to a freezing chamber. Super cooled air, produced on-site by an Air Plant, is continuously blown into the freezing chamber, and this cold air freezes the tire pieces moving through the chamber to the point where these pieces can be made to shatter like glass when subjected to forces such as pressure and bending. After approximately thirty minutes in the freezing chamber the frozen pieces exit the freezing chamber and enter our patented disintegrators.

Size Reduction and Materials Separation in the Fracturing Mill

The frozen tire pieces pass through Tirex’s patented disintegrators (the "Fracturing Mill") where the pieces are reduced to three separate output materials, including rubber crumb of varying degrees of fineness, intact pieces of steel and intact pieces of fiber. This operation does not involve any chopping, shredding, or hammer-milling. Therefore, the steel wires are neither cut nor broken. The fiber threads retain their basic shapes and characteristics. No steel powder or fiber fluff is produced.

Separation of the Steel from the rubber and fiber

On the front end steel beads can be removed before entering the freezing chamber. Upon completion of the freezing process the pieces enter the Fracturing Mill which separates the remaining steel from the rubber and fiber and the output is conveyed to a magnetic separation system where the intact steel wires are magnetically removed, leaving the rubber crumb and the fiber. The steel can then be baled for sale.

Fiber Removal

The fiber and rubber crumb is then passed through vibrating screens to separate the crumb from the fiber threads. The fiber threads are then conveyed out of the machine. The fiber can then be baled or put into a container for sale.

F-2

---

Rubber Crumb Finishing

Rubber crumb finishing operations are dictated by the output requirements of the producer and his or her customers. The basic TCS System has been configured to produce rubber crumb in mesh sizes ranging from 10 mesh to 30 mesh, at the option of the entrepreneur (limited quantities of even finer mesh rubber are also produced), and in such proportions of mesh sizes as the producer decides, according to market requirements. Back-end configuration modifications can be added to increase the proportion of finer mesh crumb rubber, even beyond 30 mesh. This reconfiguration could imply the addition of auxiliary processing equipment which does not form part of the TCS System technology.

It is possible that some very small pieces of steel and fiber can be trapped in the larger pieces of rubber coming out of the Fracturing Mill. These small amounts of steel and fiber are released during auxiliary processing and can be separated during the auxiliary processing operation, magnetically for the steel and by an air separation system for the residual fiber. Alternatively, these larger pieces could be drawn off and refrozen and re-introduced into the fracturing mills. The rubber crumb is then passed through a series of screens to sort the rubber crumb by mesh size, which is thence packaged for customer requirements.

Manufacturing

Our earlier activities focused primarily on the design and development of the original TCS Prototype, and, subsequently, on the completion of the design of a second generation version of this technology. In connection with these activities, we have been dependent upon arrangements with subcontractors for the manufacture and assembly of the principal components incorporated into a TCS System Plant. Pursuant to our signing of the exclusive manufacturing license agreement with Simpro, S.p.A., headquartered in Turin, Italy, as licensee (“Simpro”), all manufacturing activities of our company were then to be undertaken though Simpro. Under the exclusive arrangement, Simpro had the right of first refusal to any customer contract. Simpro and Tirex are currently reviewing the documentation for a contract renewal. In the event that Simpro refuses a contract offer or is unwilling to participate to the satisfaction of Tirex, Tirex has the option to seek alternate sources in the manufacture and installation of customer systems.

Simpro is a designer and manufacturer of high-technology production systems, primarily for the automobile industry, and is active internationally. Simpro has its ISO 9001, ISO 14001 and EMAS certifications. Simpro’s ability to offer us insurance-backed contract performance guarantees and to guarantee a minimum tire weight throughput on fabricated TCS systems, installed and commissioned as a turn key TCS Facility, were instrumental to our choosing Simpro as our manufacturing partner.

Patent Protection
We were issued a United States patent on our Cryogenic Tire Disintegration Process and Apparatus on April 7, 1998 (Patent No. 5,735,471). The duration of the patent is 20 years from the date the original application was filed. In November 1998, we filed our patent, for review, with the Canadian Patent Office. Canadian patent number 2193334 was granted on August 17, 2004. Canadian patents have a duration of seventeen (17) years. The US patent maintenance fee was paid in March 2010. However, the Canadian patent lapsed on December 18, 2007.

Prior to the issuance of our US patent, we relied solely on trade secrets, proprietary know-how and technological innovation to develop our technology and the designs and specifications for the TCS Prototype. The Company’s patents are free of liens. We do not presently hold any patents for our products or systems outside of the United States. We have lacked the financial resources to apply for a process patent on an international basis, but the Company intends to file for additional patent protection, in accordance with our Agreement with Simpro, should sufficient financial resources become available.

We have entered into confidentiality and invention assignment agreements with certain employees and consultants, which limit access to, and disclosure or use of, our technology. There can be no assurance, however, that the steps we have taken to deter misappropriation of our intellectual property or third party development of our technology and/or processes will be adequate, that others will not independently develop similar technologies and/or processes or that secrecy will not be breached. In addition, although Management believes that our technology has been independently developed and does not infringe on the proprietary rights of others, there can be no assurance that our technology does not and will not so infringe or that third parties will not assert infringement claims against us in the future. Management believes that the steps they have taken to date will provide some degree of protection to Tirex’s technology; however, no assurance can be given that this will be the case.

Employees
As of September 2010, we have three persons employed either directly or as consultants which act as the Company’s three executive officers. All three of these individuals devote their full time to our business and affairs, as required. At times, we also utilize the services of part-time consultants to assist us with market research and development and other matters. We could hire additional personnel, as needed, and as our financial resources permit.

F-3

---

Potential Markets
We believe that the potential markets for our TCS System will be directly affected by the level of demand for economical, high quality rubber crumb derived from the recycling of scrap tires. The following discussion of the potential markets for rubber crumb assumes that the TCS System will actually be capable of economically producing high quality recycled rubber crumb and in a variety of sizes, and capable of being used in wide range of products. Our manufacturing partner, Simpro, is prepared to offer tire throughput guarantees as a function of scrap tire weight. Simpro is also prepared to offer limited performance guarantees, backed by insurance policies.

Sales of TCS systems have been hampered by the devaluation of the U.S. dollar versus the Euro. Our manufacturing partner, Simpro, quotes system installations in Euros. When the manufacturing agreement was signed with Simpro, the US dollar and the Euro were fairly close to being at par with each other. In December 2010, one Euro was worth approximately U.S.$1.3230. This represents a large price increase for entrepreneurs.

Source of exchange rates is Pacific Exchange Rate Service http.www.fx.sauder.ubc.ca.

The manufacturing agreement with Simpro is essentially a right of first refusal agreement. In the event that Simpro would decide against accepting a specific fabrication and installation contract, for whatever reason Tirex has the right to engage any other supplier and/or sub-contractor to undertake the contract.

Rubber is a valuable raw material and we believe that recycling this valuable resource from scrap tires is an ideal way to recover that value. Recycled scrap tire rubber is already used in a great variety of products, promoting longevity by adding it to asphalt pavement, adding bulk and providing drainage as a soil additive, providing durability as a carpet under padding, increasing resiliency and enhancement in track and athletic surfaces, absorbing shock and lessening the potential for injuries as a ground cover for playgrounds and other recreational areas, and as a significant component added to plastic resins for making extruded or molded products. We are aware of significant recent developments in making finished products from crumb rubber compounded with plastic resins, particularly polypropylene. We believe that the potential for crumb rubber to substitute for either virgin or recycled plastic resins is very significant, given the relative market price for crumb rubber versus the commodity prices for such plastic resins.

Marketing Activities
Originally we concentrated our efforts on completing the design, development, and construction of our TCS Prototype and raising adequate financing to support such efforts. Our long-term objective, however, is to market TCS Systems worldwide, through national and international sales representatives, licensees or strategic partners. Pursuant to an extensive technical audit, our TCS Prototype permitted our company to be certified as an Accredited Tire Recycler by Recyc-Québec, a Quebec-governmental agency. Users of the TCS technology in Quebec could have access to tipping fees paid by Recyc-Québec, which currently work out to approximately US$0.85 per passenger car tire, based on current exchange rates. Management believes that this accreditation will be beneficial to our marketing efforts respecting our technology, not only in Quebec but elsewhere.

We can make no assurances with respect to the degree of success of our marketing and distribution strategy of our TCS Systems. Furthermore, we have limited resources to achieve the distribution of our TCS Systems and to date we have made no sales, leases or licenses. We believe that we may need additional financing, which may not be available, to achieve our long-term objectives.

Government Regulation
Insofar as the Company is not actually a tire recycler, government regulations have little direct effect on our activities. Of greater importance is the possible effect on our customers for the TCS technology. The TCS-System is a "closed loop" system which does not use any chemicals, solvents, gases or other substances which could result in noxious emissions of any kind from the operation of the Plant. The operation of a TCS-System will not result in the emission of any pollutants, the disposal of combustion residues, the storage of hazardous substances, or the production of any significant amounts of solid waste which would have to be land filled, which solid waste would not be classified as scrap tires.

F-4

---

Simpro has undertaken a formal environmental assessment of our technology using the comparatively stringent European standards, the results of which confirm these environmental assertions. However, the operation of a TCS System will involve, to varying degrees and for varying periods of time, the storage of scrap tires or tire pieces representing the feedstock to the System, and limited storage of crumb rubber prior to shipment to customers. Rubber, regardless of its physical dimensions or form, is widely defined as being a fire hazard by fire protection services in most industrially-advanced countries. As a result, many US states and Canadian provinces have either passed or have pending legislation regarding discarded tires including legislation limiting the storage of used tires to specifically designated areas. The regulatory environment of the European Union is already very stringent.

Operators of TCS Systems will therefore be subject to various local, state, and federal laws and regulations including, without limitation, regulations promulgated by federal and state environmental, health and labor agencies. Establishing and operating a TCS System for tire recycling will require numerous permits and compliance with environmental and other government regulations, on the part of our customers, both in the United States and Canada and in most other foreign countries. The process of obtaining required regulatory approvals may be lengthy and expensive for some customers of our TCS Systems. Moreover, regulatory approvals, if granted, may include significant limitations on operations. The US-EPA and comparable US state and local regulatory agencies, and similar government bodies in Canada and in other jurisdictions where TCS Systems will be marketed, for the most part, actively enforce environmental regulations and conduct periodic inspections to determine compliance with government regulations. Failure to comply with applicable regulatory requirements can result in, among other things, fines, suspension of approvals, seizure or recall of products, operating restrictions, and criminal prosecutions.

We believe that existing government regulations, while extensive, will not prevent customers of Tirex’s TCS System to operate profitably and in compliance with such regulations. In fact, we believe that restrictions on land filling and on combustion-based technologies will benefit our technology. While these regulations are usually stringent, the huge scrap tire problem must also be dealt with on a daily basis and the need for economic and environmentally friendly recycling operations is critical.

Additionally, the initiatives of the Obama Administration with respect to carbon reduction, and thus greenhouse gases, could have a significant positive impact on tire supply. Furthermore, the debate on the classification of scrap tires as fuel under the Clean Air Act (Article 112 versus Article 129) could also have a significant impact on scrap tire supply in that if the EPA would decide to apply Article 129, this would become a strong disincentive to TDF users.

Nevertheless, the burden of compliance with laws and regulations governing the installation and/or operation of TCS Systems could discourage potential customers from purchasing a TCS System. This would adversely affect our business, prospects, results, and financial condition. As a result, our business could be directly and indirectly affected by government regulations.

ITEM 1A. RISK FACTORS

Not required.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 2. PROPERTIES

Our corporate headquarters is located at Westport, Connecticut. We were previously located in Stratford CT. Prior to moving to Stratford, during Fiscal 2006, the Company occupied premises in a residential and office complex in Montreal. Prior to its residential and office complex location in Montreal, Tirex occupied an industrial building on 3828 St. Patrick Street in Montreal, where the TCS Prototype was located. After having accumulated very substantial arrearages in rent and property taxes, for which we were financially responsible, our former landlord instructed us to vacate these premises such that he could lease the space out to another lessee. As part of the settlement agreement with this former landlord, we agreed to pay to this former landlord the sum of US$560,000 out of the proceeds of the first four sales of TCS Systems, at the rate of U.S.$140,000 per system sold.

ITEM 3. LEGAL PROCEEDINGS

We are presently a party in the following legal proceedings:

F-5

---

     IM2 Merchandising and Manufacturing, Inc and David B. Sinclair v.
The Tirex Corporation, Tirex Corporation Canada, Inc., et al.

The Plaintiffs, a Canadian resident and a Canadian corporation, in March 2001, sued in the Delaware, U.S. Federal District Court claiming fraud, breach of contract, unjust enrichment and other allegations, that the Defendants, which include Tirex Corporation Canada and The Tirex Corporation, allegedly conspired to profit from their failure to comply with terms of a manufacturing agreement. The monetary demand of this complaint was unspecified. We were prepared to move to dismiss Plaintiffs' Complaint, but after consultations with the Plaintiffs' Attorneys, the Plaintiffs' withdrew this complaint voluntarily. Plaintiffs later filed a second action in the Chancery Court of Delaware alleging certain of the same allegations; fraud, breach of contract, unjust enrichment, breach of fiduciary duty and misrepresentation, but eliminated other counts including the securities fraud allegations. The Defendants in the State Court action are the same named in the Federal Court action, and again the monetary damages are unspecified. We moved to dismiss the State Court Chancery case alleging defective service of process and asserting that the Court had no jurisdiction over the Defendants in Delaware and for removal of the case to Canada based on forum non convenience and other considerations. Our motion was granted and the case dismissed.

Subsequently, on or about April 25, 2001, the Plaintiffs instituted a lawsuit in Superior Court, judicial district of Montreal alleging breach of contract and claims damages of CA$794,690 representing expenses and an additional Canadian$5,411,158 in loss of profits (court docket # 500-05-063730-021). Unlike the suit filed in the US Federal District Court in Delaware, there was no accusation of fraud. We have filed a detailed answer denying all liability, stating further that Plaintiffs failed to comply with their obligations. We believe we have meritorious defenses to all of the Plaintiffs' claims. The action is still pending.

There has been no activity relative to this suit for the last eight years.

Lefebvre Freres Limited v. The Tirex Corporation

Lefebvre Frères Limited instituted an action against us on August 13, 2001 in the Superior Court, judicial district of Montreal (court docket # 500-05-066942-010) claiming Canadian $98,513 is due and owing for the manufacturer and delivery of car tire disintegrators. We have prepared a defense and cross claim against Plaintiff as the product delivered was defective and included used parts in direct contravention of the supply agreement. We believe we are entitled to a reimbursement of sums paid.

There has been no activity relative to this suit for the last eight years.

Protection Incendie PyroSpec Inc. v. The Tirex Corporation

An action was instituted before the Court of Quebec, District of Montreal, by Protection Incendie PyroSpec Inc., which action was instituted on or about March 31, 2001, bearing docket number 500-22-055984-010. The Corporation did not defend the action and, as such, a judgment was rendered against it on or about August 8, 2001, by which judgment it was condemned to pay to the Plaintiff CA$28,442.83. Execution of judgment was attempted in 2002, without success. This matter has remained effectively dormant since February 7, 2002.

Tri-Steel Industries Inc. v. The Tirex Corporation

Our landlord Tri-Steel Industries Inc. instituted an action against us, and our subsidiaries Tirex Canada and Tirex Canada R & D Inc., on or about June 22, 2001 for arrears of rent in the amount of Canadian $177,973.62. Subsequent to the Plaintiff’s instituting this action, we continued to accumulate very substantial arrearages for rent and property taxes for which we were financially responsible. Subsequent to our vacating the premises which had been the object of the lease, we settled with our former landlord for a total amount of US$560,000, to be paid at the rate of US$140,000 from each of our first four TCS System sales.

No director, officer, or affiliate of the Company, or any associate of any of them, is a party to or has a material interest in any proceeding adverse to us.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

During the fiscal year ended June 30, 2009, the Corporation applied to the State of Delaware to increase its common share authorization from five hundred million shares to one billion, five hundred million shares. During the fiscal year 2008, the Corporation established a class of Preferred Shares, issuable in series on terms to be determined from time to time by the Board of Directors with a maximum preferred class authorization of one hundred million shares. See Report 8-K dated February 14, 2008. Series A Preferred Shares in a total of three million (3,000,000) shares was initially designated and subsequently issued to directors and officers. See Reports 8-K, dated May 16, 2008 and June 23, 2008. This designation was subsequently changed to fifteen (15) million shares, all 15,000,000 of which Series A Preferred Shares have been issued. These shares do not have a dividend attached, do have preference on residual assets in case of bankruptcy, are convertible into common shares at the rate of five common shares for each preferred share and have super-voting rights equal to 100 voting rights per share. These modifications to the Corporation’s share structure were ratified by shareholder vote during of fiscal 2009.

F-6

---

PART II

ITEM 5. MARKET FOR THE REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information
Our common stock is not traded on any exchange. The Company's common stock, under the trading symbol “TXMC”, is traded on a limited basis in the over-the-counter (“OTC”) market and, since January 2003, was listed on the Gray Sheets. In September 2008, we applied to FINRA for upgrading our listing to the Pink Sheets. This was accomplished. Following listing on the Pink Sheets, we filed amended returns in respect of those fiscal years and the Fiscal 2009 quarters and became fully-reporting. Our intention is to apply for re-listing on the the OTC Bulletin Board once we are in position to remain there with secured TCS Facility sale(s) resulting in a considerably better financial position.

Trading in stocks quoted on the Pink Sheets is often thin and is characterized by wide fluctuations in trading prices due to many factors that may have little to do with a company’s operations or business prospects. We cannot assure you that there will be a market for our common stock in the future.

Holders
As of March 1, 2011, the number of holders of record of the Company's common stock was approximately 670 according to our Stock transfer agent. The shareholders on the list who have changed does not include shares held by persons or companies in street or nominee name.

Dividends
The Company has paid no cash dividends and has no present plan to pay cash dividends, intending instead to reinvest its earnings, if any. Payment of future cash dividends will be determined from time to time by its Board of Directors, based upon its future earnings (if any), financial condition, capital requirements and other factors, the company is not presently subject to any contractual or similar restriction on its present or future ability to pay such dividends.

Equity Compensation Plans
As of October 11, 2010, we did not have any equity compensation plans except for executive stock options provided to the three executives of the Company as part of their executive employment agreements as further described under Item 11 (Executive Compansation).

Recent Sales of Unregistered Securities
During the fiscal year ended June 30, 2009, we did not complete any unreported sales of our equity securities that were not registered under the Securities Act.

ITEM 6. SELECTED FINANCIAL DATA

Not required.

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our consolidated financial statements for the fiscal year ended June 30, 2009, including the notes thereto, appearing elsewhere in this Annual Report. The discussion of results, causes and trends should not be construed to imply any conclusion that these results or trends will necessarily continue into the future.

Overview and Business Events

F-7

---

Tirex's primary objective is to sell its patented and proprietary tire recycling process, called the TCS System, to tire recyclers throughout the world (www.tirex-tcs.com). In March 2000, we announced that our TCS technology prototype was ready for replication and commercialization. The intellectual property owned by Tirex comprises both the patented "Fracturing Mill" (both US and Canadian patents) plus the proprietary freezing process of using super-cooled air (rather than the competitions’ liquid nitrogen process-- which we believe employs expensive “overkill” in terms of what is required to freeze tire chips) to freeze the tire chips to the "glass point," which permits the effective separation and disintegration of the tire components by our patented "fracturing mill", producing a semi-cryogenic crumb rubber at a significant cost savings. The intellectual property of our TCS System process is recognized in the Manufacturing License Agreement (2003) that we are currently renegotiating with Simpro S.p.A. (Simpro), headquartered in Torino, Italy http://www.simpro.it/home.php?argid=49&pagid=18&lang=en. Simpro had a semi-exclusive manufacturing license to manufacture the TCS System to the extent that they have a right of first refusal for the fabrication, installation and commissioning of any TCS system anywhere in the world, with the exclusivity lost on a case-by-case basis in those circumstances where they would elect to not accept an order, under which circumstances Tirex has the right to contract the same services to other companies. Our patent renewals and continuation for both the USA and Canada were documented in 2005 and renewed again in March 2010 for the *US patent.

In 2001 Tirex's TCS System tire recycling prototype was accredited by Recyc-Québec, the provincial recycling agency in Montreal, Quebec, Canada, as an economically viable and environmentally-friendly process that produced quality recycled rubber. While numerous Letters of Intent were signed during this early stage, none materialized into firm purchase contracts. Management attributed these failures to acquire sales contracts to the lack of a commercial history for the TCS technology, or alternatively, to the Company's inability at the time to provide performance guarantees. With the signing of the License Agreement with Simpro we engaged a reputable, highly accredited manufacturer which created the potential to offer performance guarantees. The TCS System prototype was disassembled and the Fracturing Mill was sent to Simpro's facility in Italy. Simpro is prepared to build the first commercial TCS System. However, as of February 2011, no purchase/sale contracts have been written.

Tirex has continued with its marketing structure consisting primarily of Tirex's President, John L. Threshie Jr., assisted by the Company’s Chief Financial Officer, Michael Ash, combined with Simpro's significant marketing and sales efforts, as well as independent representatives. We are also renegotiating Simpro’s non-exclusive marketing agreement applicable on a worldwide basis. Tirex continues to entertain requests for marketing agreements on several continents, but adheres to its policy of offering commissions out of sales proceeds only, and not providing exclusivities in the absence of prior-established results.

The lack of a commercial track record relative to the operation and output of the TCS System has proven to be a difficult hurdle to overcome in realizing TCS System sales. The installed cost of a TCS-2 System to a recycler, depending on the system configuration, the condition of the feedstock and the output requirements and excluding building and infrastructure costs, is in the vicinity of Euros 5,500,000 (approximately US$7.89 million at prevailing exchange rates), depending on the extent of automation requested by the customer. When one adds infrastructure costs, pre-production expenses and a reasonable provision for working capital after system commissioning, we are of the opinion that the entrepreneur has to consider his gross investment cost (prior to debt financing possibilities) to be in the vicinity of US$9 million to $10 million, depending on the customs duties which could be imposed on US and Canadian customers respecting the importing of products from non-NAFTA countries. US$9,000,000 or more represents a substantial investment for a start-up company. Simpro has been able to obtain insurance backing to support their offer of limited performance guarantees, and such potential is expected to assist the marketing effort. Simpro is now offering limited feedstock throughput guarantees on a case by case basis.

Market and sales efforts of the TCS System continues to evolve and has attracted the interests of qualified and capable companies over the past year. During Fiscal years 2009 and 2010, the Company and Simpro have entertained numerous potential TCS System customers. Out of these developments, several opportunities have presented themselves that have merited and continue to merit the expenditure of considerable time and effort to attempt close on a Purchase and Sales Agreement. Tirex and Simpro continue to pursue sales efforts in Europe, the US and Canada.

The 2009 New York negotiations ended due to terms and conditions that Tirex’s management concluded were not satisfactory to Tirex and its shareholders.

Simpro’s signing of a Memorandum of Understanding in 2009 for a US$20.8 million TCS Facility with Exchangtech in Malaysia continues to experience delays in reaching a definitive agreement due to financing facilities involved in the entire industrial project as reported by Simpro management.

Simpro’s management also reported in 2009 that the patented ‘fracturing mill’ parts of the TCS technology is 75% complete but remains on hold in the Brazilian factory until further developments. Simpro and Tirex also pursued opportunities in Brazil where the production of crumb rubber would be linked to products for the railroad and synthetic turf industries. Management has since learned that the use of ambient crumb, as opposed to Tirex’s semi-cryogenic crumb, was chosen for the synthetic fields because it was less expensive.

F-8

---

Our listing on the Internet Recycling Exchange will be renewed when our crumb becomes available. Our web site www.tirex-tcs.com continues to generate inquiries from all over the world. We believe that these enquiries confirm the interest for our new technology in the industry. These opportunities may not conclude, however, until there is a commercial system in operation and regardless of Management's optimism there can be no assurance that these opportunities will actually result in unconditional sales contracts.

The finalizing and potential renewal of the License Agreement with Simpro requires that the gross revenues from sales will be recorded on Simpro's books, not in the books of Tirex, unless Simpro would refuse the proposed contract. The revenue remitted back to Tirex will take the form of royalty payments and will be accounted for as such. Regardless of the contract structure and the accounting effects which result, generally accepted accounting principles in effect in the USA have the effect that the revenues to Tirex resulting from such transactions will not be recognizable until the systems will have been accepted by the customers. Given the time line required to manufacture, install and have accepted these systems, it is unlikely that any revenues would become recognizable during the fiscal year ending June 30, 2010. While the Company will benefit from the periodic cash inflows resulting from progress payments during the next approximately ten months, the royalty will, in fact, not have been earned until the systems are accepted by the customers.

In the third and fourth quarters of fiscal 2008 and continuing into fiscal 2009, management undertook a restructuring of the corporation. This was engaged because management believed (and still does) that the structure of the Tirex was creating an impediment to marketing efforts. We engaged the services of the Otto Law Group (Seattle WA) to assist us in the restructuring of our position. Their services are being remunerated in shares of the corporation. We also engaged the services of Legacy Trading and their affiliate company, Southern Capital Consulting, based in Oklahoma, to consult us in getting our shares listed first back onto the Pink Sheets with the goal of being re-listed onto the Bulletin Board. These services are also being remunerated by means of a share issuance. In order to be eligible for re-listing on the Bulletin Board, the Corporation is required to file audited financial statements and remain current in all of its required public filings for 12 months, and thereafter to maintain eligibility. The statements of the Corporation had not been audited since the fiscal year ended June 30, 2004. We engaged the services of Moore & Associates (Las Vegas) to undertake the audit of our accounts for the years 2004 through 2007 with a continuation for the fiscal year 2008. These audits were completed and amended filings were made. We also filed amended 10-Q reports for the periods ended December 31, 2008 and March 31, 2009, with the result that we are now fully-reporting.

In the course of this restructuring, debts to officers, directors and consultants were converted in whole or in part to equity through the issuance of shares. Part of this was accomplished through the auspices of Sequoia International which accepted assignment of $100,000 of executive accrued salaries in exchange for 100 million shares, a transaction approved by a Florida court. This transaction also provided for the creation of funding for Tirex in its restructuring efforts. Third party liabilities were examined and deleted as permitted by US and Canadian law (the term in Canada is “prescription”, in the USA “Statute of Limitations”). Management is of the opinion that the measures undertaken in the last half of fiscal 2008 and continuing into fiscal 2009 will be beneficial to the development of the Corporation.

In August 2009 we were advised that Moore & Associates’ registration with the PCAOB had been revoked and that they were thus abandoning audit services of public companies. We were advise that they had transferred it audit clients and staff to Seale & Beers. We immediately attempted to engage this firm, given a long-standing ongoing relationship with the audit technician from Moore, who was engaged by Seale & Beers, to continue with our independent accounting services. Seale & Beers thence declined to perform the audit, citing a lack of international resources to verify our assets currently located in Italy. On September 16, 2009, the Board of Directors approved the appointment of M&K, CPA’s. located in Houston, Texas, to undertake the audit of our accounts. An 8-K was filed noting this change in certifying accountant. Management asserts that there were no disagreements respecting accounting principles, auditing standards, auditing practices or any other professional issue with Moore & Associates. Management further asserts this it had had no contact with M&K, CPA’s in the two years prior to their engagement, other than the most recent discussions and negotiations in September 2009 to engage their services. The revocation of the registration of Moore with the PCAOB meant that fiscal 2008 had to be re-audited such that M&K could provide standard format audited financial statements for fiscal 2009 with comparative data for fiscal 2008.

In December 2009 Tirex engaged Capital Business Brokers (“CBB”) with an exclusive 3 month financing agreement to raise capital for TCS facilities and $50,000 working capital. CBB’s contract subsequently expired with no results.

F-9

---

In June 2010 the Board of Directors approved the engagement of Boysen Consulting (“Boysen”), a North American tire recycling expert, to augment TCS marketing efforts.

Previous and Current Financings

In February of 2001, we concluded a private financing with an investor group. Under the terms of the Agreement, we had the contractual right to require the Investor to purchase up to US$5,000,000 of put notes. We drew down US$750,000 of this amount and used the proceeds of this financing toward legal and consulting fees due, normal operating expenses such as payroll, rent and taxes and the acquisition of equipment for our prototype TCS-1 Plant. In July of 2001, the Company entered into a technical default with respect to the Agreement by not having an SB-2 Registration Statement declared effective by the SEC. After several months of negotiations, the Company entered into a Settlement Agreement with the Investor Group which provided for a cash pay down of the amount owed, including interest and penalties over a period of approximately two years starting with the date the Settlement Agreement was signed, the right of the Investor Group to continue to be able to sell up to 600,000 collateral and Rule 144 shares per month and the issuance of three series of warrants, 500,000 each, exercisable at prices of one cent, five cents and ten cents over a three year period. This Settlement Agreement was announced in April of 2002, and details of the terms of the Agreement are filed on Edgar. The Company, in the absence of having completed its first sales of TCS Systems according to our expectations, was unable to generate the cash flow necessary to pay down the Convertible Note in accordance with the terms of the Settlement Agreement. Thus, the Company once again found itself in a position of default. Numerous recourses are available to the holders of the Convertible Notes, but to date, these recourses have not been exercised. Such recourses can be exercised at any time and the fact that they have not been exercised so far does not preclude their being exercised now or in the future. The Company has kept the Convertible Note holders apprised of its efforts to sell TCS Systems and thus restart the repayments on the Convertible Notes.

Since Fiscal year 2006, the expenses of the Company have been funded by a series of non-interest bearing convertible loans with no specific terms of repayment made by a significant number of individuals investing modest amounts for a grand total of U.S.$264,400. These investors, fully cognizant of the Company’s situation and so documented in writing, accepted that their investments were being made and represented by a convertible debt, the conversion of which could occur only once the Company would have shares available for issuance. These debts are convertible at fixed prices rather than as a discount to market.

The shares referred to in the above table were mostly issued, unrestricted, during the Fiscal years 2009 and 2010.

We expect that some portion of our future overhead costs, which may be significant, will continue to be covered from sources other than commercial revenues. Since March of 2003, our monthly our-of-pocket cash costs were reduced to minimal amounts.

Our greatest expense, from an accounting standpoint, is for salaries. These salaries have not been paid for over seven years, but rather set up as payables. A portion of these payables has been converted to equity through the issuance of common stock. The company intends to continue this process to convert recorded liabilities into equity. Our cash flow deficit condition will continue until such time as the Company will start generating revenues from the sale of TCS Systems. Until we can succeed in securing an unconditional sales contract for the sale of one or more systems employing our technology, the company will not be engaging any significant financial commitments and will not be engaging in any significant research and development activities nor increasing employment.

While we continue to market TCS Systems and have in place the Simpro License Agreement, as of June 30, 2009, no unconditional sales orders for TCS Systems had been received and manufacturing of TCS Systems has not been initiated. We anticipate that we will begin selling or licensing out the sale of TCS Systems and thus initiating the manufacturing of these systems on a commercial basis inevitably as long as there is a demand for new recycling technology. Until we successfully develop and commence TCS System manufacturing and sales operations on a full-scale commercial level, however, we will not generate significant revenues from operations. Accordingly, we would be obligated to attempt to seek non-commercial sources of revenues to support operations until TCS Systems sales and manufacturing operations would become a reality. In the event of such a circumstance, there can further be no assurance that such non-commercial revenue funding would be available at all or on terms acceptable to management. Except for research, development and sales and marketing activities related to the recycled crumb rubber industry, as noted above and in previous filings, we have never engaged in any other significant business activities.

F-10

---

During the first quarter of Fiscal 2007, Tirex completed the negotiation of the employment agreements with respect to Tirex CEO and President, John L. Threshie Jr., Tirex Vice President Engineering and Research and Development, Louis V. Muro and Tirex Secretary-Treasurer and Chief Financial Officer, Michael Ash. These versions were ratified by all respective parties. Under the terms of these agreements, Mr. Threshie’s salary was augmented to US$150,000 retroactive to July 1, 2002 while Mr. Muro’s salary was reduced retroactively to July 1, 2002 to US$75,000. The salary of Mr. Muro was subsequently reinstated at $150,000, effective July 1, 2008, on a retroactive basis. The salary of Mr. Ash remained unchanged at US$100,000. Also under the terms of the agreements, Mr. Threshie received an option to acquire 3,000,000 shares of the corporation at the beginning of each year of his three-year agreement, the effective inception date being July 1 2007. Similarly, Mr. Muro received options to purchase 1,000,000 shares per year. Mr. Muro’s employment was also effective July 1, 2007. Other than for the number of shares involved, Mr. Muro’s options proposed agreement are identical to that of Mr. Threshie. As for Mr. Ash, his three-year employment agreement was be effective January 1, 2007 and provided for him to acquire 2,000,000 shares of Tirex in each of the three years of his contract. In all cases, the exercise window is three years. These options could be exercised on a cashless basis and are described in more detail elsewhere in this report.

Liquidity and Capital Resources

As of June 30, 2009, the Company had total assets of $1 as compared to $1 at June 30, 2008 reflecting a change of $0. There was no change in the value of Patents from June 30, 2008 to June 30, 2009. There were no other changes in the value of individual assets from June 30, 2008 to June 30, 2009.

As of June 30, 2009, the Company had total liabilities of $4,981,442 as compared to $7,507,611 at June 30, 2008, reflecting a decrease in liabilities of $2,526,169. The decrease in total liabilities from June 30, 2008 to June 30, 2009 is primarily attributable to: (i) a decrease in Accounts Payable and Accrued Liabilities in the amount of $201,845 from $1,742,273 as of June 30, 2008 to $1,540,428 as of June 30, 2009, (ii) a decrease in Accrued Liabilities-Related Parties in the amount of $822,373 from $2,357,021 as of June 30, 2008 to $1,534,648 as of June 30, 2009, (iii) a decrease in Notes Payable-Related Party in the amount of $162,500 from $162,500 as of June 30, 2008 to $0 as of June 30, 2009, (iv) a decrease in Convertible Notes-Non-Related Parties in the amount of $244,500 from $920,245 as of June 30, 2008 to $675,745 as of June 30, 2009, and (v) a decrease in Derivative Liability in the amount of $1,094,951 from $2,325,572 as of June 30, 2008 to $1,230,621 as of June 30, 2009.

Reflecting the foregoing, the financial statements indicate that as at June 30, 2009, the Company had a working capital deficit (current assets minus current liabilities) of $4,981,442 and that as at June 30, 2008, the Company had a working capital deficit of $7,507,611, a working capital deficit decrease of $2,526,169. There were no changes in current assets, as noted above, while there were reductions to current liabilities.

The financial statements, which are included in this report, reflect total operations and other expenses of $636,938 and a gain on change in the value of the derivative liability of $1,094,951 for the year ended June 30, 2009, which reflects a decrease in total operations and other expenses of $386,790 and a decrease in the gain from the change in the value of the derivative liability of $2,811,115 over the year ended June 30, 2008. The Company has ceased Research and Development activities thereby resulting in a significant decrease in personnel expenses and other Research and Development expenses compared with prior periods.

The success of the tire recycling manufacturing business and the ability to continue as a going concern will be dependent upon the ability of the Company to obtain adequate financing to commence profitable, commercial manufacturing and sales activities and the TCS Systems’ ability to meet anticipated performance specifications on a continuous, long term commercial basis.

The Company believes that the amounts accrued to date in respect of the shares issued to compensate the executive officers and consultants reflect the fair value of the services rendered, and that the recipients of such shares received such shares at an appropriate and reasonable discount from the then current public market price. The Company believes that the discount is warranted due to the fact that there are often restrictions on the transfer of said shares arising out of the absence of registration, and the uncertainty respecting our ability to continue as a going concern.

F-11

---

From inception (July 15, 1987) through June 30, 2009, the Company has incurred a cumulative net loss of $32,557,086. Approximately $1,057,356 of such cumulative net loss was incurred prior to the inception of the Company’s present business plan, in connection with the Company’s discontinued proposed health care business and was due primarily to the expending of costs associated with the unsuccessful attempt to establish such health care business. The Company never commenced the proposed health care operations and therefore, generated no revenues there from.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not required.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Our consolidated financial statements required to be included in this Annual Report pursuant to Item 310(a) of Regulation S-X, are included under Item 15.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

Following the end of Fiscal 2009, our former independent certifying accountant informed us that he was abandoning all SEC-oriented work because their registration with PCAOB had been revoked. Moore & Associates transferred all of their audit clients and audit staff to Seale & Beers. We immediately proposed to engage the services of this firm. The resignation of our former certifying accountant was not related in any way to any disputes respecting the Company’s accounting or its financial disclosures to shareholders or other interested parties. Seale Beers declined the audit on the basis that they did not have the resources for auditing assets located offshore. Their resignation was accepted on September 5, 2009. On September 16, 2009, the directors of the Corporation approved the appointment of M&K CPAS, PLLC (Houston, Texas) to undertake the audit of our fiscal 2009 accounts, The were never any disagreements of any nature with Seale & Beers.

ITEM 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) and Rule 15d-15(e) promulgated under the Securities Exchange Act of 1934 (the "Exchange Act"), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

As of the end of the period covered by this report, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures. Based upon this evaluation, and the material weaknesses outlined in our Management Report on Internal Control Over Financial Reporting, our management concluded that our disclosure controls and procedures were not effective to ensure that information we are required to disclose in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information was not accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Management Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining effective internal control over financial reporting. Under the supervision of our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of June 30, 2009 and 2008 using the criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. In our assessment of the effectiveness of internal control over financial reporting as of June 30, 2009 and 2008, we determined that there were control deficiencies that constituted material weaknesses, as described below.

F-12

---

1.	Certain entity level controls establishing a “tone at the top” were considered material weaknesses. We have not established an audit committee. We do not have a formal policy on fraud.
2.	Management override of existing controls is possible given our small size and lack of personnel.
3.	We do not have a system in place to review and monitor internal control over financial reporting. We maintain an insufficient complement of personnel to carry out ongoing monitoring responsibilities and ensure effective internal control over financial reporting.

Management is currently evaluating remediation plans for the above control deficiencies.

In light of the existence of these control deficiencies, we concluded that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis by our internal controls.

As a result of the material weaknesses described above, management has concluded that we did not maintain effective internal control over financial reporting as of June 30, 2009 and 2008 based on criteria established in Internal Control—Integrated Framework issued by COSO.

Changes in Internal Control

During the fiscal quarter ended June 30, 2009 there were no changes in our internal control over financial reporting (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act) that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION

None.

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Directors and Executive Officers

The following sets forth, as of June 30, 2009, the name age, office held and the terms of said office held of our directors and executive officers. Each director will hold office until the next annual meeting of shareholders and until his or her successor has been elected and qualified:

	Offices		Term of
Name	Age	Held	Office
John L. Threshie, Jr.	56	Chairman of the Board of Directors, President, and Chief Executive Officer	November 1999 - present
		Director	June 1995 - February 1999
		Vice President	June 1995- November 1999
		Secretary	December 1996 February 1999
Louis V. Muro	77	Vice President of Engineering and Director	January 1996 - present
		President	March 1994 - January 1995
		Director	December 1992 - Present
Henry Meier	53	Director	Feb. 11, 1999 to present
Michael D.A. Ash	60	Secretary, Treasurer, and Chief Financial and Accounting Officer	February 1999- present

F-13

---

Significant Employees
Other than our executive officers, we have no employees that make a significant contribution to our business.

Family Relationships
There are no family relationships among our directors or executive officers.

Legal Proceedings
None of our directors, executive officers, promoters or control persons has been involved in any of the following events during the past ten years:

• any bankruptcy petition filed by or against any business of which such person was a general partner or executive officer at the time of the bankruptcy or within two years prior to that time;
• any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offences);
• being subject to any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining or otherwise limiting his involvement in any type of business, securities or banking activities;
• being found by a court of competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been subsequently reversed, suspended or vacated;
• any judicial or administrative proceedings resulting from involvement in mail or wire fraud or fraud in connection with any business activity;
• any judicial or administrative proceedings based on violations of federal or state securities, commodities, banking or insurance laws and regulations, or any settlement to such actions; or
• any disciplinary sanctions or orders imposed by a stock, commodities or derivatives exchange or other self-regulatory organization.

Section 16(a) Beneficial Ownership Compliance Reporting
Section 16(a) of the Exchange Act requires our directors, executive officers and persons who own more than 10% of our common stock to file reports regarding ownership of, and transactions in, our securities with the SEC and to provide us with copies of those filings. Based solely on our review of the copies of such forms received by us, or written representations from certain reporting persons, we believe that, during the fiscal year ended June 30, 2009, our directors, executive officers and 10% stockholders complied with all applicable filing requirements.

Code of Ethics
We have not yet adopted a code of ethics that applies to our Chief Executive Officer, Chief Financial Officer or persons performing similar functions because we have not yet finalized the content of such a code.

Board of Directors Committees

F-14

---

The Board of Directors has no standing committees.

Nominating Committee
We do not have a nominating committee and we have not undertaken any material changes to the procedures by which security holders may recommend nominees to our Board of Directors since our last Annual Report on Form 10K.

Business Experience
The following summarizes the occupation and business experience during the past five years for each director, executive officer and significant employee of the Company. A significant employee is a person who is not an executive officer of the Company but who is expected to make a significant contribution to the business of the Company.

JOHN L. THRESHIE, JR. Mr. Threshie has served as President and Chief Executive Officer of the Company since November of 1999. Prior to that time he served as a Vice President of the Company since June 1995. He was appointed Assistant Secretary of the Company on February 11, 1999. From December 1996 until February 11, 1999, Mr. Threshie held the position of Secretary, and from June 1995 until February 11, 1999, as a Director, of the Company. He also served as a Director for The Tirex Corporation Canada Inc. and Tirex Canada R&D Inc. from June 1998 and June 1995, respectively, until February 11, 1999. He has more than 30 years of experience in the areas of management, marketing and sales including 13 years developing and marketing a new technology in the recycling industry with Tirex. Mr. Threshie holds a Bachelor’s Degree in Political Science from the University of North Carolina. He was employed as an insurance and financial broker by Primerica Financial Services from 1991 through 1994. From 1988 to 1990, Mr. Threshie was an advertising account supervisor for Ammirati & Puris Inc., an advertising firm in New York. From 1983 to 1988 Mr. Threshie was employed as a senior account executive at the advertising firm of Saatchi and Saatchi, Inc. From 1979 to 1983 Mr. Threshie was employed by Milliken & Co. as a sales representative.

LOUIS V. MURO. Mr. Muro acted as an engineering consultant to the Company from January 18, 1995 until January 1, 1996 when he was appointed as a Director and as Vice President in charge of engineering. Mr. Muro served as a Director of the Company from December 29, 1992 until January 18, 1995. He also served as the Company's Secretary from December 29, 1992 until March 1994 when he was appointed President of the Company, a position he held until January 18, 1995. He has also served as the Vice President in charge of engineering and as a director of The Tirex Corporation Canada Inc. and Tirex Canada R&D Inc. since June 1998 and May 1995 respectively. Mr. Muro received a B.S. degree in Chemical Engineering from Newark College of Engineering in 1954, since which time he has continually been employed as a chemical engineer. From 1974 to 1993 Mr. Muro has been the sole proprietor of Ace Refiners Corp. of New Jersey, a precious metals refinery. From 1971 to 1974, he worked as an independent consultant and from 1964 until 1971, he was director of research and development for Vulcan Materials Corporation in Pittsburgh, Pa., a public company engaged in the business of recovering useable tin and clean steel from scrap tin plate. From 1960 to 1964, Mr. Muro was the sole proprietor of Space Metals Refining Co. in Woodbridge, NJ, a company involved in the purification of scrap germanium to transistor grade metal. From 1959 to 1960 he was employed by Chemical Construction Co., of New Brunswick, NJ, where he developed a process for the waste-free production of urea from ammonia, carbon dioxide and water. From 1954 to 1959, Mr. Muro worked in the research and development department at U.S. Metals Refining Co. in Carteret, NJ where he was involved with the refinement of precious metals.

MICHAEL D.A. ASH. Mr. Ash joined the Company on January 11, 1999. On February 11, 1999, Mr. Ash was appointed Secretary, Treasurer, and Chief Financial and Accounting Officer of the Company. Mr. Ash graduated with a Bachelor's Degree in Business Administration, Magna Cum Laude, from Bishop's University in Quebec in 1970, and with an MBA, With Distinction, from Harvard Business School in 1975. Mr. Ash received his Chartered Accountant certification, (Canadian equivalent to a CPA) in 1972 while employed by Coopers & Lybrand (now Price Waterhouse Coopers). Mr. Ash voluntarily abandoned his C.A. designation following the ENRON and WorldCom incidents, being no longer willing to certify financial statements nor to incur the very expensive professional insurance costs associated with professional private practice as a sole practitioner. As such, the annual professional fees were no longer justifiable. Since graduation from Harvard, Mr. Ash spent a large portion of his career with the Government of Canada, until early 1999 when he joined Tirex, first with the Office of the Comptroller General in Ottawa and, for the subsequent eighteen years, with a federal regional economic and industrial development agency in Montreal where he gained exposure to a very large number of companies and industrial sectors, ranging from developmental companies to major multi-national corporations. For ten years during this time period, Mr. Ash was also a part-time lecturer in accountancy at Concordia University in Montreal for students registered in the program leading to the Chartered Accountancy designation.

Compliance With Section 16(a) of the Exchange Act.

F-15

---

     None of the securities have been registered pursuant to Section 12 of the Exchange Act of 1934, as amended (the "Exchange Act"). Therefore, Section 16(a) of the Exchange Act is not applicable.

ITEM 11. EXECUTIVE COMPENSATION

Current Remuneration

The following table sets forth information concerning the annual compensation received or accrued for services provided in all capacities for the fiscal years ended June 30, 2007, 2008 and 2009 by our Chief Executive Officer and all our executive officers serving as such as at June 30, 2009 or at any time during the year ended June 30, 2009. Future announcements concerning us, our competitors, results of testing, technological innovations or new commercial products may have a significant impact on the market price of our common stock. We believe that, as of the dates when such shares were issued, the actual market value of such shares was, and as of the date hereof remains, highly contingent upon, and subject to, extremely high risks.

The employment agreements of all of the above persons were re-negotiated during the second quarter of Fiscal 2007. The primary focus of the negotiations was on salary and options in all three cases. In the case of Mr. Threshie, his salary was be increased from U.S.$125,000 to U.S.$150,000 retroactive to July 1, 2002. In the case of Mr. Muro, his salary was reduced from U.S.$150,000 to U.S.$75,000 also effective July 1, 2002. His former salary of U.S.$150,000 was re-instated during the fourth quarter of Fiscal 2009, retroactive to July 1, 2008. Mr. Ash’s salary remained unchanged at U.S.$100,000. Under the terms of these three employment agreements, all three persons received stock options with three-year exercise windows to acquire Tirex shares, with the possibility of a cashless exercise. These annual options for Mr. Threshie, Mr. Ash and Mr. Muro imply 3,000,00 shares, 2,000,000 and 1,000,000 shares respectively. All exercises are subject to share structure modifications such as stock splits and reverse splits on a proportional basis.

(1)

No compensation was paid in cash to Messrs. Threshie, Muro and Ash during Fiscal 2008 and 2009. The amounts due have been recorded as liabilities of the Company. However common shares have been issued to all three persons in partial payment of salaries due. During fiscal 2008, Tirex assigned $100,000 of accrued salaries to each of Messrs. Threshie and Ash to Sequoia International in exchange for a Florida court approved issuance of 100 million shares. The Settlement Agreement was made under Paragraph 10(a)3 of the Securities Act. During fiscal 2009, Tirex issued shares in lieu of salary and expenses to its executive officers. As of October 2, 2008, Mr. Threshie had 47,528,721. As of September 25, 2009, he had 82,919, 925 million shares. On October 2, 2008, Mr Muro had 32,853,991 shares. On September 25, 2009, he had 77,428,344 shares (including 1,723,514 replacement collateral shares). On October 2, 2008 Mr. Ash had 30,805,000 shares, including held by his wife, two adult children and his family trust. On September 25, 2009, he had 62,355,000 shares, including shares owned his wife, two adult children and the family trust. Mr. Joe Sanzaro (brother of deceased former director, Lou Sanzaro). 1,500,000 shares were issued to Michael Ash in respect to stock options exercised but unpaid.

Executive Stock Options

F-16

---

As discussed elsewhere in this Annual Report, the following is a summary of those stock options and warrants outstanding or proposed to be outstanding, with respect to the purchase of the common stock of the Company:

Beneficiary	Issuable	Exercise Window	Price
John L. Threshie Jr.	3,000,000 share options at the beginning of each of Fiscal Years 2008, 2009 and 2010	Three (3) years from date of issue	Year 1: lesser of 20 cents or 50% of market Year 2: lesser of 40 cents or 50% of market Year 3: lesser of 50 cents or 50% of market
Michael Ash	2,000,000 share options at the beginning of each of Calendar Years 2007, 2008 and 2009	Three (3) years from date of issue	Year 1: lesser of 20 cents or 50% of market Year 2: lesser of 40 cents or 50% of market Year 3: lesser of 50 cents or 50% of market
Louis V. Muro	1,000,000 share options at the beginning of each of Fiscal Years 2008, 2009 and 2010	Three (3) years from date of issue	Year 1: lesser of 20 cents or 50% of market Year 2: lesser of 40 cents or 50% of market Year 3: lesser of 50 cents or 50% of market

In September 2008, Mr. Threshie, Mr. Ash and Mr. Muro issued their notices of exercise of 12,000,000 options on a cashless basis, relating to the Fiscal years 2008 and 2009. In August 2009, Mr. Threshie, Mr. Ash and Mr. Muro exercised their remaining 6,000,000 options on a cashless basis, relating to the Fiscal year 2010. Thusfar, common shares have been issued to Mr. Threshie, Mr. Ash and Mr. Muro relating to the exercise of their stock options for the Fiscal year 2008. These shares were issued in the Fiscal year 2009.

Employment Agreements
We seek to maintain employment agreements with all of our executive officers (the "Executive Agreements"). We currently have an employment agreement with Mr. Threshie that provides for an annual salary of $150,000 until June 30, 2010. Mr. Threshie also has options, as noted above, to purchase shares of the Company. Mr. Threshie was granted options to purchase 3,000,000 shares at each anniversary date of his Employment Agreement for the three years following the effective date of his employment contract, and, for each series of options, would have a three-year period to exercise that option. The options are exercisable at the lesser of 50% of market and 20(cent) for the first year, 40(cent) for the second year and 50(cent) for the third year. We currently employ Mr. Muro on a month-to-month basis, based on a revised annual salary of $150,000, retroactive to July 1, 2008. Mr. Muro’s salary had been reduced to $75,000 retroactively to Fiscal 2002, but was re-instated to $150,000 effective July 1, 2008. Mr. Muro also has share options which, other than for the number of shares implicated, are identical to the options of Mr. Threshie. In Mr. Muro’s case the number of shares is 1,000,000 shares annually. Under the employment agreement with Mr. Ash, he is due an annual salary of $100,000 and he has been given stock options to acquire 2,000,000 shares in each of the three calendar years of his agreement, which ends December 31, 2009.

All of the above agreements provide for the payment of bonuses at the sole discretion of the Board of Directors based upon an evaluation of the executive's performance, with payment of any such bonuses to be reviewed annually. The Executive Agreements also provide for the participation by each of the foregoing persons in any pension plan, profit-sharing plan, life insurance, hospitalization or surgical program, or insurance program hereafter adopted by us, reimbursement of business related expenses, the non-disclosure of information which we deem to be confidential to it, non-competition by the executive with us for the one-year period following termination of employment with us and for various other terms and conditions of employment.

The Executive Agreements with Messrs. Threshie, Muro and Ash also include severance provisions which provide, among other things, for severance compensation in the event that the employment of the executive is terminated by us other than for cause, or by the executive for "good reason", as that term is defined in the Executive Agreements, or pursuant to a change in control of the Company, for which the severance terms, under certain circumstances, as described below, could be different. The various Executive Agreements provide for severance compensation, as follows:

F-17

---

In the case of Messrs. Threshie, Muro and Ash, 200% of the amount of the base salary for a period of twelve months, except that in the event of a termination following a hostile takeover of the Corporation, the termination is 300%. In addition, the amount of severance compensation for termination other than for cause, or by the executive for "good reason", as that term is defined in the Executive Agreements, or pursuant to a change in control of the Company, amounts to the compensation as described above plus two months of base salary for each year of service, either under an employment agreement or under a consulting agreement.

Because of the early stage of our development, our lack of operations and insignificant cash flow, since January 18, 1995, we have not had the resources to meet fully our financial obligations under the Executive Agreements. As a result, a major portion of compensation which has been available to our executive officers has consisted of shares of our common stock, which such individuals accepted, in lieu of cash compensation, for a substantial portion of salary and/or consulting fees due to them.

Pension, Retirement or Similar Benefit Plans
There are no arrangements or plans pursuant to which we provide pension, retirement or similar benefits to our directors or executive officers.

Compensation Committee
We currently do not have a compensation committee of the Board of Directors or a committee performing a similar function. It is the view of the Board of Directors that it is appropriate for us not to have such a committee because of our size and because the Board of Directors, as a whole, determines executive compensation.

Compensation of Directors
The Directors of the Company were not compensated for their services during the fiscal year ended June 30, 2009. We have no standard arrangement pursuant to which our directors are compensated for their services in their capacity as directors.

ITEM 12 SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth information as of March 1, 2011, with respect to the persons known to the Company to be the beneficial owners of more than 5% of the common stock, $.001 par value of the Company and of more than 5% of the Class A Common Stock of the Company's subsidiary, Tirex R&D and of all Officers and Directors of the Company as that term is defined in Item 402(a)(2) of Regulation S-B. Neither the Company nor Tirex R&D have any shares of any class other than common shares and Series A preferred shares issued and outstanding.

The Corporation has a total of twenty-five million (25,000,000) Series A preferred shares outstanding, There are no other designated classes of preferred shares, but the Corporation is authorized to issue a total of one hundred million (100,000,000) Series A preferred shares.

---

	Name and	Amount and
Title	Address of	Nature of
of	Beneficial	Percent	Percent
Class	Owner	Ownership	of Class (1)
Common The Tirex Corporation	John L. Threshie, Jr. 1771 Post Road East Westport, CT 06880	82,919,925(2)	5.70%
Class A Common Tirex R&D		34 (5)	34%
Common The Tirex Corporation	Louis V. Muro 2063 Desjardins Avenue, Apt #2 Montreal, Quebec Canada H1V 2H1	77,428,344 (2),(3)	5.32%
Class A Common Tirex R&D		17(5)	17%
Common The Tirex Corporation	Henry P. Meier P.O. Box 895 Lakehurst, NJ 07755	2,500,000 (6)	0.17%
Common The Tirex Corporation	Michael D.A. Ash 310 Montée Sabourin St. Bruno, Quebec Canada J3V 4P6	62,355,000 (4)	4.28%
Common The Tirex Corporation	All directors and officers as a group (4 persons)	225,203,269	15.48%
Class A Common Tirex R&D	All directors and officers as a group (2 persons)	51	51.0%
Series A Preferred Shares	John L. Threshie, Jr. 1771 Post Road East Westport, CT 06880	7,500,000 (7)	50% of class
Series A Preferred Shares	Louis V. Muro 2063 Desjardins Avenue, Apt #2 Montreal, Quebec Canada H1V 2H1	3,750,000 (7)	25% of class
Series A Preferred Shares	Michael D.A. Ash 310 Montée Sabourin St. Bruno, Quebec Canada J3V 4P6	3,750,000 (7)	25% of class

(1) The percentages listed in the table is calculated on the basis of 1,454,283,645 common shares of the common stock, $.001 par value, of the Company outstanding as at September 25, 2009.

(2) Our executive officers, directors (including a deceased director, Louis A. Sanzaro) and principal shareholders pledged an aggregate of 11,986,315 (approximately 6% of our then outstanding shares) of their personal shareholdings in the Company as a security interest for our issuance of $750,000 of 8% convertible notes, pursuant to a Subscription Agreement and Security Agreement dated February 26, 2001. Specifically, John L. Threshie, Jr. pledged 1,891,204 shares, Louis Muro pledged 1,723,514 shares and Louis Sanzaro pledged 8,371,597 shares of our common stock. The Company was unable to respect its financial obligations under the terms of a Settlement Agreement and negotiations with respect to a new settlement have not been started. Under the terms of the first settlement agreement, the investors acquired a right to dispose of the collateral shares in their possession and did so. According to a confirmation received from the investors with respect to the convertible note, as of June 30, 2005, they were in possession of 4,000,000 conversion shares, issued in 2003, but the collateral shares were sold. The collateral shares pledged by Messrs. Threshie, Muro and Sanzaro were replaced subsequent to June 30, 2008. These 4 million conversion shares represent approximately 0.27% of our current outstanding stock.

(3) Includes: (i) 77,428,344 shares held of record by Mr. Muro as of September 25, 2009; and (ii) 734,000 shares held of record by Mr. Muro's previous wife, recently deceased, Nina Aviles Muro. There have been no subsequent changes.

F-19

---

(4) Includes: (i) 32,625,000 shares held of record by Mr. Ash as of September 25, 2009; (ii) 10,230,000 shares held of record in the name of Loryta Investments Limited, an entity directly owned by Loryta Trust and thus beneficially owned by the family of Mr. Ash. Mr. Ash is not himself a beneficiary of this trust nor does he have decisional powers over its activities. Also includes 5,250,000 shares owned by the wife of Mr. Ash and 5,750,000 shares held by each of his two adult age children.

(5) Messrs. Threshie and Muro hold all shares of Tirex R&D Class A Common Stock pursuant to the terms of a Shareholders Agreement among them and the Company (the "Tirex R&D Shareholders Agreement"), pursuant to which they will be obligated to transfer all such shares to the Company, for no consideration, on May 2, 2001, unless the term of such Agreement would be unilaterally extended by the Company. The Company does not intend to take any actions of any kind with respect to such shares which would be in violation of any Canadian government regulations governing tax and other financial incentives which may be available to the Company. Tirex Canada R&D Inc. was dissolved by the Quebec government for lack of filing of annual returns. The company can be re-established through the filing of appropriate documentation and the payment of required government fees. It is for this reason that we continue to list Mr. Threshie and Mr. Muro as shareholders, but until such time as such action would be undertaken, such share distribution has no effect.

(6) Includes 1,250,000 shares owned in the name of Mr. Meier’s two adult-age children.

(7) The Series A Preferred Shares are not dividend-bearing but have preferential rights versus the common stock in terms of participation in residual assets in the event of liquidation. The Series A Preferred Shares have voting rights equal to 100 votes per share and are exercisable in all circumstances. The Series A preferred shares are convertible into common shares at the rate of five (5) common shares for each Series A preferred share.

Change of Control
On February 26, 2001, we issued $750,000 worth of convertible notes at an annual rate of eight percent (8%) to certain investors (“Investor Group”). Interest payable on these notes is payable quarterly commencing June 30, 2001. In addition, all principal and unpaid interest due on the outstanding notes is immediately due and payable on February 26, 2003, or earlier in the event of a default. One of the conditions of this transaction was that we would file with the Securities and Exchange Commission a Registration Statement on Form SB-2 to register various securities, issuable upon the conversion of these convertible notes, by a certain date and that the Registration Statement would be effective by August 15, 2001. We failed to meet these deadlines and the investors served a notice of default on us on July 19, 2001. Negotiations were undertaken throughout the remainder of Calendar 2001 and into 2002 until a Settlement Agreement was reached on April 26, 2002. Under the terms of the Agreement, a copy of which was previously filed, the Company was obligated to pay down the amount owed to the Investor Group, including interest and penalties, over a period of approximately two years. During the time when an amount continues to be owed to the Investor Group, the Investor Group had the right to sell up to 600,000 collateral or Rule 144 shares per month and apply the proceeds to interest due, fees and finally to the reduction of the principle amount outstanding. As of June 30, 2005, all of the collateral shares had been sold. As of June 30, 2005, the Investor Group had 4,000,000 conversion shares, issued in 2003, in their possession.

ITEM 13 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The following is a description of transactions during the last two fiscal years or any presently proposed transactions to which the Company was or is to be a party, in which the amount involved in such transaction (or series of transactions) was $60,000 or more and which any of the following persons had or is to have a direct or indirect material interest: (i) any director or executive officer of the Company; (ii) any person who owns or has the right to acquire 5% or more of the issued and outstanding common stock of the Company; and (iii) any member of the immediate family of any such persons.

Pursuant to a Subscription Agreement dated February 26, 2001, we issued $750,000 of 8% convertible notes, due February 26, 2003 to three investors. Under the Subscription Agreement, we had the option, subject to conditions, to require the investors to purchase additional convertible put notes up to $4,250,000. Interest only payments were due quarterly commencing June 30, 2001, and the principal was due in one lump sum on February 26, 2003, or upon certain events of default. The number of shares of common stock issuable upon conversion of the convertible notes is 15,000,000, was based on a conversion price of $0.05 per share. The option exercise window has expired. One of the conditions of this transaction was that we would file with the Securities and Exchange Commission a Registration Statement on Form SB-2 to register various securities issuable upon the conversion of the notes by a date certain and that the Registration Statement would be effective by August 15, 2001. We failed to meet these deadlines and the investors served a notice of default on us on July 19, 2001. The conversion price for the convertible notes is the lesser of (i) 80% of the average of the three lowest closing bid prices of the common stock for the twenty-two (22) trading days prior to the closing date, or (ii) 80% of the average of the five lowest closing bid prices of the common stock for the sixty (60) trading days prior to the conversion date, as defined in the convertible note.

F-20

---

During the years ended June 30, 2001 through 2009, the Company's directors and executive officers and certain consultants to the Company necessarily waived cash payment of all of their salaries, fees and/or unreimbursed expenses made by them on behalf of, and for the account of, the Company. During fiscal 2009 and fiscal 2010 (the period following the fiscal year covered by this Annual Report) common shares were issued to such directors and executive officers and certain consultants in partial payment of accrued and unpaid salaries, fees and expenses.

Director Independence

The Pink Sheets on which our common stock is quoted on does not have any director independence requirements. We have also not developed a definition of independence, as three out of our four directors occupy the three executive officer positions of the Company and would therefore not qualify as independent. We may appoint additional directors in the future, at which time we plan to develop a definition of independence and scrutinize our Board of Directors with regard to this definition.

ITEM 14 PRINCIPAL ACCOUNTANT FEES AND SERVICES

The following table sets forth the fees for professional services rendered by our auditors in connection with the audit of our financial statements for the years ended June 30, 2009 and 2008 and the review of our quarterly financial statements during such years, as well as any other fees billed for services rendered by our auditors during these periods:

Since our inception, our Board of Directors, performing the duties of the Audit Committee. Has reviewed all audit fees and non audit-related fees at least annually. The Board of Directors, acting as the Audit Committee, pre-approved all audit related services for the year ended June 30, 2009.

F-21

---

PART IV

ITEM 15 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, CONSOLIDATED FINANCIAL STATEMENTS, REPORTS FILED ON FORM 8-K, FINANCIAL STATEMENT SCHEDULES, EXHIBITS

Consolidated Financial Statements
The consolidated financial statements filed as a partof this Annual Report are as follows:
Report of Independent Registered Public Accounting Firm	F-23
Consolidated Balance Sheets as of June 30, 2009 and 2008	F-24
Consolidated Statements of Operations for the years ended June 30, 2009 and 2008, and cumulative for the period from March 26, 1993 to June 30, 2009	F-25
Consolidated Statements of Stockholders' Equity (Deficit) for the years ended June 30, 2009 and 2008 and cumulative for the period from March 26, 1993 to June 30, 2009	F-26
Consolidated Statements of Cash Flows for the years ended June 30, 2009 and 2008 and cumulative for the period from March 26, 1993 to June 30, 2009	F-27

F-22

---

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of
Tirex Corporation

We have audited the accompanying balance sheets of the Tirex Corporation, as of June 30, 2009 and 2008, and the related statements of operations, stockholders’ equity (deficit), and cash flows for the years then ended. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. An audit includes consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Tirex Corporation as of June 30, 2009 and 2008, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has an accumulated deficit of $32,557,086, which raises substantial doubt about its ability to continue as a going concern. Management’s plans concerning these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s/ M&K CPAS, PLLC

Houston, Texas

March 1, 2011

www.mkacpas.com

F-23

---

THE TIREX CORPORATION

A DEVELOPMENT STAGE COMPANY

CONSOLIDATED BALANCE SHEETS

JUNE 30, 2009 and 2008

		June 30,			June 30,
		2009			2008
ASSETS
Other assets
Patents	$	1		$	1
Total Other Assets		1			1
Total Assets	$	1		$	1
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current Liabilities
Accounts payable and accrued liabilties	$	1,540,428		$	1,742,273
Accrued liabilties - related parties		1,534,648			2,357,021
Notes payable - related party		-			162,500
Convertible notes - non-related parties		675,745			920,245
Derivative liability		1,230,621			2,325,572
Total Current Liabilities		4,981,442			7,507,611
Total Liabilities		4,981,442			7,507,611
Stockholders' Deficit
Preferred stock, $.005 par value, authorized 15,000,000 Series A shares, issued and outstanding 15,000,000 Series A shares (June 30, 2008 - 3,000,000 shares)		75,000			15,000
Common stock, $.001 par value, authorized 1,000,000,000 shares, issued and outstanding 1,119,492,216 shares (June 30, 2008 - 291,995,892 shares)		1,119,492			291,996
Common stock payable		43,500			-
Additional paid-in capital		26,797,293			25,805,465
Deficit accumulated prior to entering development stage		(1,057,356	)		(1,057,356	)
Deficit accumulated during the development stage		(31,499,730	)		(31,957,743	)
Unrealized loss on foreign exchange		(459,640	)		(604,972	)
		(4,981,441	)		(7,507,610	)
Total Liabilities and Stockholders' Deficit	$	1		$	1

F-24

---

THE TIREX CORPORATION

A DEVELOPMENT STAGE COMPANY

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

		Twelve months ended						Cumulative from
		June 30						March 26, 1993 to
		2009			2008			June 30, 2009
					(Restated)			(Unaudited)
Revenues	$	-		$	-		$	1,354,088
Cost of Sales		-			-			1,031,075
Gross profit		-			-			323,013
Operations
General and administrative		838,404			854,945			15,103,669
Depreciation and amortization		-			-			340,545
Research and development		-			-			15,396,966
Total Expense		838,404			854,945			30,841,180
Income (loss) before other expenses		(838,404	)		(854,945	)		(30,518,167	)
Other expenses (income)
Interest expense		92,235			(18,617	)		1,071,398
Accretion expense		-			-			750,000
Interest income		-			-			(45,443	)
Income from stock options		-			-			(10,855	)
Impairment of fixed assets		-			25,000			50,000
(Gain) on change in derivative liability		(1,094,951	)		(3,906,066	)		480,621
Loss (gain) on settlement of debt		(293,701	)		162,400			(1,424,844	)
Loss on disposal of equipment		-			-			4,549
Total Other expenses (income)		(1,296,417	)		(3,737,283	)		875,426
Provision for income taxes		-			-			-
Net income (loss)		458,013			2,882,338			(31,393,593	)
Other comprehensive loss
Loss (gain) on foreign exchange		-			-			106,137
Net income and comprehensive income	$	458,013		$	2,882,338		$	(31,499,730	)
Net income and comprehensive income per share - basic	$	0.00		$	0.01
Net income and comprehensive income per share - diluted	$	0.00		$	0.00
Weighted average number of shares - basic		740,673,574			252,126,303
Weighted average number of shares - diluted		1,195,411,253			10,185,751,788

F-25

---

THE TIREX CORPORATION

A DEVELOPMENT STAGE COMPANY

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

																				Deficit			Deficit
																				Accumulated			Accumulated			Unrealized
														Common			Additional			Prior to Entering			During			gain (loss)			Total
		Common Stock						Preferred Stock						Stock			Paid-in			Developmental			Developmental			on foreign			Stockholders'
		Shares			Amount			Shares			Amount			Payable			Capital			Stage			Stage			exchange			Equity (Deficit
Balance June 30, 1992 (Unaudited)		3,383,050			3,383						-			-			- 194,980			(1,057,356	)		-		$	-			(858,993	)
Stock issued for reorganization		18,650,000			18,650												76,155												94,805
Stock issued for services		100,000			100												(100	)
Stock issued in exchange for Warrants		363,656			364												(364	)
Forgiveness of debt																	728,023												728,023
Net loss and comprehensive loss																							(165,296	)					(165,296	)
Balance June 30, 1993 (Unaudited)		22,496,706			22,497						-			-			- 998,694			(1,057,356	)		(165,296	)		-			(201,461	)
Stock issued		2,000			2												(2	)
Stock issued for services
Exchange for Debt																	149,170												149,170
Payments received for stock previously issued																	237,430												237,430
Net loss and comprehensive loss																							(179,296	)					(179,296	)
Balance June 30, 1994 (Unaudited)		22,498,706			22,499						-			-			- 1,385,292			(1,057,356	)		(344,592	)		-			5,843
Revision of common stock		(11,900,000	)		(11,900	)											11,900
Stock issued for services		5,592,857			5,592												513,908												519,500
Exchange for Debt		200,000			200												24,300												24,500
Issuance of common stock previously issued		402,857			401												21,915												22,316
Net loss and comprehensive loss																							(575,771	)					(575,771	)
Balance June 30, 1995 (Unaudited)		16,794,420			16,792						-			-			- 1,957,315			(1,057,356	)		(920,363	)		-			(3,612	)

See Notes to Consolidated Financial Statements

F-26

---

THE TIREX CORPORATION

A DEVELOPMENT STAGE COMPANY

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

																				Deficit			Deficit
																				Accumulated			Accumulated			Unrealized
														Common			Additional			Prior to Entering			During			gain (loss)			Total
		Common Stock						Preferred Stock						Stock			Paid-in			Developmental			Developmental			on foreign			Stockholders'
		Shares			Amount			Shares			Amount			Payable			Capital			Stage			Stage			exchange			Equity (Deficit)
Balance June 30, 1995 (Unaudited)		16,794,420			16,792						-			-			- 1,957,315			(1,057,356	)		(920,363	)		-			(3,612	)
Stock issued		3,975,662			5,090												846,612												851,702
Exchange for Debt		391,857			392												29,008												29,400
Issuance of common stock		710,833			710												80,161												80,871
Net loss and comprehensive loss																							(1,127,044	)					(1,127,044	)
Balance June 30, 1996 (Unaudited)		21,872,772			22,984						-			-			- 2,913,096			(1,057,356	)		(2,047,407	)		-			(168,683	)
Stock issued for options																	912,838												912,838
Stock issued for services		5,067,912			3,955												690,234												694,189
Stock in Exchange for Debt		251,382			252												43,965												44,217
Issuance of common stock		10,257,936			10,259												335,132												345,391
Grants received																	408,597												408,597
Net loss and comprehensive loss																							(2,376,279	)					(2,376,279	)
Balance June 30, 1997 (Unaudited)		37,450,002			37,450						-			-			- 5,303,862			(1,057,356	)		(4,423,686	)		-			(139,730	)
Stock issued for options																	948,500												948,500
Stock issued for services		4,396,466			4,396												922,180												926,576
Issuance of common stock		21,795,000			21,796												1,176,755												1,198,551
Stock options issued and outstanding																	1,236,913												1,236,913
Grants received																	669,906												669,906
Unrealized foreign exchange																										183,785			183,785
Net loss and comprehensive loss																							(4,570,441	)					(4,570,441	)
Balance June 30, 1998 (Unaudited)		63,641,468			63,642						-			-			- 10,258,116			(1,057,356	)		(8,994,127	)		183,785			454,060

F-27

---

THE TIREX CORPORATION

A DEVELOPMENT STAGE COMPANY

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

																				Deficit			Deficit
																				Accumulated			Accumulated			Unrealized
														Common			Additional			Prior to Entering			During			gain (loss)			Total
		Common Stock						Preferred Stock						Stock			Paid-in			Developmental			Developmental			on foreign			Stockholders'
		Shares			Amount			Shares			Amount			Payable			Capital			Stage			Stage			exchange			Equity (Deficit)
Balance June 30, 1998 (Unaudited)		63,641,468			63,642						-			-			10,258,116			(1,057,356	)		(8,994,127	)		183,785			454,060
Stock issued for options		2,234,567			2,235												38,765												41,000
Stock issued for services		24,200,439			24,200												2,735,544												2,759,744
Shares issued in exchange for debt		3,787,947			3,788												340,164												343,952
Conversion of debentures		2,816,966			2,817												290,102												292,919
Issuance of common stock		677,966			678												49,322												50,000
Stock options issued and outstanding																	385,600												385,600
Grants received																	1,057,742												1,057,742
Unrealized foreign exchange																										(29,142	)		(29,142	)
Net loss and comprehensive loss																							(4,909,879	)					(4,909,879	)
Balance June 30, 1999 (Unaudited)		97,359,353			97,360						-			-			- 15,155,355			(1,057,356	)		(13,904,006	)		154,643			445,996
Stock issued for options		5,327,486			5,327												381,600												386,927
Stock issued for services		28,873,210			28,873												2,217,758												2,246,631
Shares issued in exchange for debt		7,342,055			7,342												382,556												389,898
Conversion of debentures		12,010,073			12,010												815,796												827,806
Issuance of common stock		221,000			221												16,039												16,260
Grants received																	395,683												395,683
Unrealized foreign exchange																										5,789			5,789
Net loss and comprehensive loss																							(5,548,829	)					(5,548,829	)
Balance June 30, 2000 (Unaudited)		151,133,177			151,133						-			-			- 19,364,787			(1,057,356	)		(19,452,835	)		160,432			(833,839	)
Stock issued for services		7,375,483			7,375												864,840												872,215
Stock issued for options		5,378,507			5,379												506,998												512,377
Shares issued in exchange for debt		11,646,312			11,646												1,547,455												1,559,101
Conversion of debentures		100,000			100												19,900												20,000
Issuance of common stock		732,929			733												39,427												40,160
Unrealized foreign exchange																										(340,661	)		(340,661	)
Grants issued																	249,294												249,294
Net loss and comprehensive loss																							(3,242,572	)					(3,242,572	)
Balance June 30, 2001 (Restated and Unaudited)		176,366,408			176,366						-			-			- 22,592,701			(1,057,356	)		(22,695,407	)		(180,229	)		(1,163,925	)

See Notes to Consolidated Financial Statements

F-28

---

THE TIREX CORPORATION

A DEVELOPMENT STAGE COMPANY

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

																				Deficit			Deficit
																				Accumulated			Accumulated			Unrealized
														Common			Additional			Prior to Entering			During			gain (loss)			Total
		Common Stock						Preferred Stock						Stock			Paid-in			Developmental			Developmental			on foreign			Stockholders'
		Shares			Amount			Shares			Amount			Payable			Capital			Stage			Stage			exchange			Equity (Deficit)
Balance June 30, 2001 (Restated and Unaudited)		176,366,408			176,366						-			-			- 22,592,701			(1,057,356	)		(22,695,407	)		(180,229	)		(1,163,925	)
Stock issued for services		18,466,162			18,466												314,859												333,325
Shares issued in exchange for debt		24,075,502			24,076												1,649,442												1,673,518
Issuance of common stock		5,849,487			5,850												61,897												67,747
Interest expense on convertible note discount																	3,403												3,403
Unrealized foreign exchange																										(19,940	)		(19,940	)
Net loss and comprehensive loss																							(4,089,933	)					(4,089,933	)
Balance June 30, 2002 (Restated and Unaudited)		224,757,559			224,758						-			-			- 24,622,302			(1,057,356	)		(26,785,340	)		(200,169	)		(3,195,805	)
Stock issued for services		5,455,000			5,455												130,920												136,375
Shares issued in exchange for debt		15,400,000			15,400												441,183												456,583
Issuance of common stock		4,283,333			4,283												31,217												35,500
Interest expense on convertible note discount																	999												999
Unrealized foreign exchange																										(182,365	)		(182,365	)
Net loss and comprehensive loss																							(2,763,145	)					(2,763,145	)
Balance June 30, 2003 (Restated and Unaudited)		249,895,892			249,896						-			-			- 25,226,621			(1,057,356	)		(29,548,485	)		(382,534	)		(5,511,858	)
Interest expense on convertible note discount																	1,000												1,000
Unrealized foreign exchange																										(30,325	)		(30,325	)
Net loss and comprehensive loss																							(82,082	)					(82,082	)
Balance June 30, 2004 (Restated and Unaudited)		249,895,892			249,896						-			-			- 25,227,621			(1,057,356	)		(29,630,567	)		(412,859	)		(5,623,265	)
Unrealized foreign exchange																										(63,448	)		(63,448	)
Net loss and comprehensive loss																							(7,717,592	)					(7,717,592	)
Balance June 30, 2005 (Restated and Unaudited)		249,895,892			249,896						-			-			- 25,227,621			(1,057,356	)		(37,348,159	)		(476,307	)		(13,404,305	)

F-29

---

THE TIREX CORPORATION

A DEVELOPMENT STAGE COMPANY

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

																				Deficit			Deficit
																				Accumulated			Accumulated			Unrealized
														Common			Additional			Prior to Entering			During			gain (loss)			Total
		Common Stock						Preferred Stock						Stock			Paid-in			Developmental			Developmental			on foreign			Stockholders'
		Shares			Amount			Shares			Amount			Payable			Capital			Stage			Stage			exchange			Equity (Deficit)
Balance June 30, 2005 (Restated and Unaudited)		249,895,892			249,896			-			-						25,227,621			(1,057,356	)		(37,348,159	)		(476,307	)		(13,404,305	)
Unrealized foreign exchange																										(78,596	)		(78,596	)
Net income and comprehensive income																							2,624,041						2,624,041
Balance June 30, 2006 (Restated and Unaudited)		249,895,892			249,896			-			-			-			25,227,621			(1,057,356	)		(34,724,118	)		(554,903	)		(10,858,860	)
Unrealized foreign exchange																										(44,174	)		(44,174	)
Net loss and comprehensive loss																							(115,963	)					(115,963	)
Balance June 30, 2007 (Restated and Unaudited)		249,895,892			249,896			-			-			-			25,227,621			(1,057,356	)		(34,840,081	)		(599,077	)		(11,018,997	)
Common stock issued for settlement		20,000,000			20,000												124,000												144,000
Common stock issued for services		22,100,000			22,100												130,500												152,600
Preferred stock issued								3,000,000			15,000						271,000												286,000
Stock options granted																	24,000												24,000
Imputed interest																	28,344												28,344
Unrealized foreign exchange																										(5,895	)		(5,895	)
Net income and comprehensive income																							2,882,338						2,882,338
Balance June 30, 2008 (Restated)		291,995,892			291,996			3,000,000			15,000			-			25,805,465			(1,057,356	)		(31,957,743	)		(604,972	)		(7,507,610	)
Common stock issued for liability settlements		191,750,000			191,750												157,366												349,116
Common stock issued for services		64,900,000			64,900												22,563												87,463
Common stock issued for debt conversion		50,140,000			50,140												153,660												203,800
Common stock issued to related parties		513,206,324			513,206									43,500			520,739												1,077,445
Stock options exercised on a cashless basis		7,500,000			7,500												(7,500	)											-
Preferred stock issued								12,000,000			60,000						115,000												175,000
Stock options granted																	30,000												30,000
Derivative financial instruments																													-
Unrealized foreign exchange																										145,332			145,332
Net income and comprehensive income																							458,013						458,013
Balance June 30, 2009		1,119,492,216			1,119,492			15,000,000			75,000			43,500			26,797,293			(1,057,356	)		(31,499,730	)		(459,640	)		(4,981,441	)

See Notes to Consolidated Financial Statements

F-30

---

THE TIREX CORPORATION

A DEVELOPMENT STAGE COMPANY

CONSOLIDATED STATEMENTS OF CASH FLOWS

		Twelve months ended						Cumulative from
		June 30						March 26, 1993 to
		2009			2008			June 30, 2009
					(Restated)			(Unaudited)
Cash flows from operating activities:
Net income (loss)	$	458,013		$	2,882,338		$	(31,499,730	)
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization		-			-			340,545
Imputed interest		-			28,344			28,344
Accretion expense		-			-			750,000
Impairment of fixed assets		-			25,000			50,000
(Gain) loss on disposal and abandonment of assets		-			-			2,005,498
(Gain) loss on settlement of debt		(293,701	)		162,400			(1,424,844	)
Loss on issuance of preferred stock		115,000			271,000			386,000
Common stock issued in exchange for services and expenses		102,335			102,200			10,948,649
Stock options issued in exchange for services		30,000			24,000			3,137,390
Change in derivative liability		(1,094,951	)		(3,906,066	)		480,621
Changes in assets and liabilities:
(Increase) decrease in:
Inventory		-			-			(73,323	)
Sales tax receivable		-			-			(36	)
Other assets		-			-			(10,120	)
(Decrease) increase in :
Accounts payable and accrued liabilities		103,403			106,416			2,406,800
Accrued liabilities - related parties		387,269			233,163			2,751,580
Net cash used in operating activities		(192,632	)		(71,205	)		(9,722,626	)
Cash flow from investing activities:
Increase in notes receivable		-			-			(259,358	)
Reduction in notes receivable		-			-			237,652
Investment		-			-			(89,500	)
Equipment		-			-			(321,567	)
Equipment assembly costs		-			-			(1,999,801	)
Organization cost		-			-			6,700
Reduction in security deposit		-			-			(1,542	)
Net cash used in investing activities		-			-			(2,427,416	)
Cash flow from financing activities:
Loans from related parties								4,354,835
Deferred financing costs		-			-			180,557
Due to stockholders		-			-			5,000
Proceeds from deposits		-			-			143,500
Payments on notes payable		-			-			(409,939	)
Proceeds from convertible notes		-			-			754,999
Proceeds from notes payable		-			-			409,939
Payments on lease obligations		-			-			(86,380	)
Proceeds from issuance of convertible subordinated debentures		-			-			1,035,000
Proceeds from convertible debts - non-related parties		47,300			77,100			239,100
Proceeds from loan payable		-			-			591,619
Payments on loan payable		-			-			(488,439	)
Proceeds from issuance of stock options		-			-			20,000
Proceeds from grants		-			-			3,628,277
Proceeds from issuance of common stock		-			-			85,582
Proceeds from additional paid-in capital		-			-			2,145,775
Net cash provided by financing activities		47,300			77,100			12,609,425
Effect of Exchange rate changes on cash and cash equivalents		145,332			(5,895	)		(459,640	)
Net (decrease) increase in cash and cash equivalents		(145,332	)		5,895			459,383
Cash and cash equivalents - beginning of period		-			-			257
Cash and cash equivalents - end of period	$	-		$	-		$	-

F-31

---

		Twelve months  ended
		June 30,
		2009			2008
					(Restated)
Non-Cash Financing and Investing Activities:
Issuance of common stock for exercise of stock options		7,500			-
Issuance of common stock for the settlement of accounts payable and accrued liabilities		257,018			-
Issuance of common stock for the settlement of accrued liabilities - related parties		1,154,372			20,000
Common stock to be issued to related parties for accrued expenses		43,500			-
Issuance of common stock for the settlement of convertible notes - related parties		162,500			-
Issuance of common stock for the settlement of convertible notes - non-related parties		291,800			12,000
Supplemental Disclosures  - Cash paid for:
Interest		-			-
Income taxes		-			-

F-32

---

NOTE 1 BACKGROUND

NATURE OF BUSINESS
The Tirex Corporation (the "Company" or “Tirex”) was incorporated under the laws of the State of Delaware on August 19, 1987 as Tirex America, Inc. The Company was originally organized to provide comprehensive health care services, but due to its inability to raise sufficient capital, was unable to implement its business plan. The Company became inactive in November 1990.

REORGANIZATION
On March 26, 1993, the Company entered into an acquisition agreement (the "Acquisition Agreement") with Louis V. Muro, currently an officer and a director of the Company, and former Officers and Directors of the Company (collectively the "Seller"), for the purchase of certain technology owned and developed by the Seller (the "Technology") to be used to design, develop and construct a prototype machine and thereafter a production quality machine for the cryogenic disintegration of used tires. The Technology was conceptually developed by the Seller prior to their affiliation or association with the Company. On March 26, 1993, the Company entered the development stage.

CHANGE OF NAME
On July 11, 1997, the Company changed its name from Tirex America, Inc. to The Tirex Corporation.

DEVELOPMENT STAGE
At June 30, 2009, the Company is still in the development stage. The operations consist mainly of raising capital, obtaining financing, developing equipment, obtaining customers and supplies, installing and testing equipment and administrative activities.

NOTE 2 GOING CONCERN

The Company’s consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business.

In March 1993, the Company had begun its developmental stage with a new business plan. As of March 2000, the Company had developed a production quality prototype of its patented system for the disintegration of scrap tires, but nonetheless continued its research and development efforts to improve the machine's performance and to permit greater flexibility in design for specific customer applications. Due to the Company’s lack of working capital during the year ended June 30, 2002, all rubber crumb production was suspended and research and development efforts have been hampered. Pending receipt of funding from operations, government assistance, loans or equity financing, crumb rubber production and previous research and development efforts will not be resumed. While the Company has engaged the process of marketing the TCS System to numerous potential clients since the beginning of the fiscal year commencing July 1, 2000, as of June 30, 2009, the Company had not yet consummated an unconditional purchase order for a TCS System. As a result, the Company expects to continue to incur operating losses and may not have enough capital to grow its business in the future or continue as a going concern. The Company can give no assurance that it will achieve profitability or be capable of sustaining profitable operations. As a result, operations in the near future are expected to continue to use working capital. The accompanying financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result if the Company is unable to continue as a going concern.

To successfully grow the business, the Company must decrease its cash outflows, improve its cash position and succeed in its ability to raise additional capital through a combination of primarily public or private equity offerings or strategic alliances. The Company is also dependent on the success of its marketing of its TCS Systems. The Company's uncertainty as to its ability to generate revenue and its ability to raise sufficient capital, raise substantial doubt about the entity's ability to continue as a going concern.

F-33

---

The Company is currently in the process of trying to obtain additional financing for its current operations and consummate an initial sale of its TCS Systems.

As reported in the accompanying financial statements, the Company incurred a net profit of $458,013 for the year ended June 30, 2009 and a net profit of $2,882,338 for the year ended June 30, 2008. The net profit realized is primarily due to the change in derivative value. The change in derivative value is recorded in other income and expense in the statements of operations and is a non-cash transaction.

NOTE 3 SUMMARY OF ACCOUNTING POLICIES

This summary of significant accounting policies is provided to assist the reader in understanding the Company’s financial statements. The financial statements and notes thereto are the representations of the Company’s management. The Company’s management is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States and have been consistently applied in the preparation of the financial statements.

BASIS OF PRESENTATION
These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in U.S. Dollars. The Company’s fiscal year-end is June 30.

BASIS OF CONSOLIDATION
The consolidated financial statements include the consolidated accounts of The Tirex Corporation, Tirex Canada R&D Inc., The Tirex Corporation Canada Inc., Tirex Advanced Products Quebec Inc. and Tirex Acquisition Corp., all of these subsidiaries currently being dormant. Certain of these companies have actually been de-registered by government authorities but could easily be revived if circumstances would warrant such action. Tirex Canada R&D Inc. is held 51% by two shareholders of the Company. The shares owned by these shareholders are held in escrow by the Company's attorney and are restricted from transfer thereby, substantively for recording purposes, allowing for a full consolidation of this Company. The Tirex Corporation Canada Inc., Tirex Advanced Products Quebec Inc. and Tirex Acquisition Corp. are 100% held by the Company. All subsidiary companies are dormant. All material inter-company transactions and accounts have been eliminated in consolidation.

CASH AND CASH EQUIVALENTS
For purposes of the statement of cash flows, the Company considers all highly liquid debt instruments, with a maturity of three months or less, to be cash equivalents. There were no cash equivalents as of June 30, 2009 and 2008.

PROPERTY AND EQUIPMENT
Property and equipment are stated at cost less accumulated depreciation and provisions for write-downs. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets which is generally five years for machinery and equipment.

Maintenance and repair costs are expensed as incurred while additions and betterments are capitalized. The cost and related accumulated depreciation of assets sold or retired are eliminated from the accounts and any gains or losses are reflected in earnings.

The Company has taken depreciation and impairment charges over the years on its machinery and equipment bringing its carrying value, at June 30, 2009 and 2008, to $0.

F-34

---

INTANGIBLE ASSETS
Intangible assets are carried at the purchased cost less accumulated amortization. Amortization is computed over the estimated useful lives of the respective assets, generally from fifteen to twenty years.

ESTIMATES
The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

BASIC AND DILUTED INCOME (LOSS) PER COMMON SHARE
Basic net income (loss) per share includes no dilution and is computed by dividing net income (loss) available to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares outstanding and, when dilutive, potential shares from stock options, stock warrants to purchase common stock using the treasury method, and conversions of preferred stock and outstanding debt using the “if converted” method.

FAIR VALUE OF FINANCIAL INSTRUMENTS
The Company accounts for its financial instruments in accordance with ASC Topic 825, which requires the disclosure of fair value information about financial instruments when it is practicable to estimate that value. The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, inventory, accounts payable, accrued liabilities and convertible notes. The estimated fair value of cash, cash equivalents, accounts receivable, accounts payable and accrued liabilities and other short-term liabilities approximate their carrying amounts due to the short-term nature of these instruments. The fair value of related party transactions is not determinable due to their related party nature. The carrying value of the convertible notes also approximates fair value since their terms are similar to those in the lending market for comparable loans with comparable risks. None of these instruments are held for trading purposes.

F-35

---

FAIR VALUE MEASUREMENTS
In accordance with the authoritative guidance on fair value measurements and disclosure under U.S. GAAP, the Company determines fair value using a fair value hierarchy that distinguishes between market participant assumptions developed based on market data (observable inputs) obtained from sources independent of the reporting entity, and a reporting entity’s own assumptions (unobservable inputs) about market participant assumptions developed based on the best information available in the circumstances and expands disclosure about fair value measurements.

Fair value is the price that would be received to sell an asset or paid to transfer a liability in the Company’s principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date, essentially the exit price.

The levels of fair value hierarchy are as follows:

• Level one – Quoted market prices in active markets for identical assets or liabilities;
• Level two – Inputs other than level one inputs that are either directly or indirectly observable; and
• Level three – Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

Level 1 investments are valued based on quoted market prices in active markets. Level 2 investments are valued based on quoted prices in markets that are not active, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency.

A financial instrument’s level within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair value measurement. However, the determination of what constitutes “observable” requires significant judgment by the Company. The Company evaluates its hierarchy disclosures each quarter.

The Company utilizes various types of financing to fund its business needs including convertible notes with warrants attached. The Company reviews its warrants and conversion features of securities issued as to whether they are freestanding or contain an embedded derivative, and if so, whether they are classified as a liability at each reporting period until the amount is settled and reclassified into equity with changes in fair value recognized in current earnings. At June 30, 2009 and 2008, the Company’s only asset or liability measured at fair value on a recurring basis is its derivative liability associated with the units consisting of convertible notes. The Company classifies the fair value of these warrants under level three. The fair value of the derivative liability as of June 30, 2009 was $1,230,621 (June 30, 2008 - $2,325,572) and the gain due to valuation for the twelve months ended June 30, 2009 and 2008 was $1,007,865 and $4,088,506, respectively.

INCOME TAXES
The Company uses the liability method of accounting for income taxes under which deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as part of the provision for income taxes in the period that includes the enactment date. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized in the future.

F-36

---

The Company has net operating loss carry forwards of approximately $18.6 million as of June 30, 2009, expiring through 2029, that may be offset against future taxable income. Because of the uncertainties discussed in Note 2, however, any deferred tax asset established for utilization of the Company's tax-loss carry forwards correspondingly requires a valuation allowance of the same amount. The Company had no uncertain tax positions at June 30, 2009 or 2008.

Utilization of net operating loss carry forwards may be subject to a substantial annual limitation due to ownership change limitations provided by the Internal Revenue Code of 1986, as well as state and foreign provisions. These ownership changes may limit the amount of net operating loss carry forwards that can be utilized annually to offset future taxable income and tax, respectively. Subsequent ownership changes could further affect the limitation in future years. These annual limitation provisions may result in the expiration of certain net operating losses and credits before utilization.

DERIVATIVE INSTRUMENTS

The Company does not enter into derivative contracts for purposes of risk management or speculation. However, from time to time, the Company enters into contracts, namely convertible notes, that are not considered derivative financial instruments in their entirety, but that include embedded derivative features.

In accordance with FASB ASC Topic 815-15, Embedded Derivatives, and guidance provided by the SEC Staff, the Company accounts for these embedded features as a derivative liability at fair value, and the unrealized changes in the values of these derivatives are recorded in the statement of operations as gain or loss on derivatives.

FOREIGN CURRENCY TRANSLATION

a) Reporting Currency
The Company's functional currency is the Canadian dollar. Accordingly, the consolidated financial statements are converted into the reporting currency (the U.S. dollar) using the current rate method. Under this method, the consolidated financial statements are converted into U.S. dollars as follows: assets and liabilities are converted at the exchange rate in effect at the date of the balance sheet, and revenue and expenses are converted using the average exchange rate for the period. All gains and losses resulting from the conversion of the consolidated financial statements into the reporting currency are included in other comprehensive income or loss for the period and accumulated in a separate component of stockholders’ equity as accumulated other comprehensive income or loss.

b) Foreign Currency Transactions
Transactions denominated in currencies other than the functional currency are converted into Canadian dollars (the functional currency) using the exchange rate in effect at the date of the transaction or the average rate for the period in the case of recurring revenue and expense transactions. Monetary assets and liabilities are revalued into the functional currency at each balance sheet date using the exchange rate in effect at that date, with any resulting exchange gains or losses being credited or charged to the statement of operations. Non-monetary assets and liabilities are recorded in the functional currency using the exchange rate in effect at the date of the transaction and are not revalued for subsequent changes in exchange rates.

STOCK BASED COMPENSATION
The Company estimates the fair value of share-based payment awards made to employees and directors, including stock options, restricted stock and employee stock purchases related to employee stock purchase plans, on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense ratably over the requisite service periods. The Company uses the Black-Scholes option pricing model to determine the fair value of the stock-based compensation that it grants to employees and non-employees. The Company is required to make certain assumptions in connection with this determination, the most important of which involves the calculation of volatility with respect to the price of its common stock. The computation of volatility is intended to produce a volatility value that is representative of the Company’s expectations about the future volatility of the price of its common stock over an expected term. The Company used its share price history to determine volatility and cannot predict how the price of its common shares of common stock will react on the open market in the future. As a result, the volatility value that the Company calculated may differ from the future volatility of the price of its shares of common stock.

F-37

---

CASHLESS EXERCISE OF STOCK OPTIONS
The Company issued stock options to directors to purchase common stock where the holder is entitled to exercise the stock options on a cashless basis. The Company accounts for the issuance of common stock on the cashless exercise of stock options on a net basis.

REVENUE RECOGNITION
The Company will generally recognize revenue from the sale of TCS Systems using the percentage-of-completion method when persuasive evidence of an arrangement exists, the fee is fixed or determinable and collectability is probable. The percentage-of-completion method will also require management to make certain estimates and assumptions that will affect the reported amounts of revenues and expenses. All other revenue from other products will be recognized when shipped to the customer. The Company has recognized a small amount of revenue since entering the development stage.

PRIOR PERIOD RECLASSIFICATION
Certain reclassifications to the financial statements have been made to prior period amounts to conform to the presentation of the current period.

RECENT ACCOUNTING PRONOUNCEMENTS
Effective January 1, 2010, the Company adopted changes issued by the Financial Accounting Standards Board (“FASB”) on January 21, 2010, to disclosure requirements for fair value measurements. Specifically, the changes require a reporting entity to disclose separately the amounts of significant transfers in and out of Level 1 and Level 2 fair value measurements and describe the reasons for the transfers. The changes also clarify existing disclosure requirements related to how assets and liabilities should be grouped by class and valuation techniques used for recurring and nonrecurring fair value measurements. The adoption of these changes had no impact on the interim condensed consolidated financial statements.

Effective January 1, 2010, the Company adopted changes issued by the FASB on February 24, 2010, to accounting for and disclosure of events that occur after the balance sheet date, but before financial statements are issued or available to be issued, otherwise known as “subsequent events.” Specifically, these changes clarified that an entity that is required to file or furnish its financial statements with the Securities and Exchange Commission (“SEC”) is not required to disclose the date through which subsequent events have been evaluated. Other than the elimination of disclosing the date through which management has performed its evaluation for subsequent events, the adoption of these changes had no impact on the interim condensed consolidated financial statements.

In January 2010, the FASB issued changes to disclosure requirements for fair value measurements. Specifically, the changes require a reporting entity to disclose, in the reconciliation of fair value measurements using significant unobservable inputs (Level 3), separate information about purchases, sales, issuances, and settlements (that is, on a gross basis rather than as one net number). These changes become effective for the Company beginning January 1, 2011. Other than the additional disclosure requirements, management has determined these changes will not have an impact on the interim condensed consolidated financial statements.

In October 2009, the Financial Accounting Standards Board (“FASB”) issued new revenue recognition standards for arrangements with multiple deliverables, where certain of those deliverables are non-software related. The new standards permit entities to initially use management’s best estimate of selling price to value individual deliverables when those deliverables do not have Vendor Specific Objective Evidence (“VSOE”) of fair value or when third-party evidence is not available. Additionally, these new standards modify the manner in which the transaction consideration is allocated across the separately identified deliverables by no longer permitting the residual method of allocating arrangement consideration. These new standards are effective for annual periods ending after June 15, 2010 and early adoption is permitted. The adoption of the new standards will not have an impact on the Company’s consolidated financial position, results of operations and cash flows.

F-38

---

In June 2009, the FASB issued guidance establishing the Codification as the source of authoritative U.S. Generally Accepted Accounting Principles (U.S. GAAP”) recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the Securities and Exchange Commission (“SEC”) under authority of federal securities laws are also sources of authoritative U.S. GAAP for SEC registrants. The Codification supersedes all existing non-SEC accounting and reporting standards. All other non-grandfathered non-SEC accounting literature not included in the Codification will become non-authoritative. The FASB will no longer issue new standards in the form of Statements, FASB Staff Positions, or Emerging Issues Task Force Abstracts. Instead, the FASB will issue Accounting Standards Updates, which will serve only to update the Codification, provide background information about the guidance and provide the vases for conclusions on changes in the Codification. All content in the Codification carries the same level of authority, and the U.S. GAAP hierarchy was modified to include only two levels of U.S. GAAP: authoritative and non-authoritative. The Codification is effective for the Company’s interim and annual periods beginning with the Company’s year ending June 30, 2009. Adoption of the Codification affected disclosures in the Consolidated Financial Statements by eliminating references to previously issued accounting literature, such as SFASs, EITFs and FSPs.

In June 2009, the FASB issued amended standards for determining whether to consolidate a variable interest entity. These new standards amend the evaluation criteria to identify the primary beneficiary of a variable interest entity and require ongoing reassessment of whether an enterprise is the primary beneficiary of the variable interest entity. The provisions of the new standards are effective for annual reporting periods beginning after November 15, 2009 and interim periods within those fiscal years. The adoption of the new standards will not have an impact on the Company’s consolidated financial position, results of operations and cash flows.

In May 2009, the FASB issued guidance establishing general standards for accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued and shall be applied to subsequent events not addressed in other applicable generally accepted accounting principles. This guidance, among other things, sets forth the period after the balance sheet date during which management should evaluate events or transactions that may occur for potential recognition or disclosure in the financial statements, the circumstances under which an entity should recognize events or transactions occurring after the balance sheet date in its financial statements and the disclosures an entity should make about events or transactions that occurred after the balance sheet date. The adoption of this guidance had no impact on the Company’s consolidated financial position, results of operations and cash flows.

Note 4 PROPERTY AND EQUIPMENT

As at June 30, 2009 and 2008, plant and equipment consisted of the following:

Total

$

0

F-39

---

Depreciation and amortization expense charged to operations for the years ended June 30, 2009 and 2008 was $0.

During the year ended June 30, 2008, the Company recorded an impairment in the value of its remaining manufacturing equipment in the amount of $25,000 reducing its carrying value to $0.

NOTE 5 PATENTS

The Company’s technology is patent protected in both the United States and Canada. Patent maintenance fees are current in both countries. The valuation on the Balance Sheet reflects a nominal value in recognition of valid patents initiated and obtained by the Company and does not attempt to establish the true commercial value.

NOTE 6 CONVERTIBLE SUBORDINATED DEBENTURES

The Company issued Type B Convertible Subordinated Debentures between December 1997 and February 1998. These debentures bore interest at 10% and were convertible into common shares of the Company at $0.20 per share. The conversion privilege on the remaining $55,000 of these debentures expired.

NOTE 7 CONVERTIBLE NOTES

The Convertible Notes appearing on the balance sheet consisted of an investment arrangement with a group of institutional investors involving a multi-stage financing under which the Company had access to, at its option, up to $5,000,000. A first tranche of $750,000 was completed but no further draw downs were made. The terms of the convertible note were:

Balance at June 30, 2009 and 2008	$399,389
Interest rate	8%, payable quarterly, commencing June 30, 2001, and 18% after March 10, 2003, the default date
Issue date	February 26, 2001
Maturity date	February 26, 2003
Redemption rights	If not converted, the holder may require the Company to redeem at any time after maturity for the principal amount plus interest.
Conversion ratio	Lower of (i) – 80% of the average of the three lowest closing bid prices for the thirty trading days prior to the issue date, which equals $.073, or (ii) – 80% of the average of the three lowest closing bid prices for the sixty trading days prior to the conversion date.
Common stock warrants	The Convertible Notes carried an option to purchase Common stock warrants at the rate of one Warrant for each $1.25 of purchase price. The exercise price on the first tranche of $ 750,000 is $ .077 per share. As of June 30, 2009 and 2008, the term of these warrants had expired.

F-40

---

Certain current and previous Directors and Officers of the Company have pledged approximately 12,000,000 of their personal shares of Common Stock of the Company as security for the Convertible Notes until such time as the Company would successfully file with the Securities and Exchange Commission a Registration Statement on Form SB-2, to register common stock and warrants issuable upon the conversion of the notes, no later than 150 days after the issue date of the Convertible Notes. This deadline was not met and, as such, the investors served a notice of default to the Company on July 19, 2001. The Registration Statement was never declared effective by the Securities and Exchange Commission and was eventually withdrawn. Thus, the Convertible Notes cannot be converted to Common Stock nor may the Common Stock warrants be exercised. On April 24, 2002 the Company entered into a Settlement Agreement with the Note holders. The Company was forced to default on this Settlement Agreement. Accordingly, the terms of the Convertible Notes have become effective once again. 8,371,597 collateral common shares provided to the investors were the property of former Tirex Director, Louis A, Sanzaro, now deceased. The shares due to Louis A. Sanzaro have been issued during the quarter ended September 30, 2008 to a family member. The collateral shares provided by Louis V. Muro, 1,723,514 common shares, were replaced during the quarter ended September 30, 2008. The collateral shares provided by John L. Threshie Jr., 1,891,204 shares, were replaced during the quarter ended December 31, 2008.

A convertible note, under a private arrangement, consists of the following:

Balance at June 30, 2009 and 2008	$ 185,556
Interest rate	8%
Issue date	July 19th , 2000
Maturity date	January 19th , 2002
Redemption rights	If not converted, the holder may require the Company to redeem at any time after maturity for the principal amount plus interest.
Conversion ratio	As stated in the note agreement, it is not convertible prior to July 19th , 2001, at 20% discount to market between July 19th , 2001 and January 19th , 2002 or at 25% to market if held to maturity, to a maximum of not more than 2,500,000 shares. The note holder subsequently amended the agreement to provide for a conversion price of $0.33 per share.

A convertible note, under a private arrangement, consisted of the following:
Balance at June 30, 2009	$	0
Balance at June 30, 2008	$	88,000

The note is due on demand and is non-interest bearing. The note was converted in 2009 to common stock.

F-41

---

NOTE 8 CONVERTIBLE NOTES - PRIVATE INVESTORS

Commencing in Fiscal year 2006, certain expenses of the Company have been funded by a series of non-interest bearing convertible notes with no specific terms of repayment made by a significant number of private individuals investing modest amounts. The total dollars received from these private investors up to June 30, 2009 is U.S.$239,100. These private investors, fully cognizant of the Company’s situation, accepted that their investments were being made and represented by a convertible debt, the conversion of which could occur only once the Company would have shares available for issuance. These debts are convertible at fixed prices rather than as a discount to market and range from $.0007 to $.006 per share.

Of the above shares, most were issued, unrestricted, during the year ended June 30, 2009. The remaining shares will be issued during Fiscal year 2010. The balance owing to private investors awaiting conversion to common shares, at June 30, 2009 and 2008, was $35,300 and $191,800, respectively.

NOTE 9 DERIVATIVE FINANCIAL INSTRUMENTS

ASC Topic 815 (“ASC 815”) requires that all derivative financial instruments be recorded on the balance sheet at fair value. Fair values for exchange traded securities and derivatives are based on quoted market prices. Where market prices are not readily available, fair values are determined using market based pricing models incorporating readily observable market data and requiring judgment and estimates.

The Company issued convertible notes and stock warrants and has evaluated the terms and conditions of the conversion features contained in the notes and warrants to determine whether they represent embedded or freestanding derivative instruments under the provisions of ASC 815. The Company determined that the conversion features contained in the notes and warrants represent freestanding derivative instruments that meet the requirements for liability classification under ASC 815. As a result, the fair value of the derivative financial instruments in the notes and warrants is reflected in the Company’s balance sheet as a liability. The fair value of the derivative financial instruments of the convertible notes and warrants was measured at the inception date of the notes and warrants and each subsequent balance sheet date. Any changes in the fair value of the derivative financial instruments are recorded as non-operating, non-cash income or expense at each balance sheet date.

Tirex valued the conversion features in its convertible notes using the Black-Scholes model. The Black-Scholes model values the embedded derivatives based on a risk-free rate of return ranging from 1.32% to 4.87%, grant dates of stock warrants, the term of the stock warrants, conversion prices ranging from $0.00008 to $0.33, current stock prices on the measurement date ranging from $0.0007 to $0.076, and the computed measure of the Company’s stock volatility, ranging from 166% to 2,986%. The balances as of June 30, 2008 and 2009 are $2,325,572 and $1,230,621, respectively.

F-42

---

NOTE 10 RELATED PARTY TRANSACTIONS

Accrued liabilities include amounts primarily due to Directors, Officers and employees. Historically, such amounts due have been repaid through the issuance of stock. At June 30, 2009 and June 30, 2008, the balances owing to Directors and Officers was $1,534,648 and $2,357,021, respectively. These amounts are without interest or terms of repayment. An amount of $9,750 for rental expense was charged by John Threshie, the Company’s President & CEO, for the year ended June 30, 2009.

Notes payable at June 30, 2008 included an amount of $162,500 which was payable to Ocean Tire Recycling & Processing Co., Inc., a company previously owned by a former Director of the Company, Louis A. Sanzaro, and now deceased. The Company negotiated a Settlement Agreement with the family of Louis A. Sanzaro with respect to this note, lease obligations and other expenses paid by Mr. Sanzaro, under which the Company would issue a total of 50,000,000 shares. 34,249,800 million shares were issued during the quarter ended September 30, 2008 and the remaining 15,750,200 shares will be issued in the future. A common stock payable of $43,500 has been recorded for the remaining 15,750,200 shares to be issued in the future.

Note 11 COMMON STOCK

On January 31, 2001, the Company's stockholders approved an amendment to the Articles of Incorporation of the Company to increase the number of authorized shares of Common stock, par value $0.001, from 165,000,000 shares to 250,000,000 shares. On February 11, 2008, the Company's Board of Directors approved an amendment to the Articles of Incorporation of the Company to increase the number of authorized shares of Common stock, par value $0.001, from 250,000,000 shares to 1,000,000,000 shares. On May 7, 2009, the Company's Board of Directors approved an amendment to the Articles of Incorporation of the Company to increase the number of authorized shares of Common stock, par value $0.001, from 1,000,000,000 shares to 1,500,000,000 shares. As at June 30, 2009, the Company had 1,119,492,216 Common shares issued and outstanding.

During the year ended June 30, 2009, the Company issued 827,496,324 common shares summarized as follows:

	a)	Common Stock Issued for Settlement of Convertible Notes and Accounts Payable and Accrued Liabilities – Non-Related Parties
		During 2009, the Company issued 191,750,000 common shares, valued at $349,116, in settlement of $345,018 of convertible notes previously issued by the Company and accounts payable and accrued liabilities at stock prices between .001 and .004, recording a total net loss

F-43

---

		on settlement of $4,098. The common stock was valued at the conversion rate in accordance with the convertible debt or at the market price on the date of grant.
	b)	Common Stock Issued for Services
		During 2009, the Company issued 64,900,000 common shares, valued at $87,463, in settlement of $102,335 of services rendered at stock prices between $.001 and $.004, recording a total net gain on settlement of $14,872. The common stock was valued at the market price on the date of grant.
	c)	Common Stock Issued for Conversion of Debt (private investors)
		During 2009, the Company issued 50,140,000 common shares in settlement of $203,800 of funding from private investors, as described in Note 8, at stock prices between $.0007 and $.006. The common stock was valued using the conversion rate in accordance with the terms of the agreement. No gain or loss on conversion was recorded.
	d)	Common Stock Issued to Related Parties
		During 2009, the Company issued 513,206,324 common shares, valued at $1,033,946, in settlement of $1,316,873 of convertible debts and accrued liabilities from related parties, Directors and Officers, as described in Note 10, at stock prices between $.001 and $.008, recording a total net gain on settlement of $282,927. The common stock was valued at the market price on the date of grant.
	e)	Common Stock Issued for Stock Options exercised on a Cashless Basis
		During 2009, the Company issued 6,000,000 common shares in settlement of options exercised by Directors and Officer, as described in Note 13, on a cashless basis at an exercise price of $.002. During the year ended June 30, 2004, an Officer of the Company exercised stock options pursuant to a services agreement. The exercise of these stock options entitled the Officer to 1,500,000 common shares of the Company on a cashless basis. These shares were issued during the first quarter of Fiscal year 2009 at an exercise price of $.001.

During the year ended June 30, 2008, the Company issued 42,100,000 common shares summarized as follows:

	a)	Common Stock Issued for Settlement of Convertible Notes and Accounts Payable and Accrued Liabilities – Non-Related Parties
		During 2008, the Company issued 20,000,000 common shares, valued at $144,000, in settlement of $40,000 of convertible notes previously issued by the Company and accounts payable and accrued liabilities at stock prices between .005 and .008, recording a total loss on settlement of $104,000. The common stock was valued at the conversion rate in accordance with the convertible debt or at the market price on the date of grant.
	b)	Common Stock Issued for Services
		During 2008, the Company issued 22,100,000 common shares, valued at $152,600, in settlement of $94,200 of services rendered at stock prices between $.006 and $.007, recording a loss on settlement of $58,400. The common stock was valued at the market price on the date of grant.

F-44

---

Note 12 PREFERRED STOCK

On June 19, 2008, the Company’s Board of Directors approved an amended Certificate of Designation with respect to the authorization and issuance of up to 3,000,000 Series A Preferred shares, an increase from the 1,000,000 shares of Series A Preferred stock that were authorized to be issued in the Certificate of Designation of Series A Preferred stock passed by the Board of Directors on February 12, 2008. No cash dividends shall be paid with respect to the shares of Series A Preferred stock. The Series A Preferred stock shall give its holders the right to 100 votes per share on any matter properly before the shareholders for a vote. The voting rights of the Series A Preferred stock shall be subject to all splits and each share will be convertible into 5 shares of Common stock upon the earlier of: (i) the holders’ election or (ii) January 8, 2009. The holders of all shares of Series A Preferred stock shall not be subject to any non-cash distributions to holders of shares of Common stock, including without limitation, stock dividends, stock splits and securities issued in a recapitalization. In the event of liquidation or winding up of the Corporation, the holders of the Series A Preferred stock will be entitled to receive, prior and in preference to the holders of the Common stock, an amount up to but not greater than the original purchase price per share of Series A Preferred stock, notwithstanding the par value of the Series A Preferred stock. These three million Series A Preferred Shares were issued to three Directors and Officers in June 2008. The value assigned to this issuance is $286,000, based on an estimate of the fair market value on the issuance date. The fair market value is calculated as the greater of (i) the converted value to common stock at a ratio of 1:5 and, (ii) the value of the voting rights. These shares as a group represent a controlling voting interest. The fair market value also takes into account this control premium. The control premium is based on publicly traded companies or comparable entities which have been recently acquired in arm’s-length transactions. The preferred shares were issued to settle accrued liabilities to the Directors and Officers in the amount of $15,000. A loss on issuance of these preferred shares was recognized in the income statement in the amount of $271,000.

On March 31, 2009, the Company’s Board of Directors approved an amended Certificate of Designation with respect to the authorization and issuance of up to 15,000,000 Series A Preferred shares, an increase from the 3,000,000 shares of Series A Preferred stock that were authorized to be issued in the Certificate of Designation of Series A Preferred stock passed by the Board of Directors on May 12, 2008. No cash dividends shall be paid with respect to the shares of Series A Preferred stock. The Series A Preferred stock shall give its holders the right to 100 votes per share on any matter properly before the shareholders for a vote. The voting rights of the Series A Preferred stock shall be subject to all splits and each share will be convertible into 5 shares of Common stock upon the earlier of: (i) the holders’ election or (ii) January 8, 2009. The holders of all shares of Series A Preferred stock shall not be subject to any non-cash distributions to holders of shares of Common stock, including without limitation, stock dividends, stock splits and securities issued in a recapitalization. In the event of liquidation or winding up of the Corporation, the holders of the Series A Preferred stock will be entitled to receive, prior and in preference to the holders of the Common stock, an amount up to but not greater than the original purchase price per share of Series A Preferred stock, notwithstanding the par value of the Series A Preferred stock. These twelve million Series A Preferred Shares were issued to three Directors and Officers in March 2009. The value assigned to this issuance is $175,000, based on an estimate of the fair market value on the issuance date. The fair market value is calculated as the greater of (i) the converted value to common stock at a ratio of 1:5 and, (ii) the value of the voting rights. These shares as a group represent a controlling voting interest. The the fair market value also takes into account this control premium. The control premium is based on publicly traded companies or comparable entities which have been recently acquired in arm’s-length transactions. The preferred shares were issued to settle accrued liabilities to the Directors and Officers in the amount of $60,000. A loss on issuance of these preferred shares was recognized in the income statement in the amount of $115,000.

F-45

---

Note 13 STOCK OPTIONS

a) Stock Options

Under executive employment agreements with Tirex, its three officers, John Threshie, Lou Muro and Michael Ash have been granted stock options for each of the fiscal years June 30, 2008 and 2009.

1) John L. Threshie Jr., President

3,000,000 stock options at the beginning of the fiscal years 2008 and 2009. The stock options are exercisable within three years of the date of issue of the stock options. The exercise price of the stock options are as follows:

Year 1 – Lesser of $.20 or 50% of market

Year 2 – Lesser of $.40 or 50% of market

Year 3 – Lesser of $.50 or 50% of market

2) Michael D.A. Ash, Secretary-Treasurer & Chief Financial Officer

2,000,000 stock options at the beginning of the fiscal years 2008 and 2009. The stock options are exercisable within three years of the date of issue of the stock options. The exercise price of the stock options are as follows:

Year 1 – Lesser of $.20 or 50% of market.

Year 2 – Lesser of $.40 or 50% of market.

Year 3 – Lesser of $.50 or 50% of market.

3) Louis V. Muro, Vice President - Engineering

1,000,000 stock options at the beginning of the fiscal years 2008 and 2009. The stock options are exercisable within three years of the date of issue of the stock options. The exercise price of the stock options are as follows:

Year 1 – Lesser of $.20 or 50% of market.

Year 2 – Lesser of $.40 or 50% of market.

Year 3 – Lesser of $.50 or 50% of market.

A summary of the changes in the Company’s common share stock options is presented below:

F-46

---

			June 30, 2009						June 30, 2008
						Weighted						Weighted
			Number of			Average Exercise			Number of			Average Exercise
			Stock Options			Price ($)			Stock Options			Price ($)
	Balance at beginning of the year		6,000,000			0.002			-			-
	Granted		6,000,000			0.001			6,000,000			0.002
	Exercised		(6,000,000	)		(0.002	)		-			-
	Forfeited		-			-			-			-
	Balance at end of the year		6,000,000			0.001			6,000,000			0.002

The fair value of the options granted during the year was measured at the date of grant using the Black-Scholes option pricing model with the following weigthed-average assumptions:

			Year ended
			June 30,
			2009			2008
	Risk - free interest rate		0.795%			2.51%
	Expected volatility		1805.3%			2739.2%
	Expected life of stocks options (in years)		1.5			1.50
	Assumed dividends		None			None

The Company recognized compensation expense related to stock options for the years ended June 30, 2009 and 2008 of $30,000 and $24,000, respectively.

Note 14 RENTAL EXPENSE AND COMMITMENTS

Rental expense for the year ended June 30, 2009 amounted to $9,750, and was payable to John Threshie, the Company’s President & CEO. Rental expense for the year ended June 30, 2008 amounted to $0.

At June 30, 2009, the Company was in arrears of rent, including interest and related charges, in the approximate amount of $560,000 related to its former occupation of premises in Montreal up to the end of Fiscal year 2003. A settlement agreement with the former landlord is in place under the terms of which the Company would pay to the former landlord the sum of $140,000 from the proceeds to the Company of revenues from each of the first four sales of TCS Systems.

As of June 30, 2009, the Company does not have any outstanding lease commitments or minimum annual rental payments and sub-lease income.

Note 15 LITIGATION

An action was instituted by Plaintiffs, an individual and a corporation, in March 2001, in a Canadian court alleging a breach of contract and claims damages of approximately $795,000 representing expenses and an additional approximate amount of $5,411,000 in loss of profits. The current action follows two similar actions taken in United States courts, the first of which was withdrawn and the second of which was dismissed based on forum non convenience and other considerations. A detailed answer has been filed by the Company denying all liability, stating further that Plaintiffs failed to comply with their obligations. Counsel for the Company believes that the Company has meritorious defenses to all of the Plaintiff's claims. The action is still pending.

F-47

---

A Plaintiff instituted an action, a corporation, in August 2001 in a Canadian court claiming approximately $99,000 is due and owing for the manufacture and delivery of tire disintegrators. The Company has prepared its defense and a cross claim of $100,000 against the Plaintiff as the product delivered was defective and the Company believes it is entitled to a reimbursement of sums paid. The action is still pending.

An action was instituted by a Plaintiff, the Company’s landlord, against the Company in June 2001 for arrears of rent in the amount of approximately $113,900. Subsequent additions to arrearages with respect to rent and property taxes raised the amount due to approximately $560,000. A settlement agreement with the former landlord is in place, under the terms of which the Company would pay to the former landlord the sum of $140,000 from the proceeds to the Company of revenues from the first four sales of TCS Systems.

An action was instituted by a Plaintiff, a corporation, in March 2001 in a Canadian court. The Company did not defend the action and, as such, a judgment was rendered against it in August 2001, by which judgment it was ordered to pay the Plaintiff $28,443. Execution of the judgment was attempted in 2002, without success. This matter has remained effectively dormant since February 2002. The Company has fully accrued the amount of the judgment.

Note 16 RESTATEMENT OF FINANCIAL STATEMENTS (UNAUDITED)

On August 27, 2009, the Company was informed that the Public Company Accounting Oversight Board (“PCAOB”) revoked the registration of Moore & Associates who was serving as the Company’s independent registered public accounting firm. The revocation was a result of Moore’s violation of PCAOB rules and auditing standards. This revocation of Moore’s registration required the Company to have the financial statements previously issued for the fiscal year ended June 30, 2008 reaudited.

This reaudit produced material differences from the previously issued financial statements. These misstatements are the result of errors described in the annotations following the restated financial statements. One such significant error is described more fully in the following paragraph:

The Company issued Convertible Notes on February 26, 2001 having a face value of $750,000 but had not implemented ASC Topic 815 (“ASC 815”). As a result of the implementation of ASC 815 during Fiscal 2009, the Company recorded a derivative liability, note discount, gain (loss) on the change in the fair value of the derivative liability, accretion expense and interest expense on the accretion of the note discount, as applicable, during the Fiscal years 2001 to 2009. The accounting policies adopted are more fully explained in Note 3, Fair Value Measurements, and Note 9, Derivative Financial Instruments. The restated financial statements provide the impact, for each of the years, on the balance sheet and statement of operations and comprehensive income (loss).

Included in this note are the restated 2001 to 2008 fiscal year financial statements, presented by annual period restatements and by each year’s quarterly period restatements. For comparative purposes, the table below presents the restated balance sheets and income statements compared to the original financial statements issued. With the exception of the 2008 fiscal year, all the adjustments relate to the liabilities and shareholders’ equity (deficit) sections of the balance sheet. Since the restated balance sheets from 2001 to 2007 do not include adjustments to any asset values, only the value of total assets has been presented on the balance sheet for each of those restated fiscal years.

a) Annual Periods

F-48

---

CONSOLIDATED BALANCE SHEET

JUNE 30, 2008

		June 30,									June 30,
		2008			Net Change						2008
		Original									Restated
ASSETS
Property and equipment	$	25,000			(25,000	)				$	-
Other assets
Patents		1			-						1
Total Other Assets		1			-						1
Total Assets	$	25,001			(25,000	)		(h)		$	1
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	1,478,922			263,351			(g)		$	1,742,273
Accrued liabilties - related parties		-			2,357,021			(g)			2,357,021
Notes payable - related party		-			162,500			(g)			162,500
								(g),(b),
Convertible notes - non-related parties		-			920,245			(d)			920,245
Derivative liability		-			2,325,572			(a),(c)			2,325,572
Total Current Liabilities		1,478,922			6,028,689						7,507,611
Other liabilities
Long-term deposits and convertible notes		306,000			(306,000	)		(g)			-
Convertible notes		399,389			(399,389	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		2,756,215			(2,756,215	)		(g)			-
Total Other Liabilities		3,647,160			(3,647,160	)					-
Total Liabilities		5,126,082			2,381,529						7,507,611
Stockholders' Equity (Deficit)
Preferred stock, $.005 par value, authorized 15,000,000 Series A shares, issued and outstanding 3,000,000 Series A shares		15,000			-						15,000
Common stock, $.001 par value, authorized 1,000,000,000 shares, issued and outstanding 291,995,892 shares		291,996			-						291,996
								(e),(f),(j
Additional paid-in capital		25,255,619			549,846			),(k)			25,805,465
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(s)			(1,057,356	)
								(c),(d),
								(e),(f),
								(h),(i),
								(j),(k),
								(l),(m),
								(n),(o),
Deficit accumulated during the development stage		(30,058,456	)		(1,899,287	)		(p)			(31,957,743	)
Unrealized loss on foreign exchange		(605,240	)		268						(604,972	)
		(5,101,081	)		(2,406,529	)					(7,507,610	)
Total Liabilities and Stockholders' Equity (Deficit)	$	25,001			(25,000	)				$	1

F-49

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

FOR THE YEAR ENDED JUNE 30, 2008

					For the Year
					Ended June 30,
		2008			Net Change						2008
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
								(f),(l),
								(m),(o),
General and administrative		451,526			403,419			(p)			854,945
Total Expense		451,526			403,419						854,945
Income (loss) before other expenses		(451,526	)		(403,419	)					(854,945	)
Other expenses (income)
Interest expense		46,795			(65,412	)		(i)			(18,617	)
Impairment of fixed assets		-			25,000			(h)			25,000
(Gain) on change in derivative liability		-			(3,906,066	)		(c)			(3,906,066	)
Loss on settlement of debt		-			162,400			(k)			162,400
Total Other expenses (income)		46,795			(3,784,078	)					(3,737,283	)
Provision for income taxes		-			-						-
Net income (loss)		(498,321	)		3,380,659						2,882,338
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net income (loss) and comprehensive income (loss)	$	(498,321	)		3,380,659					$	2,882,338
Net income and comprehensive income per share - basic	$	(0.00	)							$	0.01
Net income and comprehensive income per share - diluted										$	0.00
Weighted average number of shares - basic		252,126,303									252,126,303
Weighted average number of shares - diluted											10,185,751,788

F-50

---

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE YEAR ENDED JUNE 30, 2008

					For the Year
					Ended June 30,
		2008			Net Change						2008
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(498,322	)	$	3,380,660					$	2,882,338
Adjustments to reconcile net income to net cash used in operating activities:
Imputed interest		-			28,344			(e)			28,344
Impairment of fixed assets		-			25,000			(h)			25,000
(Gain) loss on settlement of debt		-			162,400			(k)			162,400
Loss on issuance of preferred stock		-			271,000			(f)			271,000
Common stock issued in exchange for services and expenses		-			102,200			(l)			102,200
Stock options issued in exchange for services		-			24,000			(m)			24,000
Change in derivative liability		-			(3,906,066	)		(c)			(3,906,066	)
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		504,485			(398,069	)		(g)			106,416
Accrued liabilities - related parties		-			233,163			(g)			233,163
Net cash used provided by (used in) operating activities		6,163			(77,368	)					(71,205	)
Cash flow from financing activities:
Proceeds from private investors		-			77,100			(g)			77,100
Net cash provided by financing activities		-			77,100						77,100
Effect of Exchange rate changes on cash and cash equivalents		(6,163	)		268						(5,895	)
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-
											Twelve months ended
											June 30, 2008
Non-cash financing and Investing Activities:
Issuance of common stock for the settlement of accrued liabilities - related parties											20,000
Issuance of common stock for the settlement of convertible notes - non-related parties											12,000

F-51

---

CONSOLIDATED BALANCE SHEET

JUNE 30, 2007

		June 30,									June 30,
		2007			Net Change						2007
		Original									Restated
ASSETS
Total Assets	$	25,001			-					$	25,001
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	1,488,211			275,856			(g)		$	1,764,067
Accrued liabilties - related parties		-			2,131,148			(g)			2,131,148
Notes payable - related party		-			162,500			(g)			162,500
Convertible notes - non-related parties		-			754,645			(g),(b),(d)			754,645
Derivative liability		-			6,231,638			(a),(c)			6,231,638
Total Current Liabilities		1,488,211			9,555,787						11,043,998
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Convertible notes		399,389			(399,389	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		2,421,442			(2,421,442	)		(g)			-
Total Other Liabilities		3,223,887			(3,223,887	)					-
Total Liabilities		4,712,098			6,331,900						11,043,998
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized
250,000,000 shares, issued and outstanding
249,895,892 shares		249,896									249,896
Additional paid-in capital		25,222,219			5,402			(e)			25,227,621
Deficit accumulated prior to entering development stage		-			(1,057,356	)					(1,057,356	)
								(c),(d),(e),
Deficit accumulated during the development stage		(29,560,135	)		(5,279,946	)		(j)			(34,840,081	)
Unrealized loss on foreign exchange		(599,077	)								(599,077	)
		(4,687,097	)		(6,331,900	)					(11,018,997	)
Total Liabilities and Stockholders' Equity (Deficit)	$	25,001			-					$	25,001

F-52

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

FOR THE YEAR ENDED JUNE 30, 2007

					For the Year
					Ended June 30,
		2007			Net Change						2007
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		409,054						(j)			409,054
Total Expense		409,054			-						409,054
Income (loss) before other expenses		(409,054	)		-						(409,054	)
Other expenses (income)
Interest expense		46,795			-						46,795
(Gain) on change in derivative liability		-			(339,886	)		(c)			(339,886	)
Total Other expenses (income)		46,795			(339,886	)					(293,091	)
Provision for income taxes		-			-						-
Net income (loss)		(455,849	)		339,886						(115,963	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net loss and comprehensive loss	$	(455,849	)		339,886					$	(115,963	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.00	)							$	(0.00	)
Weighted average number of shares - basic and diluted		249,895,892									249,895,892

F-53

---

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE YEAR ENDED JUNE 30, 2007

					For the Year
					Ended June 30,
		2007			Net Change						2007
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(455,849	)	$	339,886					$	(115,963	)
Adjustments to reconcile net income to net cash used in operating activities:
Change in derivative liability		-			(339,886	)		(c)			(339,886	)
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		446,023			(325,000	)		(g)			121,023
Accrued liabilities - related parties		-			325,000			(g)			325,000
Net cash used in operating activities		(9,826	)		-						(9,826	)
Cash flow from financing activities:
Proceeds from notes payable		54,000			-						54,000
Net cash provided by financing activities		54,000			-						54,000
Effect of Exchange rate changes on cash and cash equivalents		(44,174	)		-						(44,174	)
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-54

---

CONSOLIDATED BALANCE SHEET

JUNE 30, 2006

		June 30,									June 30,
		2006			Net Change						2006
		Original									Restated
ASSETS
Total Assets	$	25,001			-					$	25,001
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	1,400,688			275,856			(g)		$	1,676,544
Accrued liabilties - related parties		-			1,772,648			(g)			1,772,648
Notes payable - related party		-			162,500			(g)			162,500
Convertible notes - non-related parties		-			700,645			(g),(b),(d)			700,645
Derivative liability		-			6,571,524			(a),(c)			6,571,524
Total Current Liabilities		1,400,688			9,483,173						10,883,861
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Convertible notes		399,389			(399,389	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		2,008,942			(2,008,942	)		(g)			-
Total Other Liabilities		2,811,387			(2,811,387	)					-
Total Liabilities		4,212,075			6,671,786						10,883,861
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized
250,000,000 shares, issued and outstanding
249,895,892 shares		249,896									249,896
Additional paid-in capital		25,222,219			5,402			(e)			25,227,621
Deficit accumulated prior to entering development stage		-			(1,057,356	)					(1,057,356	)
								(c),(d),
Deficit accumulated during the development stage		(29,104,286	)		(5,619,832	)		(e),(j)			(34,724,118	)
Unrealized loss on foreign exchange		(554,903	)								(554,903	)
		(4,187,074	)		(6,671,786	)					(10,858,860	)
Total Liabilities and Stockholders' Equity (Deficit)	$	25,001			-					$	25,001

F-55

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

FOR THE YEAR ENDED JUNE 30, 2006

					For the Year
					Ended June 30,
		2006			Net Change						2006
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		173,778			-						173,778
Total Expense		173,778			-						173,778
Income (loss) before other expenses		(173,778	)		-						(173,778	)
Other expenses (income)
Interest expense		46,794			-						46,794
(Gain) on change in derivative liability		-			(2,844,613	)		(c)			(2,844,613	)
Total Other expenses (income)		46,794			(2,844,613	)					(2,797,819	)
Provision for income taxes		-			-						-
Net income (loss)		(220,572	)		2,844,613						2,624,041
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net income (loss) and comprehensive income (loss)	$	(220,572	)		2,844,613					$	2,624,041
Net income (loss) and comprehensive income (loss)
per common share - basic	$	(0.00	)							$	0.01
Net income and comprehensive income per share - diluted										$	0.00
Weighted average number of shares - basic		249,895,892									249,895,892
Weighted average number of shares - diluted											664,391,517

F-56

---

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE YEAR ENDED JUNE 30, 2006

					For the Year
					Ended June 30,
		2006			Net Change						2006
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(220,572	)	$	2,844,613					$	2,624,041
Adjustments to reconcile net income to net cash used in operating activities:
Change in derivative liability		-			(2,844,613	)		(c)			(2,844,613	)
Changes in assets and liabilities:
(Decrease) increase in :
Accounts payable and accrued liabilities		238,468			(219,281	)		(g)			19,187
Accrued liabilities - related parties		-			219,281			(g)			219,281
Net cash provided by operating activities		17,896			-						17,896
Cash flow from financing activities:
Proceeds from notes payable		60,700			-						60,700
Net cash provided by financing activities		60,700			-						60,700
Effect of Exchange rate changes on cash and cash equivalents		(78,596	)		-						(78,596	)
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-57

---

CONSOLIDATED BALANCE SHEET

JUNE 30, 2005

		June 30,									June 30,
		2005			Net Change						2005
		Original									Restated
ASSETS
Total Assets	$	25,001			-					$	25,001
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	1,210,657			259,919			(g)		$	1,470,576
Accrued liabilties - related parties		-			1,740,148			(g)			1,740,148
Notes payable - related party		-			162,500			(g)			162,500
								(g),(b),
Convertible notes - non-related parties		-			639,945			(d)			639,945
Derivative liability		-			9,416,137			(a),(c)			9,416,137
Total Current Liabilities		1,210,657			12,218,649						13,429,306
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Convertible notes		399,389			(399,389	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		1,899,805			(1,899,805	)		(g)			-
Total Other Liabilities		2,702,250			(2,702,250	)					-
Total Liabilities		3,912,907			9,516,399						13,429,306
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized
250,000,000 shares, issued and outstanding
249,895,892 shares		249,896									249,896
Additional paid-in capital		25,222,219			5,402			(e)			25,227,621
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
								(c),(d),
Deficit accumulated during the development stage		(28,883,714	)		(8,464,445	)		(e),(j)			(37,348,159	)
Unrealized loss on foreign exchange		(476,307	)								(476,307	)
		(3,887,906	)		(9,516,399	)					(13,404,305	)
Total Liabilities and Stockholders' Equity (Deficit)	$	25,001			-					$	25,001

F-58

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

FOR THE YEAR ENDED JUNE 30, 2005

					For the Year
					Ended June 30,
		2005			Net Change						2005
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		524,146			-						524,146
Total Expense		524,146			-						524,146
Income (loss) before other expenses		(524,146	)		-						(524,146	)
Other expenses (income)
Interest expense		52,620			-						52,620
Loss on change in derivative liability		-			7,140,826			(c)			7,140,826
Total Other expenses (income)		52,620			7,140,826						7,193,446
Provision for income taxes		-			-						-
Net loss		(576,766	)		(7,140,826	)					(7,717,592	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net loss and comprehensive loss	$	(576,766	)		(7,140,826	)				$	(7,717,592	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.00	)							$	(0.03	)
Weighted average number of shares - basic and diluted		249,895,892									249,895,892

F-59

---

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE YEAR ENDED JUNE 30, 2005

					For the Year
					Ended June 30,
		2005			Net Change						2005
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(576,766	)	$	(7,140,826	)				$	(7,717,592	)
Adjustments to reconcile net income to net cash used in operating activities:
Change in derivative liability		-			7,140,826			(c)			7,140,826
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		640,214			(255,533	)		(g)			384,681
Accrued liabilities - related parties		-			442,500			(g)			442,500
Net cash provided by operating activities		63,448			186,967						250,415
Cash flow from financing activities:
Convertible notes - non-related parties		-			(186,967	)		(g)			(186,967	)
Net cash used in financing activities		-			(186,967	)					(186,967	)
Effect of Exchange rate changes on cash and cash equivalents		(63,448	)		-						(63,448	)
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-60

---

CONSOLIDATED BALANCE SHEET

JUNE 30, 2004

		June 30,									June 30,
		2004			Net Change						2004
		Original									Restated
ASSETS
Total Assets	$	25,001			-					$	25,001
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	1,049,489			36,406			(g)		$	1,085,895
Accrued liabilties - related parties		-			1,297,648			(g)			1,297,648
Notes payable - related party		-			162,500			(g)			162,500
								(g),(b),
Convertible notes - non-related parties		-			826,912			(d)			826,912
Derivative liability		-			2,275,311			(a),(c)			2,275,311
Total Current Liabilities		1,049,489			4,598,777						5,648,266
Other liabilities
											-
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Convertible notes		586,356			(586,356	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		1,233,792			(1,233,792	)		(g)			-
Total Other Liabilities		2,223,204			(2,223,204	)					-
Total Liabilities		3,272,693			2,375,573						5,648,266
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized
250,000,000 shares, issued and outstanding											-
249,895,892 shares		249,896									249,896
Additional paid-in capital		25,222,219			5,402			(e)			25,227,621
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
								(c),(d),
Deficit accumulated during the development stage		(28,306,948	)		(1,323,619	)		(e),(j)			(29,630,567	)
Unrealized loss on foreign exchange		(412,859	)		-						(412,859	)
		(3,247,692	)		(2,375,573	)					(5,623,265	)
Total Liabilities and Stockholders' Equity (Deficit)	$	25,001			-					$	25,001

F-61

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

FOR THE YEAR ENDED JUNE 30, 2004

					For the Year
					Ended June 30,
		2004			Net Change						2004
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		666,267			-						666,267
Total Expense		666,267			-						666,267
Income (loss) before other expenses		(666,267	)		-						(666,267	)
Other expenses (income)
Interest expense		83,438			1,000			(e)			84,438
Loss on change in derivative liability		-			725,182			(c)			725,182
Gain from extinguishment of debt		(1,047,921	)		(345,884	)					(1,393,805	)
Total Other expenses (income)		(964,483	)		380,298						(584,185	)
Provision for income taxes		-			-						-
Net income (loss)		298,216			(380,298	)					(82,082	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net income (loss) and comprehensive income (loss)	$	298,216			(380,298	)				$	(82,082	)
Net income (loss) and comprehensive income (loss) per common share - basic and diluted	$	0.00								$	(0.00	)
Weighted average number of shares - basic and diluted		249,895,892									249,895,892

F-62

---

FOR THE YEAR ENDED JUNE 30, 2004

					For the Year
					Ended June 30,
		2004			Net Change						2004
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	298,216		$	(380,298	)				$	(82,082	)
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization		25,000			-						25,000
Accretion expense		-			1,000			(d)			1,000
(Gain) from extinguishment of debt		-			(1,393,805	)		(s)			(1,393,805	)
Change in derivative liability		-			725,182			(c)			725,182
Changes in assets and liabilities:
(Increase) decrease in:
Account receivable		-			20,475			(s)			20,475
Inventory		-			73,323			(s)			73,323
(Decrease) increase in :
Accounts payable and accrued liabilities		(292,891	)		658,588			(g)			365,697
Accrued liabilities - related parties		-			378,186			(g)			378,186
Net cash provided by operating activities		30,325			82,651						112,976
Cash flow from investing activities:
Patents		-			(1	)		(s)			(1	)
Investment		-			89,500			(s)			89,500
Net cash provided by investing activities		-			89,499						89,499
Cash flow from financing activities:
Current portion of long-term debt		-			(172,150	)		(s)			(172,150	)
Net cash used in financing activities		-			(172,150	)					(172,150	)
Effect of Exchange rate changes on cash and cash equivalents		(30,325	)		-						(30,325	)
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-63

---

CONSOLIDATED BALANCE SHEET

JUNE 30, 2003

		June 30,									June 30,
		2003			Net Change						2003
		Original									Restated
ASSETS
Total Assets	$	233,335			-					$	233,335
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	1,792,432			321,608			(g)		$	2,114,040
Accrued liabilties - related parties					919,462			(g)			919,462
Current portion of long-term debt		85,070			87,080			(g)			172,150
Notes payable - related party					162,500			(g)			162,500
Convertible notes - non-related parties					826,912			(g),(b),(d)			826,912
Derivative liability					1,550,129			(a),(c)			1,550,129
Total Current Liabilities		1,877,502			3,867,691						5,745,193
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Government loans (net of current)		87,080			(87,080	)		(g)			-
Convertible notes		932,240			(932,240	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		794,924			(794,924	)		(g)			-
Total Other Liabilities		2,217,300			(2,217,300	)					-
Total Liabilities		4,094,802			1,650,391						5,745,193
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized
250,000,000 shares, issued and outstanding
249,895,892 shares		249,896									249,896
Additional paid-in capital		25,222,219			4,402			(e)			25,226,621
Deficit accumulated prior to entering development stage		-			(1,057,356	)					(1,057,356	)
								(c),(d),
Deficit accumulated during the development stage		(28,951,048	)		(597,437	)		(e),(j)			(29,548,485	)
Unrealized loss on foreign exchange		(382,534	)								(382,534	)
		(3,861,467	)		(1,650,391	)					(5,511,858	)
Total Liabilities and Stockholders' Equity (Deficit)	$	233,335			-					$	233,335

F-64

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

FOR THE YEAR ENDED JUNE 30, 2003

					For the Year
					Ended June 30,
		2003			Net Change						2003
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		981,170			-						981,170
Depreciation and amortization		24,960			-						24,960
Research and development		450,000			-						450,000
Total Expense		1,456,130			-						1,456,130
Income (loss) before other expenses		(1,456,130	)		-						(1,456,130	)
Other expenses (income)
Interest expense		105,245			999			(e)			106,244
Accretion expense		-			490,893			(d)			490,893
Loss on change in derivative liability		-			609,616			(c)			609,616
Loss (gain) from extinguishment of debt		-			100,262			(j),(q)			100,262
Total Other expenses (income)		105,245			1,201,770						1,307,015
Provision for income taxes		-			-						-
Net income (loss)		(1,561,375	)		(1,201,770	)					(2,763,145	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net loss and comprehensive loss	$	(1,561,375	)		(1,201,770	)				$	(2,763,145	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.01	)							$	(0.01	)
Weighted average number of shares - basic and diluted		237,326,726									237,326,726

F-65

---

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE YEAR ENDED JUNE 30, 2003

					For the Year
					Ended June 30,
		2003			Net Change						2003
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(1,561,375	)	$	(1,201,770	)				$	(2,763,145	)
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization		24,960			-						24,960
Imputed interest		-			999			(e)			999
Accretion expense		-			490,893			(e)			490,893
(Gain) loss on disposal and abandonment of assets		530,651			-						530,651
(Gain) loss on settlement of debt		-			100,262			(s)			100,262
Common stock issued in exchange for services and expenses		43,250			-						43,250
Change in derivative liability		-			609,616			(c)			609,616
Changes in assets and liabilities:
(Increase) decrease in:
Accounts receivable		33,213			1,231			(c)			34,444
Inventory		(8,158	)		-						(8,158	)
Sales tax receivable		22,053			-						22,053
Research and experimental development tax credits receivable		246,970			-						246,970
Other assets		242,956			-						242,956
(Decrease) increase in :
Accounts payable and accrued liabilities		306,666			(143	)		(g)			306,523
Accrued liabilities - related parties		-			(10,567	)		(g)			(10,567	)
Net cash used in operating activities		(118,814	)		(9,479	)					(128,293	)
Cash flow from investing activities:
Increase in notes receivable		(2,415	)		-						(2,415	)
Net cash used in investing activities		(2,415	)		-						(2,415	)
Cash flow from financing activities:
Loans from related parties		133,600			-						133,600
Payments on loan payable		(52,628	)		-						(52,628	)
Proceeds from grants		187,122			-						187,122
Proceeds from issuance of common stock		4,283			-						4,283
Proceeds from additional paid-in capital		31,217			-						31,217
Net cash provided by financing activities		303,594			-						303,594
Effect of Exchange rate changes on cash and cash equivalents		(182,365	)		-						(182,365	)
Net (decrease) increase in cash and cash equivalents		-			(9,479	)					(9,479	)
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	(9,479	)				$	(9,479	)

F-66

---

CONSOLIDATED BALANCE SHEET

JUNE 30, 2002

		June 30,									June 30,
		2002			Net Change						2002
		Original									Restated
ASSETS
Total Assets	$	1,302,955			-					$	1,302,955
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	1,485,767			110,250			(g)		$	1,596,017
Accrued liabilties - related parties		-			902,528			(g)			902,528
Current portion of long-term debt		62,033			153,266			(g)			215,299
Notes payable - related party		-			162,500			(g)			162,500
Convertible notes - non-related parties		-			681,903			(g),(b),(d)			681,903
Derivative liability		-			940,513			(a),(c)			940,513
Total Current Liabilities		1,547,800			2,950,960						4,498,760
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Government loans (net of current)		139,707			(139,707	)		(g)			-
Capital lease obligations (net of current)		13,559			(13,559	)		(g)			-
Convertible notes		932,240			(932,240	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		1,012,778			(1,012,778	)		(g)			-
Total Other Liabilities		2,501,340			(2,501,340	)					-
Total Liabilities		4,049,140			449,620						4,498,760
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized
250,000,000 shares, issued and outstanding
224,757,559 shares		224,758									224,758
Additional paid-in capital		24,618,899			3,403			(e)			24,622,302
Deficit accumulated prior to entering development stage		-			(1,057,356	)					(1,057,356	)
Deficit accumulated during the development stage		(27,389,673	)		604,333			(c),(d),(e)			(26,785,340	)
Unrealized loss on foreign exchange		(200,169	)								(200,169	)
		(2,746,185	)		(449,620	)					(3,195,805	)
Total Liabilities and Stockholders' Equity (Deficit)	$	1,302,955			-					$	1,302,955

F-67

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

FOR THE YEAR ENDED JUNE 30, 2002

					For the Year
					Ended June 30,
		2002			Net Change						2002
		Original									Restated
Revenues	$	28,515			-					$	28,515
Cost of Sales		12,981			-						12,981
Gross profit		15,534			-						15,534
Operations
General and administrative		1,209,913			-						1,209,913
Depreciation and amortization		53,184			-						53,184
Research and development		2,297,577			-						2,297,577
Total Expense		3,560,674			-						3,560,674
Income (loss) before other expenses		(3,545,140	)		-						(3,545,140	)
Other expenses (income)
Interest expense		222,204			3,403			(e)			225,607
Accretion expense		-			186,524			(d)			186,524
Loss on change in derivative liability		-			132,662			(c)			132,662
Total Other expenses (income)		222,204			322,589						544,793
Provision for income taxes		-			-						-
Net loss		(3,767,344	)		(322,589	)					(4,089,933	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net loss and comprehensive loss	$	(3,767,344	)		(322,589	)				$	(4,089,933	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.02	)							$	(0.02	)
Weighted average number of shares - basic and diluted		204,212,265									204,212,265

F-68

---

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE YEAR ENDED JUNE 30, 2002

					For the Year
					Ended June 30,
		2002			Net Change						2002
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(3,767,344	)	$	(322,589	)				$	(4,089,933	)
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization		53,184			-						53,184
Accretion expense		-			189,927			(d)			189,927
Impairment of fixed assets		-			-						-
(Gain) loss on disposal and abandonment of assets		1,500,000			-						1,500,000
Common stock issued in exchange for services and expenses		333,325			-						333,325
Change in derivative liability		-			132,662			(c)			132,662
Changes in assets and liabilities:
(Increase) decrease in:
Account receivable		(33,213	)		-						(33,213	)
Inventory		10,794			-						10,794
Sales tax receivable		25,261			-						25,261
Research and experimental development tax credits receivable		114,059			-						114,059
Other assets		193,297			-						193,297
(Decrease) increase in :
Accounts payable and accrued liabilities		135,447			415,273			(g)			550,720
Accrued liabilities - related parties		90,874			(415,273	)		(g)			(324,399	)
Net cash used in operating activities		(1,344,316	)		-						(1,344,316	)
Cash flow from investing activities:
Increase in notes receivable		(5,949	)		-						(5,949	)
Investment		(89,500	)		-						(89,500	)
Net cash used in investing activities		(95,449	)		-						(95,449	)
Cash flow from financing activities:
Loans from related parties		1,070,823									1,070,823
Deferred financing costs		100,614			-						100,614
Payments on lease obligations		(7,668	)		-						(7,668	)
Payments on loan payable		(342,278	)		-						(342,278	)
Proceeds from grants		569,111			-						569,111
Proceeds from issuance of common stock		5,850			-						5,850
Proceeds from additional paid-in capital		61,897			-						61,897
Net cash provided by financing activities		1,458,349			-						1,458,349
Effect of Exchange rate changes on cash and cash equivalents		(19,940	)		-						(19,940	)
Net (decrease) increase in cash and cash equivalents		18,584			-						18,584
Cash and cash equivalents - beginning of period		1,356			-						1,356
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-69

---

CONSOLIDATED BALANCE SHEET
JUNE 30, 2001

		June 30,									June 30,
		2001			Net Change						2001
		Original									Restated
ASSETS
Total Assets	$	3,072,245			-					$	3,072,245
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	1,259,446			83,835			(g)		$	1,343,281
Accrued liabilties - related parties		-			1,120,828			(g)			1,120,828
Current portion of long-term debt		381,111			107,460			(g)			488,571
Notes payable - related party		-			162,500			(g)			162,500
Convertible notes - non-related parties		-			313,139			(g),(b),(d)			313,139
Derivative liability		-			807,851			(a),(c)			807,851
Total Current Liabilities		1,640,557			2,595,613						4,236,170
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Government loans (net of current)		80,500			(80,500	)		(g)			-
Capital lease obligations (net of current)		26,960			(26,960	)		(g)			-
Convertible notes		750,000			(750,000	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		1,204,663			(1,204,663	)		(g)			-
Total Other Liabilities		2,465,179			(2,465,179	)					-
Total Liabilities		4,105,736			130,434						4,236,170
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized   250,000,000 shares, issued and outstanding   176,366,408 shares		176,366									176,366
Additional paid-in capital		22,592,701									22,592,701
Deficit accumulated prior to entering development stage		-			(1,057,356	)					(1,057,356	)
Deficit accumulated during the development stage		(23,622,329	)		926,922			(c),(d)			(22,695,407	)
Unrealized loss on foreign exchange		(180,229	)								(180,229	)
		(1,033,491	)		(130,434	)					(1,163,925	)
Total Liabilities and Stockholders' Equity (Deficit)	$	3,072,245			-					$	3,072,245

F-70

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE YEAR ENDED JUNE 30, 2001

		For the Year
		Ended June 30,
		2001			Net Change						2001
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		1,992,559			-						1,992,559
Depreciation and amortization		147,611			-						147,611
Research and development		807,272			-						807,272
Total Expense		2,947,442			-						2,947,442
Income (loss) before other expenses		(2,947,442	)		-						(2,947,442	)
Other expenses (income)
Interest expense		161,956			-						161,956
Accretion expense		-			72,583			(d)			72,583
Loss on change in derivative liability		-			57,851			(c)			57,851
Total Other expenses (income)		161,956			130,434						292,390
Provision for income taxes		-			-						-
Net loss		(3,109,398	)		(130,434	)					(3,239,832	)
Other comprehensive income (loss)
Loss on foreign exchange		2,740			-						2,740
Net loss and comprehensive loss	$	(3,112,138	)		(130,434	)				$	(3,242,572	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.02	)							$	(0.02	)
Weighted average number of shares - basic and diluted		170,139,483									170,139,483

F-71

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE YEAR ENDED JUNE 30, 2001

		For the Year
		Ended June 30,
		2001			Net Change						2001
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(3,112,138	)	$	(130,434	)				$	(3,242,572	)
Adjustments to reconcile net income to net cash         used in operating activities:
Depreciation and amortization		147,611			-						147,611
Accretion expense		-			72,583			(d)			72,583
(Gain) loss on disposal and abandonment of assets		(47,492	)		-						(47,492	)
Common stock issued in exchange for interest		4,200			-						4,200
Common stock issued in exchange for services and expenses		872,215			-						872,215
Stock options issued in exchange for services		512,377			-						512,377
Change in derivative liability		-			57,851			(c)			57,851
Changes in assets and liabilities:
(Increase) decrease in:
Inventory		34,002			-						34,002
Sales tax receivable		(28,062	)		-						(28,062	)
Research and experimental development tax credits receivable		114,192			-						114,192
Other assets		(109,361	)		-						(109,361	)
(Decrease) increase in :
Accounts payable and accrued liabilities		71,734			244,821			(g)			316,555
Accrued liabilities - related parties		-			(244,821	)		(g)			(244,821	)
Net cash used in operating activities		(1,540,722	)		-						(1,540,722	)
Cash flow from investing activities:
Reduction in notes receivable		116,089			-						116,089
Equipment		(60,769	)		-						(60,769	)
Net cash provided by investing activities		55,320			-						55,320
Cash flow from financing activities:
Loans from related parties		728,305			-						728,305
Deferred financing costs		79,943			-						79,943
Proceeds from convertible notes		754,999			-						754,999
Payments on lease obligations		(57,339	)		-						(57,339	)
Payments on loan payable		(75,147	)		-						(75,147	)
Proceeds from grants		353,725			-						353,725
Proceeds from issuance of common stock		733			-						733
Proceeds from additional paid-in capital		39,427			-						39,427
Net cash provided by financing activities		1,824,646			-						1,824,646
Effect of Exchange rate changes on cash and cash equivalents		(340,681	)		-						(340,681	)
Net (decrease) increase in cash and cash equivalents		339,244			-						339,244
Cash and cash equivalents - beginning of period		2,793			-						2,793
Cash and cash equivalents - end of period	$	1,356		$	-					$	1,356

b) Quarterly Periods

F-72

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED JUNE 30, 2008

					For the Three
		For the Three			Months Ended						For the Three
		Months Ended			June 30, 2008						Months Ended
		June 30, 2008			Net Change						June 30, 2008
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
								(f),(l),(m),
General and administrative		159,980			403,419			(o),(p)			563,399
Total Expense		159,980			403,419						563,399
Loss before other expenses		(159,980	)		(403,419	)					(563,399	)
Other expenses (income)
Interest expense		11,698			(16,353	)		(i)			(4,655	)
Impairment of fixed assets					25,000			(h)			25,000
Loss (gain) on change in derivative liability		-			(23,245,092	)		(c)			(23,245,092	)
Loss (gain) from extinguishment of debt		-			162,400			(k)			162,400
Total Other expenses (income)		11,698			(23,074,045	)					(23,062,347	)
Provision for income taxes		-			-						-
Net income (loss)		(171,678	)		22,670,626						22,498,948
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net income (loss) and comprehensive income (loss)	$	(171,678	)	$	22,670,626					$	22,498,948
Net income (loss) and comprehensive income (loss)
per share - basic	$	(0.00	)							$	0.09
Net income (loss) and comprehensive income (loss) per share - diluted										$	0.00
Weighted average number of shares - basic		252,126,303									252,126,303
Weighted average number of shares - diluted											10,188,251,788

F-73

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED JUNE 30, 2008

					For the Three						For the Three
		For the Three			Months Ended						Months
		Months Ended			June 30, 2008						Ended
		June 30, 2008			Net Change						June 30,2008
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(171,678	)	$	22,670,626					$	22,498,948
Adjustments to reconcile net income to net cash          used in operating activities:
Impairment of fixed assets		-			25,000			(h)			25,000
Loss (gain) on settlement of debt		-			162,400			(k)			162,400
Preferred stock issued for professional fees		-			271,000			(f)			271,000
Stock options issued in exchange for services		-			24,000			(m)			24,000
Change in derivative liability		-			(23,245,092	)		(c)			(23,245,092	)
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		(12,396	)		92,066			(o),(p),(i)			79,670
Accrued liabilities - related parties		112,500			-						112,500
Net cash used in operating activities		(71,574	)		-						(71,574	)
Effect of Exchange rate changes on cash and cash equivalents		71,574			-						71,574
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-74

---

CONSOLIDATED BALANCE SHEET
MARCH 31, 2008

		March 31,									March 31,
		2008			Net Change						2008
		Original									Restated
ASSETS
Total Assets	$	208,297			-					$	208,297
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	3,029,086			(1,084,341	)		(g)		$	1,944,745
Accrued liabilties - related parties					2,528,179			(g)			2,528,179
Current portion of long-term debt		108,678			-			(g)			108,678
Notes payable - related party					162,500			(g)			162,500
Convertible notes - non-related parties					816,745			(g),(b),(d)			816,745
Derivative liability					25,570,664			(a),(c)			25,570,664
Total Current Liabilities		3,137,764			27,993,747						31,131,511
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Convertible notes		399,389			(399,389	)		(g)			-
Convertible notes		195,556			(195,556	)		(g)			-
Convertible loans		2,442,885			(2,442,885	)		(g)			-
Total Other Liabilities		3,255,330			(3,255,330	)					-
Total Liabilities		6,393,094			24,738,417						31,131,511
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding  249,895,892 shares		249,896			-						249,896
Additional paid-in capital		25,222,219			5,402			(e),(f),(j),(k)			25,227,621
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
								(c),(d),(e),(f)
								,(h),(i),(j),(k),
								(l),(m),(n),(o)
Deficit accumulated during the development stage		(30,770,228	)		(23,686,463	)		,(p)			(54,456,691	)
Unrealized loss on foreign exchange		(886,684	)		-						(886,684	)
		(6,184,797	)		(24,738,417	)					(30,923,214	)
Total Liabilities and Stockholders' Equity (Deficit)	$	208,297			-					$	208,297

F-75

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED MARCH 31, 2008

					For the Three
		For the Three			Months Ended						For the Three
		Months Ended			March 31, 2008						Months  Ended
		March 31,2008			Net Change						March 31,2008
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		97,219			-						97,219
Total Expense		97,219			-						97,219
Loss before other expenses		(97,219	)		-						(97,219	)
Other expenses (income)
Interest expense		11,699			(16,353	)		(i)			(4,654	)
Loss (gain) on change in derivative liability		-			(8,438,912	)		(c)			(8,438,912	)
Total Other expenses (income)		11,699			(8,455,265	)					(8,443,566	)
Provision for income taxes		-			-						-
Net income (loss)		(108,918	)		8,455,265						8,346,347
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net income (loss) and comprehensive income (loss)	$	(108,918	)	$	8,455,265					$	8,346,347
Net income (loss) and comprehensive income (loss) per share - basic	$	(0.00	)							$	0.03
Net income (loss) and comprehensive income (loss) per share - diluted										$	0.00
Weighted average number of shares - basic		249,895,892									249,895,892
Weighted average number of shares - diluted											2,811,899,975

F-76

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED MARCH 31, 2008

					For the Three
		For the Three			Months Ended						For the Three
		Months Ended			March 31, 2008						Months Ended
		March 31, 2008			Net Change						March 31, 2008
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(108,918	)	$	8,455,265					$	8,346,347
Adjustments to reconcile net income to net cash         used in operating activities:
Change in derivative liability		-			(8,438,912	)		(c)			(8,438,912	)
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		(79,875	)		(16,353	)		(i)			(96,228	)
Accrued liabilities - related parties		112,500			-						112,500
Net cash used in operating activities		(76,293	)		-						(76,293	)
Effect of Exchange rate changes on cash and cash equivalents		76,293			-						76,293
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-77

---

CONSOLIDATED BALANCE SHEET
DECEMBER 31, 2007

		December 31,									December 31,
		2007			Net Change						2007
		Original									Restated
ASSETS
Total Assets	$	208,297			-					$	208,297
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	3,076,624			(1,048,488	)		(g)		$	2,028,136
Accrued liabilties - related parties		-			2,446,929			(g)			2,446,929
Current portion of long-term debt		112,537			-			(g)			112,537
Notes payable - related party		-			162,500			(g)			162,500
Convertible notes - non-related parties		-			794,745			(g),(b),(d)			794,745
Derivative liability		-			34,009,576			(a),(c)			34,009,576
Total Current Liabilities		3,189,161			36,365,262						39,554,423
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Convertible notes		399,389			(399,389	)		(g)			-
Convertible notes		195,556			(195,556	)		(g)			-
Convertible loans		2,359,135			(2,359,135	)		(g)			-
Total Other Liabilities		3,171,580			(3,171,580	)					-
Total Liabilities		6,360,741			33,193,682						39,554,423
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding  249,895,892 shares		249,896			-						249,896
Additional paid-in capital		25,222,219			5,402			(e),(f),(j),(k)			25,227,621
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
								(c),(d),(e),(f)
								,(h),(i),(j),(k),
								(l),(m),(n),(o),
Deficit accumulated during the development stage		(30,661,310	)		(32,141,728	)		(p)			(62,803,038	)
Unrealized loss on foreign exchange		(963,249	)		-						(963,249	)
		(6,152,444	)		(33,193,682	)					(39,346,126	)
Total Liabilities and Stockholders' Equity (Deficit)	$	208,297			-					$	208,297

F-78

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED DECEMBER 31, 2007

		For the Three			For the Three						For the Three
		Months  Ended			Months  Ended						Months  Ended
		December 31,			December 31,						December 31,
		2007			2007 - Net Change						2007
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		97,378			-						97,378
Total Expense		97,378			-						97,378
Loss before other expenses		(97,378	)		-						(97,378	)
Other expenses (income)
Interest expense		11,699			(16,353	)		(i)			(4,654	)
Loss (gain) on change in derivative liability		-			6,082,964			(c)			6,082,964
Total Other expenses (income)		11,699			6,066,611						6,078,310
Provision for income taxes		-			-						-
Net loss		(109,077	)		(6,066,611	)					(6,175,688	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net loss and comprehensive loss	$	(109,077	)	$	(6,066,611	)				$	(6,175,688	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.00	)							$	(0.02	)
Weighted average number of shares - basic and diluted		249,895,892									249,895,892

F-79

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED DECEMBER 31, 2007

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		December 31,			December 31,						December 31,
		2007			2007 - Net Change						2007
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(109,077	)	$	(6,066,611	)				$	(6,175,688	)
Adjustments to reconcile net income to net        cash used in operating activities:
Change in derivative liability		-			6,082,964			(c)			6,082,964
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		4,325			(16,353	)		(i)			(12,028	)
Accrued liabilities - related parties		112,500			-						112,500
Net cash used in operating activities		7,748			-						7,748
Effect of Exchange rate changes on cash and cash equivalents		(7,748	)		-						(7,748	)
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-80

---

CONSOLIDATED BALANCE SHEET
SEPTEMBER 30, 2007

		September 30,									September 30,
		2007			Net Change						2007
		Original									Restated
ASSETS
Total Assets	$	208,297			-					$	208,297
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	3,043,945			(1,015,235	)		(g)		$	2,028,710
Accrued liabilties - related parties		-			2,365,679			(g)			2,365,679
Current portion of long-term debt		112,141			-			(g)			112,141
Notes payable - related party		-			162,500			(g)			162,500
Convertible notes - non-related parties		-			775,345			(g),(b),(d)			775,345
Derivative liability		-			27,926,612			(a),(c)			27,926,612
Total Current Liabilities		3,156,086			30,214,901						33,370,987
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Convertible notes		399,389			(399,389	)		(g)			-
Convertible notes		195,556			(195,556	)		(g)			-
Convertible loans		2,275,385			(2,275,385	)		(g)			-
Total Other Liabilities		3,087,830			(3,087,830	)					-
Total Liabilities		6,243,916			27,127,071						33,370,987
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding  249,895,892 shares		249,896			-						249,896
Additional paid-in capital		25,222,219			5,402			(e),(f),(j),(k)			25,227,621
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
								(c),(d),(e),(f)
								,(h),(i),(j),(k),
								(l),(m),(n),(o)
Deficit accumulated during the development stage		(30,552,233	)		(26,075,117	)		,(p)			(56,627,350	)
Unrealized loss on foreign exchange		(955,501	)		-						(955,501	)
		(6,035,619	)		(27,127,071	)					(33,162,690	)
Total Liabilities and Stockholders' Equity (Deficit)	$	208,297			-					$	208,297

F-81

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2007

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		September 30,			September 30,						September 30,
		2007			2007 - Net Change						2007
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		96,949			-						96,949
Total Expense		96,949			-						96,949
Loss before other expenses		(96,949	)		-						(96,949	)
Other expenses (income)
Interest expense		11,699			(16,353	)		(i)			(4,654	)
Loss (gain) on change in derivative liability		-			21,694,974			(c)			21,694,974
Total Other expenses (income)		11,699			21,678,621						21,690,320
Provision for income taxes		-			-						-
Net loss		(108,648	)		(21,678,621	)					(21,787,269	)
Other comprehensive income (loss)
Loss on foreign exchange		-			-						-
Net loss and comprehensive loss	$	(108,648	)	$	(21,678,621	)				$	(21,787,269	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.00	)							$	(0.09	)
Weighted average number of shares - basic and diluted		249,895,892									249,895,892

F-82

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2007

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		September 30,			September 30,						September 30,
		2007			2007 - Net Change						2007
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(108,648	)	$	(21,678,621	)				$	(21,787,269	)
Adjustments to reconcile net income to net cash          used in operating activities:
Change in derivative liability		-			21,694,974			(c)			21,694,974
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		258,854			(16,353	)		(i)			242,501
Accrued liabilities - related parties		112,500			-						112,500
Net cash used in operating activities		262,706			-						262,706
Effect of Exchange rate changes on cash and cash equivalents		(262,706	)		-						(262,706	)
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-83

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED JUNE 30, 2007

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		June 30,			June 30, 2007						June 30,
		2007			Net Change						2007
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		94,124			-						94,124
Total Expense		94,124			-						94,124
Loss before other expenses		(94,124	)		-						(94,124	)
Other expenses (income)
Interest expense		11,698			-						11,698
Loss (gain) on change in derivative liability		-			(21,005,687	)		(c)			(21,005,687	)
Total Other expenses (income)		11,698			(21,005,687	)					(20,993,989	)
Provision for income taxes		-			-						-
Net income (loss)		(105,822	)		21,005,687						20,899,865
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net income (loss) and comprehensive income (loss)	$	(105,822	)	$	21,005,687					$	20,899,865
Net income (loss) and comprehensive income (loss) per share - basic	$	(0.00	)							$	0.08
Net income (loss) and comprehensive income (loss) per share - basic										$	0.00
Weighted average number of shares - basic		249,895,892									249,895,892
Weighted average number of shares - diluted											9,128,133,475

F-84

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED JUNE 30, 2007

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		June 30,			June 30, 2007						June 30,
		2007			Net Change						2007
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(105,822	)	$	21,005,687					$	20,899,865
Adjustments to reconcile net income to net cash
used in operating activities:
Change in derivative liability		-			(21,005,687	)		(c)			(21,005,687	)
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		144,093			-						144,093
Accrued liabilities - related parties		112,500			-						112,500
Net cash used in operating activities		150,771			-						150,771
Effect of Exchange rate changes on cash and cash equivalents		(150,771	)		-						(150,771	)
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-85

---

CONSOLIDATED BALANCE SHEET
MARCH 31, 2007

		March 31,									March 31,
		2007			Net Change						2007
		Original									Restated
ASSETS
Total Assets	$	233,297			-					$	233,297
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	2,704,580			(958,182	)		(g)		$	1,746,398
Accrued liabilties - related parties					2,203,179			(g)			2,203,179
Current portion of long-term debt		78,091			-			(g)			78,091
Notes payable - related party					162,500			(g)			162,500
Convertible notes - non-related parties					757,145			(g),(b),(d)			757,145
Derivative liability					27,237,325			(a),(c)			27,237,325
Total Current Liabilities		2,782,671			29,401,967						32,184,638
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Convertible notes		399,389			(399,389	)		(g)			-
Convertible notes		195,556			(195,556	)		(g)			-
Convertible loans		2,110,385			(2,110,385	)		(g)			-
Total Other Liabilities		2,922,830			(2,922,830	)					-
Total Liabilities		5,705,501			26,479,137						32,184,638
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding  249,895,892 shares		249,896			-						249,896
Additional paid-in capital		25,222,219			5,402			(e)			25,227,621
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
Deficit accumulated during the development stage		(30,312,763	)		(25,427,183	)		(c),(d),(e),(j)			(55,739,946	)
Unrealized loss on foreign exchange		(631,556	)		-						(631,556	)
		(5,472,204	)		(26,479,137	)					(31,951,341	)
Total Liabilities and Stockholders' Equity (Deficit)	$	233,297			-					$	233,297

F-86

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED MARCH 31, 2007

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		March 31,			March 31, 2007						March 31,
		2007			Net Change						2007
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		93,724			-						93,724
Total Expense		93,724			-						93,724
Loss before other expenses		(93,724	)		-						(93,724	)
Other expenses (income)
Interest expense		11,699			-						11,699
Loss (gain) on change in derivative liability		-			1,068,758			(c)			1,068,758
Total Other expenses (income)		11,699			1,068,758						1,080,457
Provision for income taxes		-			-						-
Net loss		(105,423	)		(1,068,758	)					(1,174,181	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net loss and comprehensive loss	$	(105,423	)	$	(1,068,758	)				$	(1,174,181	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.00	)							$	(0.00	)
Weighted average number of shares - basic and diluted		249,895,892									249,895,892

F-87

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED MARCH 31, 2007

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		March 31,			March 31, 2007						March 31,
		2007			Net Change						2007
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(105,423	)	$	(1,068,758	)				$	(1,174,181	)
Adjustments to reconcile net income to net cash         used in operating activities:
Change in derivative liability		-			1,068,758			(c)			1,068,758
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		9,621			-						9,621
Accrued liabilities - related parties		112,500			-						112,500
Net cash used in operating activities		16,698			-						16,698
Effect of Exchange rate changes on cash and cash equivalents		(16,698	)		-						(16,698	)
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-88

---

CONSOLIDATED BALANCE SHEET
DECEMBER 31, 2006

		December 31,									December 31,
		2006			Net Change						2006
		Original									Restated
ASSETS
Total Assets	$	233,297			-					$	233,297
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	2,663,708			(947,682	)		(g)		$	1,716,026
Accrued liabilties - related parties		-			2,121,929			(g)			2,121,929
Current portion of long-term debt		78,091			-			(g)			78,091
Notes payable - related party		-			162,500			(g)			162,500
Convertible notes - non-related parties		-			746,645			(g),(b),(d)			746,645
Derivative liability		-			26,168,567			(a),(c)			26,168,567
Total Current Liabilities		2,741,799			28,251,959						30,993,758
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Convertible notes		399,389			(399,389	)		(g)			-
Convertible notes		195,556			(195,556	)		(g)			-
Convertible loans		2,029,135			(2,029,135	)		(g)			-
Total Other Liabilities		2,841,580			(2,841,580	)					-
Total Liabilities		5,583,379			25,410,379						30,993,758
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding  249,895,892 shares		249,896			-						249,896
Additional paid-in capital		25,222,219			5,402			(e)			25,227,621
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
Deficit accumulated during the development stage		(30,207,340	)		(24,358,425	)		(c),(d),(e)			(54,565,765	)
Unrealized loss on foreign exchange		(614,857	)		-						(614,857	)
		(5,350,082	)		(25,410,379	)					(30,760,461	)
Total Liabilities and Stockholders' Equity (Deficit)	$	233,297			-					$	233,297

F-89

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED DECEMBER 31, 2006

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		December 31,			December 31,						December 31,
		2006			2006 - Net Change						2006
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		127,215			-						127,215
Total Expense		127,215			-						127,215
Loss before other expenses		(127,215	)		-						(127,215	)
Other expenses (income)
Interest expense		11,699			-						11,699
Loss (gain) on change in derivative liability		-			25,796,778			(c)			25,796,778
Total Other expenses (income)		11,699			25,796,778						25,808,477
Provision for income taxes		-			-						-
Net loss		(138,914	)		(25,796,778	)					(25,935,692	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net loss and comprehensive loss	$	(138,914	)	$	(25,796,778	)				$	(25,935,692	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.00	)							$	(0.10	)
Weighted average number of shares - basic and diluted		249,895,892									249,895,892

F-90

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED DECEMBER 31, 2006

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		December 31,			December 31,						December 31,
		2006			2006 - Net Change						2006
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(138,914	)	$	(25,796,778	)				$	(25,935,692	)
Adjustments to reconcile net income to net cash        used in operating activities:
Change in derivative liability		-			25,796,778			(c)			25,796,778
Other non-cash items		83,500									83,500
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		(51,324	)		-						(51,324	)
Accrued liabilities - related parties		31,250			-						31,250
Net cash used in operating activities		(75,488	)		-						(75,488	)
Effect of Exchange rate changes on cash and cash equivalents		75,488			-						75,488
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-91

---

CONSOLIDATED BALANCE SHEET
SEPTEMBER 30, 2006

		September 30,									September 30,
		2006			Net Change						2006
		Original									Restated
ASSETS
Total Assets	$	233,297			-					$	233,297
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	2,715,032			(948,682	)		(g)		$	1,766,350
Accrued liabilties - related parties		-			2,040,679			(g)			2,040,679
Current portion of long-term debt		78,091			-			(g)			78,091
Notes payable - related party		-			162,500			(g)			162,500
Convertible notes - non-related parties		-			714,145			(g),(b),(d)			714,145
Derivative liability		-			371,789			(a),(c)			371,789
Total Current Liabilities		2,793,123			2,340,431						5,133,554
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Convertible notes		399,389			(399,389	)		(g)			-
Convertible notes		195,556			(195,556	)		(g)			-
Convertible loans		1,914,385			(1,914,385	)		(g)			-
Total Other Liabilities		2,726,830			(2,726,830	)					-
Total Liabilities		5,519,953			(386,399	)					5,133,554
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding  249,895,892 shares		249,896			-						249,896
Additional paid-in capital		25,222,219			5,402			(e)			25,227,621
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
Deficit accumulated during the development stage		(30,068,426	)		1,438,353			(c),(d)			(28,630,073	)
Unrealized loss on foreign exchange		(690,345	)		-						(690,345	)
		(5,286,656	)		386,399						(4,900,257	)
Total Liabilities and Stockholders' Equity (Deficit)	$	233,297			-					$	233,297

F-92

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2006

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		September 30,			September 30,						September 30,
		2006			2006 - Net Change						2006
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		93,991			-						93,991
Total Expense		93,991			-						93,991
Loss before other expenses		(93,991	)		-						(93,991	)
Other expenses (income)
Interest expense		11,699			-						11,699
Loss (gain) on change in derivative liability		-			(6,199,735	)		(c)			(6,199,735	)
Total Other expenses (income)		11,699			(6,199,735	)					(6,188,036	)
Provision for income taxes		-			-						-
Net income (loss)		(105,690	)		6,199,735						6,094,045
Other comprehensive income (loss)
Loss on foreign exchange		-			-						-
Net income (loss) and comprehensive income (loss)	$	(105,690	)	$	6,199,735					$	6,094,045
Net income (loss) and comprehensive income (loss) per share - basic	$	(0.00	)							$	0.02
Net income (loss) and comprehensive income (loss) per share - diluted										$	0.01
Weighted average number of shares - basic		249,895,892									249,895,892
Weighted average number of shares - diluted											623,623,021

F-93

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2006

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		September 30,			September 30,						September 30,
		2006			2006 - Net Change						2006
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(105,690	)	$	6,199,735					$	6,094,045
Adjustments to reconcile net income to net cash          used in operating activities:
Change in derivative liability		-			(6,199,735	)		(c)			(6,199,735	)
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		21,990			-						21,990
Accrued liabilities - related parties		81,250			-						81,250
Net cash used in operating activities		(2,450	)		-						(2,450	)
Effect of Exchange rate changes on cash and cash equivalents		2,450			-						2,450
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-94

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED JUNE 30, 2006

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		June 30,			June 30, 2006						June 30,
		2006			Net Change						2006
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		(209,562	)		-						(209,562	)
Total Expense		(209,562	)		-						(209,562	)
Income before other expenses		209,562			-						209,562
Other expenses (income)
Interest expense		11,698			-						11,698
Loss (gain) on change in derivative liability		-			(25,519,178	)		(c)			(25,519,178	)
Total Other expenses (income)		11,698			(25,519,178	)					(25,507,480	)
Provision for income taxes		-			-						-
Net income		197,864			25,519,178						25,717,042
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net income and comprehensive income	$	197,864		$	25,519,178					$	25,717,042
Net income and comprehensive income per share - basic	$	0.00								$	0.10
Net income and comprehensive income per share - diluted	$	0.00								$	0.04
Weighted average number of shares - basic		249,895,892									249,895,892
Weighted average number of shares - diluted		664,391,517									664,391,517

F-95

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED JUNE 30, 2006

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		June 30,			June 30, 2006						June 30,
		2006			Net Change						2006
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	197,864		$	25,519,178					$	25,717,042
Adjustments to reconcile net income to net cash         used in operating activities:
Change in derivative liability		-			(25,519,178	)		(c)			(25,519,178	)
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		171,061			-						171,061
Accrued liabilities - related parties		(287,500	)		-						(287,500	)
Net cash used in operating activities		81,425			-						81,425
Effect of Exchange rate changes on cash and cash equivalents		(81,425	)		-						(81,425	)
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-96

---

CONSOLIDATED BALANCE SHEET
MARCH 31, 2006

		March 31,									March 31,
		2006			Net Change						2006
		Original									Restated
ASSETS
Total Assets	$	233,297			-					$	233,297
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	2,526,981			(921,982	)		(g)		$	1,604,999
Accrued liabilties - related parties					2,241,929			(g)			2,241,929
Current portion of long-term debt		78,091			-			(g)			78,091
Notes payable - related party					162,500			(g)			162,500
Convertible notes - non-related parties					687,445			(g),(b),(d)			687,445
Derivative liability					32,090,702			(a),(c)			32,090,702
Total Current Liabilities		2,605,072			34,260,594						36,865,666
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Convertible notes		399,389			(399,389	)		(g)			-
Convertible notes		195,556			(195,556	)		(g)			-
Convertible loans		2,115,635			(2,115,635	)		(g)			-
Total Other Liabilities		2,928,080			(2,928,080	)					-
Total Liabilities		5,533,152			31,332,514						36,865,666
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding  249,895,892 shares		249,896			-						249,896
Additional paid-in capital		25,222,219			5,402			(e)			25,227,621
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
Deficit accumulated during the development stage		(30,160,600	)		(30,280,560	)		(c),(d),(e),(j)			(60,441,160	)
Unrealized loss on foreign exchange		(611,370	)		-						(611,370	)
		(5,299,855	)		(31,332,514	)					(36,632,369	)
Total Liabilities and Stockholders' Equity (Deficit)	$	233,297			-					$	233,297

F-97

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED MARCH 31, 2006

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		March 31,			March 31, 2006						March 31,
		2006			Net Change						2006
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		117,564			-						117,564
Total Expense		117,564			-						117,564
Loss before other expenses		(117,564	)		-						(117,564	)
Other expenses (income)
Interest expense		11,699			-						11,699
Loss (gain) on change in derivative liability		-			31,063,252			(c)			31,063,252
Total Other expenses (income)		11,699			31,063,252						31,074,951
Provision for income taxes		-			-						-
Net loss		(129,263	)		(31,063,252	)					(31,192,515	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net loss and comprehensive loss	$	(129,263	)	$	(31,063,252	)				$	(31,192,515	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.00	)							$	(0.12	)
Weighted average number of shares - basic and diluted		249,895,892									249,895,892

F-98

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED MARCH 31, 2006

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		March 31,			March 31, 2006						March 31,
		2006			Net Change						2006
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(129,263	)	$	(31,063,252	)				$	(31,192,515	)
Adjustments to reconcile net income to net cash         used in operating activities:
Change in derivative liability		-			31,063,252			(c)			31,063,252
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		16,677			-						16,677
Accrued liabilities - related parties		105,000			-						105,000
Net cash used in operating activities		(7,586	)		-						(7,586	)
Effect of Exchange rate changes on cash and cash equivalents		7,586			-						7,586
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-99

---

CONSOLIDATED BALANCE SHEET
DECEMBER 31, 2005

		December 31,									December 31,
		2005			Net Change						2005
		Original									Restated
ASSETS
Total Assets	$	233,297			-					$	233,297
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	2,510,304			(904,482	)		(g)		$	1,605,822
Accrued liabilties - related parties		-			2,136,929			(g)			2,136,929
Current portion of long-term debt		78,091			-			(g)			78,091
Notes payable - related party		-			162,500			(g)			162,500
Convertible notes - non-related parties		-			669,945			(g),(b),(d)			669,945
Derivative liability		-			1,027,450			(a),(c)			1,027,450
Total Current Liabilities		2,588,395			3,092,342						5,680,737
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Convertible notes		399,389			(399,389	)		(g)			-
Convertible notes		195,556			(195,556	)		(g)			-
Convertible loans		2,010,635			(2,010,635	)		(g)			-
Total Other Liabilities		2,823,080			(2,823,080	)					-
Total Liabilities		5,411,475			269,262						5,680,737
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding  249,895,892 shares		249,896			-						249,896
Additional paid-in capital		25,222,219			5,402			(e)			25,227,621
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
Deficit accumulated during the development stage		(30,031,337	)		782,692			(c),(d),(e)			(29,248,645	)
Unrealized loss on foreign exchange		(618,956	)		-						(618,956	)
		(5,178,178	)		(269,262	)					(5,447,440	)
Total Liabilities and Stockholders' Equity (Deficit)	$	233,297			-					$	233,297

F-100

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED DECEMBER 31, 2005

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		December 31,			December 31,						December 31,
		2005			2005 - Net Change						2005
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		138,950			-						138,950
Total Expense		138,950			-						138,950
Loss before other expenses		(138,950	)		-						(138,950	)
Other expenses (income)
Interest expense		11,699			-						11,699
Loss (gain) on change in derivative liability		-			43,118			(c)			43,118
Total Other expenses (income)		11,699			43,118						54,817
Provision for income taxes		-			-						-
Net loss		(150,649	)		(43,118	)					(193,767	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net loss and comprehensive loss	$	(150,649	)	$	(43,118	)				$	(193,767	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.00	)							$	(0.00	)
Weighted average number of shares - basic and diluted		249,895,892									249,895,892

F-101

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED DECEMBER 31, 2005

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		December 31,			December 31,						December 31,
		2005			2005 - Net Change						2005
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(150,649	)	$	(43,118	)				$	(193,767	)
Adjustments to reconcile net income to net cash          used in operating activities:
Change in derivative liability		-			43,118			(c)			43,118
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		45,447			-						45,447
Accrued liabilities - related parties		105,000			-						105,000
Net cash used in operating activities		(202	)		-						(202	)
Effect of Exchange rate changes on cash and cash equivalents		202			-						202
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-102

---

CONSOLIDATED BALANCE SHEET
SEPTEMBER 30, 2005

		September 30,									September 30,
		2005			Net Change						2005
		Original									Restated
ASSETS
Total Assets	$	233,297			-					$	233,297
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	2,464,858			(884,482	)		(g)		$	1,580,376
Accrued liabilties - related parties		-			2,031,929			(g)			2,031,929
Current portion of long-term debt		78,091			-			(g)			78,091
Notes payable - related party		-			162,500			(g)			162,500
Convertible notes - non-related parties		-			649,945			(g),(b),(d)			649,945
Derivative liability		-			984,332			(a),(c)			984,332
Total Current Liabilities		2,542,949			2,944,224						5,487,173
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Convertible notes		399,389			(399,389	)		(g)			-
Convertible notes		195,556			(195,556	)		(g)			-
Convertible loans		1,905,635			(1,905,635	)		(g)			-
Total Other Liabilities		2,718,080			(2,718,080	)					-
Total Liabilities		5,261,029			226,144						5,487,173
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding  249,895,892 shares		249,896			-						249,896
Additional paid-in capital		25,222,219			5,402			(e)			25,227,621
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
Deficit accumulated during the development stage		(29,880,688	)		825,810			(c),(d)			(29,054,878	)
Unrealized loss on foreign exchange		(619,159	)		-						(619,159	)
		(5,027,732	)		(226,144	)					(5,253,876	)
Total Liabilities and Stockholders' Equity (Deficit)	$	233,297			-					$	233,297

F-103

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2005

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		September 30,			September 30,						September 30,
		2005			2005 - Net Change						2005
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		126,825			-						126,825
Total Expense		126,825			-						126,825
Loss before other expenses		(126,825	)		-						(126,825	)
Other expenses (income)
Interest expense		11,699			-						11,699
Loss (gain) on change in derivative liability		-			(8,431,805	)		(c)			(8,431,805	)
Total Other expenses (income)		11,699			(8,431,805	)					(8,420,106	)
Provision for income taxes		-			-						-
Net income (loss)		(138,524	)		8,431,805						8,293,281
Other comprehensive income (loss)
Loss on foreign exchange		-			-						-
Net income (loss) and comprehensive income (loss)	$	(138,524	)	$	8,431,805					$	8,293,281
Net income (loss) and comprehensive income (loss) per share - basic	$	(0.00	)							$	0.03
Net income (loss) and comprehensive income (loss) per share - diluted										$	0.00
Weighted average number of shares - basic		249,895,892									249,895,892
Weighted average number of shares - diluted											10,095,154,240

F-104

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2005

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		September 30,			September 30,						September 30,
		2005			2005 - Net Change						2005
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(138,524	)	$	8,431,805					$	8,293,281
Adjustments to reconcile net income to net cash
used in operating activities:
Change in derivative liability		-			(8,431,805	)		(c)			(8,431,805	)
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		61,833			-						61,833
Accrued liabilities - related parties		155,000			-						155,000
Net cash used in operating activities		78,309			-						78,309
Cash flow from financing activities:
Proceeds from notes payable		10,000			-						10,000
Net cash provided by financing activities		10,000			-						10,000
Effect of Exchange rate changes on cash and cash equivalents		(88,309	)		-						(88,309	)
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-105

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED JUNE 30, 2005

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		June 30,			June 30, 2005						June 30,
		2005			Net Change						2005
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		136,551			-						136,551
Total Expense		136,551			-						136,551
Loss before other expenses		(136,551	)		-						(136,551	)
Other expenses (income)
Interest expense		26,487			-						26,487
Loss (gain) on change in derivative liability		-			(58,272,817	)		(c)			(58,272,817	)
Total Other expenses (income)		26,487			(58,272,817	)					(58,246,330	)
Provision for income taxes		-			-						-
Net income (loss)		(163,038	)		58,272,817						58,109,779
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net income (loss) and comprehensive income (loss)	$	(163,038	)	$	58,272,817					$	58,109,779
Net income (loss) and comprehensive income (loss) per share - basic	$	(0.00	)							$	0.23
Net income (loss) and comprehensive income (loss) per share - diluted										$	0.01
Weighted average number of shares - basic		249,895,892									249,895,892
Weighted average number of shares - diluted											9,667,970,892

F-106

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED JUNE 30, 2005

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		June 30,			June 30, 2005						June 30,
		2005			Net Change						2005
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(163,038	)	$	58,272,817					$	58,109,779
Adjustments to reconcile net income to net cash        used in operating activities:
Change in derivative liability		-			(58,272,817	)		(c)			(58,272,817	)
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		(12,581	)		-						(12,581	)
Accrued liabilities - related parties		155,000			-						155,000
Net cash used in operating activities		(20,619	)		-						(20,619	)
Effect of Exchange rate changes on cash and cash equivalents		20,619			-						20,619
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-107

---

CONSOLIDATED BALANCE SHEET
MARCH 31, 2005

		March 31,									March 31,
		2005			Net Change						2005
		Original									Restated
ASSETS
Total Assets	$	233,298			-					$	233,298
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	2,315,605			(884,482	)		(g)		$	1,431,123
Accrued liabilties - related parties					1,634,962			(g)			1,634,962
Current portion of long-term debt		78,091			-			(g)			78,091
Notes payable - related party					162,500			(g)			162,500
Convertible notes - non-related parties					826,912			(g),(b),(d)			826,912
Derivative liability					67,688,954			(a),(c)			67,688,954
Total Current Liabilities		2,393,696			69,428,846						71,822,542
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Convertible notes		586,356			(586,356	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		1,508,668			(1,508,668	)		(g)			-
Total Other Liabilities		2,498,080			(2,498,080	)					-
Total Liabilities		4,891,776			66,930,766						71,822,542
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding  249,895,892 shares		249,896			-						249,896
Additional paid-in capital		25,222,219			5,402			(e)			25,227,621
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
Deficit accumulated during the development stage		(29,579,126	)		(65,878,812	)		(c),(d),(e),(j)			(95,457,938	)
Unrealized loss on foreign exchange		(551,467	)		-						(551,467	)
		(4,658,478	)		(66,930,766	)					(71,589,244	)
Total Liabilities and Stockholders' Equity (Deficit)	$	233,298			-					$	233,298

F-108

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED MARCH 31, 2005

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		March 31,			March 31, 2005						March 31,
		2005			Net Change						2005
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		116,705			-						116,705
Total Expense		116,705			-						116,705
Loss before other expenses		(116,705	)		-						(116,705	)
Other expenses (income)
Interest expense		8,711			-						8,711
Loss (gain) on change in derivative liability		-			66,759,770			(c)			66,759,770
Total Other expenses (income)		8,711			66,759,770						66,768,481
Provision for income taxes		-			-						-
Net loss		(125,416	)		(66,759,770	)					(66,885,186	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net loss and comprehensive loss	$	(125,416	)	$	(66,759,770	)				$	(66,885,186	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.00	)							$	(0.27	)
Weighted average number of shares - basic and diluted		249,895,892									249,895,892

F-109

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED MARCH 31, 2005

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		March 31,			March 31, 2005						March 31,
		2005			Net Change						2005
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(125,416	)	$	(66,759,770	)				$	(66,885,186	)
Adjustments to reconcile net income to net cash         used in operating activities:
Change in derivative liability		-			66,759,770			(c)			66,759,770
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		(39,766	)		-						(39,766	)
Accrued liabilities - related parties		155,000			-						155,000
Net cash used in operating activities		(10,182	)		-						(10,182	)
Effect of Exchange rate changes on cash and cash equivalents		10,182			-						10,182
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-110

---

CONSOLIDATED BALANCE SHEET
DECEMBER 31, 2004

		December 31,									December 31,
		2004			Net Change						2004
		Original									Restated
ASSETS
Total Assets	$	233,297			-					$	233,297
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	2,305,370			(884,482	)		(g)		$	1,420,888
Accrued liabilties - related parties		-			1,529,962			(g)			1,529,962
Current portion of long-term debt		78,091			-			(g)			78,091
Notes payable - related party		-			162,500			(g)			162,500
Convertible notes - non-related parties		-			826,912			(g),(b),(d)			826,912
Derivative liability		-			929,184			(a),(c)			929,184
Total Current Liabilities		2,383,461			2,564,076						4,947,537
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Convertible notes		586,356			(586,356	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		1,403,668			(1,403,668	)		(g)			-
Total Other Liabilities		2,393,080			(2,393,080	)					-
Total Liabilities		4,776,541			170,996						4,947,537
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding  249,895,892 shares		249,896			-						249,896
Additional paid-in capital		25,222,219			5,402			(e)			25,227,621
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
Deficit accumulated during the development stage		(29,453,710	)		880,958			(c),(d),(e)			(28,572,752	)
Unrealized loss on foreign exchange		(561,649	)		-						(561,649	)
		(4,543,244	)		(170,996	)					(4,714,240	)
Total Liabilities and Stockholders' Equity (Deficit)	$	233,297			-					$	233,297

F-111

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED DECEMBER 31, 2004

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		December 31,			December 31,						December 31,
		2004			2004 - Net Change						2004
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		150,485			-						150,485
Total Expense		150,485			-						150,485
Loss before other expenses		(150,485	)		-						(150,485	)
Other expenses (income)
Interest expense		8,711			-						8,711
Loss (gain) on change in derivative liability		-			38,641			(c)			38,641
Total Other expenses (income)		8,711			38,641						47,352
Provision for income taxes		-			-						-
Net loss		(159,196	)		(38,641	)					(197,837	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net loss and comprehensive loss	$	(159,196	)	$	(38,641	)				$	(197,837	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.00	)							$	(0.00	)
Weighted average number of shares - basic and diluted		249,895,892									249,895,892

F-112

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED DECEMBER 31, 2004

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		December 31,			December 31,						December 31,
		2004			2004 - Net Change						2004
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(159,196	)	$	(38,641	)				$	(197,837	)
Adjustments to reconcile net income to net cash         used in operating activities:
Change in derivative liability		-			38,641			(c)			38,641
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		28,680			-						28,680
Accrued liabilities - related parties		207,500			-						207,500
Net cash used in operating activities		76,984			-						76,984
Effect of Exchange rate changes on cash and cash equivalents		(76,984	)		-						(76,984	)
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-113

---

CONSOLIDATED BALANCE SHEET
SEPTEMBER 30, 2004

		September 30,									September 30,
		2004			Net Change						2004
		Original									Restated
ASSETS
Total Assets	$	233,297			-					$	233,297
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	2,207,940			(884,482	)		(g)		$	1,323,458
Accrued liabilties - related parties		-			1,391,212			(g)			1,391,212
Current portion of long-term debt		78,091			-			(g)			78,091
Notes payable - related party		-			162,500			(g)			162,500
Convertible notes - non-related parties		-			826,912			(g),(b),(d)			826,912
Derivative liability		-			890,543			(a),(c)			890,543
Total Current Liabilities		2,286,031			2,386,685						4,672,716
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Convertible notes		586,356			(586,356	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		1,264,918			(1,264,918	)		(g)			-
Total Other Liabilities		2,254,330			(2,254,330	)					-
Total Liabilities		4,540,361			132,355						4,672,716
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized   250,000,000 shares, issued and outstanding  249,895,892 shares		249,896			-						249,896
Additional paid-in capital		25,222,219			5,402			(e)			25,227,621
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
Deficit accumulated during the development stage		(29,294,514	)		919,599			(c),(d)			(28,374,915	)
Unrealized loss on foreign exchange		(484,665	)		-						(484,665	)
		(4,307,064	)		(132,355	)					(4,439,419	)
Total Liabilities and Stockholders' Equity (Deficit)	$	233,297			-					$	233,297

F-114

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2004

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		September 30,			September 30,						September 30,
		2004			2004 - Net Change						2004
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		120,405			-						120,405
Total Expense		120,405			-						120,405
Loss before other expenses		(120,405	)		-						(120,405	)
Other expenses (income)
Interest expense		8,711			-						8,711
Loss (gain) on change in derivative liability		-			(1,384,768	)		(c)			(1,384,768	)
Total Other expenses (income)		8,711			(1,384,768	)					(1,376,057	)
Provision for income taxes		-			-						-
Net income (loss)		(129,116	)		1,384,768						1,255,652
Other comprehensive income (loss)
Loss on foreign exchange		-			-						-
Net income (loss) and comprehensive income (loss)	$	(129,116	)	$	1,384,768					$	1,255,652
Net income (loss) and comprehensive income (loss) per share - basic	$	(0.00	)							$	0.01
Net income (loss) and comprehensive income (loss) per share - diluted										$	0.00
Weighted average number of shares - basic		249,895,892									249,895,892
Weighted average number of shares - diluted											9,155,758,747

F-115

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2004

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		September 30,			September 30,						September 30,
		2004			2004 - Net Change						2004
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(129,116	)	$	1,384,768					$	1,255,652
Adjustments to reconcile net income to net cash         used in operating activities:
Change in derivative liability		-			(1,384,768	)		(c)			(1,384,768	)
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		168,900			-						168,900
Accrued liabilities - related parties		43,750			-						43,750
Net cash used in operating activities		83,534			-						83,534
Effect of Exchange rate changes on cash and cash equivalents		(83,534	)		-						(83,534	)
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-116

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED JUNE 30, 2004

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		June 30,			June 30, 2004						June 30,
		2004			Net Change						2004
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		272,589			-						272,589
Total Expense		272,589			-						272,589
Loss before other expenses		(272,589	)		-						(272,589	)
Other expenses (income)
Interest expense		30,970			250			(e)			31,220
Loss (gain) on change in derivative liability		-			78,249			(c)			78,249
Loss (gain) from extinguishment of debt		(1,047,921	)		-						(1,047,921	)
Total Other expenses (income)		(1,016,951	)		78,499						(938,452	)
Provision for income taxes		-			-						-
Net income (loss)		744,362			(78,499	)					665,863
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net income (loss) and comprehensive income (loss)	$	744,362		$	(78,499	)				$	665,863
Net income (loss) and comprehensive income (loss) per share - basic	$	0.00								$	0.00
Net income (loss) and comprehensive income (loss) per share - diluted	$	0.00								$	0.00
Weighted average number of shares - basic		249,895,892									249,895,892
Weighted average number of shares - diluted		1,101,590,892									1,101,590,892

F-117

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED JUNE 30, 2004

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		June 30,			June 30, 2004						June 30,
		2004			Net Change						2004
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	744,362		$	(78,499	)				$	665,863
Adjustments to reconcile net income to net cash          used in operating activities:
Imputed interest		-			250			(e)			250
Impairment of fixed assets		25,000			-						25,000
(Gain) from extinguishment of debt		(1,047,921	)		-						(1,047,921	)
Change in derivative liability		-			78,249			(c)			78,249
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		183,723			-						183,723
Accrued liabilities - related parties		87,500			-						87,500
Net cash used in operating activities		(7,336	)		-						(7,336	)
Effect of Exchange rate changes on cash and cash equivalents		7,336			-						7,336
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-118

---

CONSOLIDATED BALANCE SHEET
MARCH 31, 2004

		March 31,									March 31,
		2004			Net Change						2004
		Original									Restated
ASSETS
Total Assets	$	233,297			-					$	233,297
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	2,005,897			(24,277	)		(g)		$	1,981,620
Accrued liabilties - related parties					1,200,712			(g)			1,200,712
Current portion of long-term debt		126,625			34,580			(g)			161,205
Notes payable - related party					162,500			(g)			162,500
Convertible notes - non-related parties					826,912			(g),(b),(d)			826,912
Derivative liability					2,197,062			(a),(c)			2,197,062
Total Current Liabilities		2,132,522			4,397,489						6,530,011
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Long term debt (net of current)		34,580			(34,580	)		(g)			-
Convertible notes		586,356			(586,356	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		1,076,173			(1,076,173	)		(g)			-
Total Other Liabilities		2,100,165			(2,100,165	)					-
Total Liabilities		4,232,687			2,297,324						6,530,011
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding  249,895,892 shares		249,896			-						249,896
Additional paid-in capital		25,222,219			5,152			(e)			25,227,371
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
Deficit accumulated during the development stage		(29,051,310	)		(1,245,120	)		(c),(d),(e),(j)			(30,296,430	)
Unrealized loss on foreign exchange		(420,195	)		-						(420,195	)
		(3,999,390	)		(2,297,324	)					(6,296,714	)
Total Liabilities and Stockholders' Equity (Deficit)	$	233,297			-					$	233,297

F-119

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED MARCH 31, 2004

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		March 31,			March 31, 2004						March 31,
		2004			Net Change						2004
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		124,033			-						124,033
Total Expense		124,033			-						124,033
Loss before other expenses		(124,033	)		-						(124,033	)
Other expenses (income)
Interest expense		14,845			250			(e)			15,095
Loss (gain) on change in derivative liability		-			(1,759,984	)		(c)			(1,759,984	)
Total Other expenses (income)		14,845			(1,759,734	)					(1,744,889	)
Provision for income taxes		-			-						-
Net income (loss)		(138,878	)		1,759,734						1,620,856
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net income (loss) and comprehensive income (loss)	$	(138,878	)	$	1,759,734					$	1,620,856
Net income (loss) and comprehensive income (loss) per share - basic	$	(0.00	)							$	0.01
Net income (loss) and comprehensive income (loss) per share - diluted										$	0.00
Weighted average number of shares - basic		249,895,892									249,895,892
Weighted average number of shares - diluted											1,349,364,848

F-120

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED MARCH 31, 2004

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		March 31,			March 31, 2004						March 31,
		2004			Net Change						2004
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(138,878	)	$	1,759,734					$	1,620,856
Adjustments to reconcile net income to net cash           used in operating activities:
Imputed interest		-			250			(e)			250
Change in derivative liability		-			(1,759,984	)		(c)			(1,759,984	)
Changes in assets and liabilities:
(Increase) decrease in:
Sales tax receivable		36			-						36
(Decrease) increase in :
Accounts payable and accrued liabilities		33,176			-						33,176
Net cash used in operating activities		(105,666	)		-						(105,666	)
Cash flow from financing activities:
Loans from related parties		90,006			-						90,006
Net cash provided by financing activities		90,006			-						90,006
Effect of Exchange rate changes on cash and cash equivalents		15,660			-						15,660
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-121

---

CONSOLIDATED BALANCE SHEET
DECEMBER 31, 2003

		December 31,									December 31,
		2003			Net Change						2003
		Original									Restated
ASSETS
Total Assets	$	233,333			-					$	233,333
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	1,972,721			(24,277	)		(g)		$	1,948,444
Accrued liabilties - related parties		-			1,106,962			(g)			1,106,962
Current portion of long-term debt		77,869			87,080			(g)			164,949
Notes payable - related party		-			162,500			(g)			162,500
Convertible notes - non-related parties		-			826,912			(g),(b),(d)			826,912
Derivative liability		-			3,957,046			(a),(c)			3,957,046
Total Current Liabilities		2,050,590			6,116,223						8,166,813
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Long term debt (net of current)		87,080			(87,080	)		(g)			-
Convertible notes		586,356			(586,356	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		982,423			(982,423	)		(g)			-
Total Other Liabilities		2,058,915			(2,058,915	)					-
Total Liabilities		4,109,505			4,057,308						8,166,813
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding  249,895,892 shares		249,896			-						249,896
Additional paid-in capital		25,222,219			4,902			(e)			25,227,121
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
Deficit accumulated during the development stage		(28,912,432	)		(3,004,854	)		(c),(d),(e)			(31,917,286	)
Unrealized loss on foreign exchange		(435,855	)		-						(435,855	)
		(3,876,172	)		(4,057,308	)					(7,933,480	)
Total Liabilities and Stockholders' Equity (Deficit)	$	233,333			-					$	233,333

F-122

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED DECEMBER 31, 2003

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		December 31,			December 31,						December 31,
		2003			2003 - Net Change						2003
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		123,574			-						123,574
Total Expense		123,574			-						123,574
Loss before other expenses		(123,574	)		-						(123,574	)
Other expenses (income)
Interest expense		14,942			250			(e)			15,192
Loss (gain) on change in derivative liability		-			2,740,476			(c)			2,740,476
Total Other expenses (income)		14,942			2,740,726						2,755,668
Provision for income taxes		-			-						-
Net loss		(138,516	)		(2,740,726	)					(2,879,242	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net loss and comprehensive loss	$	(138,516	)	$	(2,740,726	)				$	(2,879,242	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.00	)							$	(0.01	)
Weighted average number of shares - basic and diluted		249,895,892									249,895,892

F-123

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED DECEMBER 31, 2003

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		December 31,			December 31,						December 31,
		2003			2003 - Net Change						2003
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(138,516	)	$	(2,740,726	)				$	(2,879,242	)
Adjustments to reconcile net income to net cash        used in operating activities:
Imputed interest		-			250			(e)			250
Change in derivative liability		-			2,740,476			(c)			2,740,476
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		59,355			-						59,355
Accrued liabilities - related parties		43,750			-						43,750
Net cash used in operating activities		(35,411	)		-						(35,411	)
Cash flow from financing activities:
Loans from related parties		90,102			-						90,102
Net cash provided by financing activities		90,102			-						90,102
Effect of Exchange rate changes on cash and cash equivalents		(54,691	)		-						(54,691	)
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-124

---

CONSOLIDATED BALANCE SHEET
SEPTEMBER 30, 2003

		September 30,									September 30,
		2003			Net Change						2003
		Original									Restated
ASSETS
Total Assets	$	233,333			-					$	233,333
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	1,869,619			(24,277	)		(g)		$	1,845,342
Accrued liabilties - related parties		-			1,013,212			(g)			1,013,212
Current portion of long-term debt		81,516			87,080			(g)			168,596
Notes payable - related party		-			162,500			(g)			162,500
Convertible notes - non-related parties		-			826,912			(g),(b),(d)			826,912
Derivative liability		-			1,216,570			(a),(c)			1,216,570
Total Current Liabilities		1,951,135			3,281,997						5,233,132
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Long term debt (net of current)		87,080			(87,080	)		(g)			-
Convertible notes		586,356			(586,356	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		888,673			(888,673	)		(g)			-
Total Other Liabilities		1,965,165			(1,965,165	)					-
Total Liabilities		3,916,300			1,316,832						5,233,132
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding  249,895,892 shares		249,896			-						249,896
Additional paid-in capital		25,222,219			4,652			(e)			25,226,871
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
Deficit accumulated during the development stage		(28,773,916	)		(264,128	)		(c),(d)			(29,038,044	)
Unrealized loss on foreign exchange		(381,164	)		-						(381,164	)
		(3,682,965	)		(1,316,832	)					(4,999,797	)
Total Liabilities and Stockholders' Equity (Deficit)	$	233,335			-					$	233,335

F-125

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2003

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		September 30,			September 30,						September 30,
		2003			2003 - Net Change						2003
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		146,071			-						146,071
Total Expense		146,071			-						146,071
Loss before other expenses		(146,071	)		-						(146,071	)
Other expenses (income)
Interest expense		22,681			250			(e)			22,931
Loss (gain) on change in derivative liability		-			(333,559	)		(c)			(333,559	)
Loss (gain) from extinguishment of debt		-			(345,884	)					(345,884	)
Total Other expenses (income)		22,681			(679,193	)					(656,512	)
Provision for income taxes		-			-						-
Net income (loss)		(168,752	)		679,193						510,441
Other comprehensive income (loss)
Loss on foreign exchange		-			-						-
Net income (loss) and comprehensive income (loss)	$	(168,752	)	$	679,193					$	510,441
Net income (loss) and comprehensive income (loss) per share - basic	$	(0.00	)							$	0.00
Net income (loss) and comprehensive income (loss) per share - diluted										$	0.00
Weighted average number of shares - basic		249,895,892									249,895,892
Weighted average number of shares - diluted											856,035,313

F-126

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2003

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		September 30,			September 30,						September 30,
		2003			2003 - Net Change						2003
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(168,752	)	$	679,193					$	510,441
Adjustments to reconcile net income to net cash           used in operating activities:
Imputed interest		-			250			(e)			250
(Gain) from extinguishment of debt		-			(345,884	)					(345,884	)
Change in derivative liability		-			(333,559	)		(c)			(333,559	)
Changes in assets and liabilities:
(Increase) decrease in:
(Decrease) increase in :
Accounts payable and accrued liabilities		33,435			-						33,435
Accrued liabilities - related parties		43,750			-						43,750
Net cash used in operating activities		(91,567	)		-						(91,567	)
Cash flow from financing activities:
Loans from related parties		90,197			-						90,197
Net cash provided by financing activities		90,197			-						90,197
Effect of Exchange rate changes on cash and cash equivalents		1,370			-						1,370
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-127

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED JUNE 30, 2003

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		June 30,			June 30, 2003						June 30,
		2003			Net Change						2003
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		359,911			-						359,911
Depreciation and amortization		19,046			-						19,046
Research and development		-			-						-
Total Expense		378,957			-						378,957
Loss before other expenses		(378,957	)		-						(378,957	)
Other expenses (income)
Interest expense		22,773			249			(e)			23,022
Accretion expense		-			122,724			(d)			122,724
Loss (gain) on change in derivative liability		-			58,828			(c)			58,828
Loss (gain) from extinguishment of debt		-			100,262			(j),(q)			100,262
Total Other expenses (income)		22,773			282,063						304,836
Provision for income taxes		-			-						-
Net income (loss)		(401,730	)		(282,063	)					(683,793	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net income (loss) and comprehensive income (loss)	$	(401,730	)	$	(282,063	)				$	(683,793	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.00	)							$	(0.00	)
Weighted average number of shares - basic and diluted		237,326,726									237,326,726

F-128

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED JUNE 30, 2003

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		June 30,			June 30, 2003						June 30,
		2003			Net Change						2003
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(401,730	)	$	(282,063	)				$	(683,793	)
Adjustments to reconcile net income to net cash          used in operating activities:
Depreciation and amortization		19,046			-						19,046
Imputed interest		-			249			(e)			249
Accretion expense		-			122,724			(d)			122,724
Loss (gain) on settlement of debt		-			100,262			(j),(q)			100,262
Change in derivative liability		-			58,828			(c)			58,828
Changes in assets and liabilities:											-
(Increase) decrease in:											-
Account receivable		30,902			-						30,902
Inventory		(6,009	)		-						(6,009	)
Sales tax receivable		39,840			-						39,840
Other assets		242,956			-						242,956
(Decrease) increase in :
Accounts payable and accrued liabilities		(68,692	)		-						(68,692	)
Accrued liabilities - related parties		21,482			-						21,482
Net cash used in operating activities		(122,205	)		-						(122,205	)
Cash flow from investing activities:
Increase in notes receivable		(548	)		-						(548	)
Net cash used in investing activities		(548	)		-						(548	)
Cash flow from financing activities:
Loans from related parties		226,460			-						226,460
Payments on loan payable		(11,874	)		-						(11,874	)
Net cash provided by financing activities		214,586			-						214,586
Effect of Exchange rate changes on cash and cash equivalents		(91,833	)		-						(91,833	)
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-129

---

CONSOLIDATED BALANCE SHEET
MARCH 31, 2003

		March 31,									March 31,
		2003			Net Change						2003
		Original									Restated
ASSETS
Total Assets	$	542,914			-					$	542,914
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	1,839,642			49,113			(g)		$	1,888,755
Accrued liabilties - related parties					509,310			(g)			509,310
Current portion of long-term debt		43,685			133,772			(g)			177,457
Notes payable - related party					162,500			(g)			162,500
Convertible notes - non-related parties					1,050,072			(g),(b),(d)			1,050,072
Derivative liability					1,491,301			(a),(c)			1,491,301
Total Current Liabilities		1,883,327			3,396,068						5,279,395
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Long term debt (net of current)		133,772			(133,772	)		(g)			-
Convertible notes		932,240			(932,240	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		558,423			(558,423	)		(g)			-
Total Other Liabilities		2,027,491			(2,027,491	)					-
Total Liabilities		3,910,818			1,368,577						5,279,395
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding  249,895,892 shares		249,896			-						249,896
Additional paid-in capital		25,222,219			4,153			(e)			25,226,372
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
Deficit accumulated during the development stage		(28,549,318	)		(315,374	)		(c),(d),(e),(j)			(28,864,692	)
Unrealized loss on foreign exchange		(290,701	)		-						(290,701	)
		(3,367,904	)		(1,368,577	)					(4,736,481	)
Total Liabilities and Stockholders' Equity (Deficit)	$	542,914			-					$	542,914

F-130

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED MARCH 31, 2003

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		March 31,			March 31, 2003						March 31,
		2003			Net Change						2003
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		106,578			-						106,578
Total Expense		106,578			-						106,578
Loss before other expenses		(106,578	)		-						(106,578	)
Other expenses (income)
Interest expense		22,838			250			(e)			23,088
Accretion expense		-			122,723			(d)			122,723
Loss (gain) on change in derivative liability		-			(6,508,036	)		(c)			(6,508,036	)
Total Other expenses (income)		22,838			(6,385,063	)					(6,362,225	)
Provision for income taxes		-			-						-
Net income (loss)		(129,416	)		6,385,063						6,255,647
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net income (loss) and comprehensive income (loss)	$	(129,416	)		6,385,063					$	6,255,647
Net income (loss) and comprehensive income (loss) per share - basic	$	(0.00	)							$	0.03
Net income (loss) and comprehensive income (loss) per share - diluted										$	0.01
Weighted average number of shares - basic		231,042,142									231,042,142
Weighted average number of shares - diluted											978,733,933

F-131

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED MARCH 31, 2003

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		March 31,			March 31, 2003						March 31,
		2003			Net Change						2003
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(129,416	)	$	6,385,063					$	6,255,647
Adjustments to reconcile net income to net cash            used in operating activities:
Imputed interest		-			250			(e)			250
Accretion expense		-			122,723			(d)			122,723
Change in derivative liability		-			(6,508,036	)		(c)			(6,508,036	)
Changes in assets and liabilities:
(Increase) decrease in:
Account receivable		(2,151	)		-						(2,151	)
Inventory		(4,685	)		-						(4,685	)
Sales tax receivable		(2,773	)		-						(2,773	)
Research and experimental development tax credits receivable		126,428			-						126,428
Other assets		(5,317	)		-						(5,317	)
(Decrease) increase in :
Accounts payable and accrued liabilities		89,620			-						89,620
Accrued liabilities - related parties		11,598			-						11,598
Net cash used in operating activities		83,304			-						83,304
Cash flow from investing activities:
Increase in notes receivable		(1,387	)		-						(1,387	)
Net cash used in investing activities		(1,387	)		-						(1,387	)
Cash flow from financing activities:
Loans from related parties		(74,897	)		-						(74,897	)
Proceeds from grants		75,350			-						75,350
Proceeds from issuance of common stock		4,283			-						4,283
Proceeds from additional paid-in capital		31,217			-						31,217
Net cash provided by financing activities		35,953			-						35,953
Effect of Exchange rate changes on cash and cash equivalents		(117,870	)		-						(117,870	)
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-132

---

CONSOLIDATED BALANCE SHEET
DECEMBER 31, 2002

		December 31,									December 31,
		2002			Net Change						2002
		Original									Restated
ASSETS
Total Assets	$	653,029			-					$	653,029
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	1,740,397			219,394			(g)		$	1,959,791
Accrued liabilties - related parties		-			924,948			(g)			924,948
Current portion of long-term debt		41,299			137,516			(g)			178,815
Notes payable - related party		-			162,500			(g)			162,500
Convertible notes - non-related parties		-			927,349			(g),(b),(d)			927,349
Derivative liability		-			7,999,337			(a),(c)			7,999,337
Total Current Liabilities		1,781,696			10,371,044						12,152,740
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Long term debt (net of current)		137,516			(137,516	)		(g)			-
Convertible notes		932,240			(932,240	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		1,144,342			(1,144,342	)		(g)			-
Total Other Liabilities		2,617,154			(2,617,154	)					-
Total Liabilities		4,398,850			7,753,890						12,152,740
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding  224,757,559 shares		224,758			-						224,758
Additional paid-in capital		24,618,899			3,903			(e)			24,622,802
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
Deficit accumulated during the development stage		(28,419,902	)		(6,700,437	)		(c),(d),(e)			(35,120,339	)
Unrealized loss on foreign exchange		(169,576	)		-						(169,576	)
		(3,745,821	)		(7,753,890	)					(11,499,711	)
Total Liabilities and Stockholders' Equity (Deficit)	$	653,029			-					$	653,029

F-133

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED DECEMBER 31, 2002

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		December 31,			December 31,						December 31,
		2002			2002 - Net Change						2002
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		269,322			-						269,322
Total Expense		269,322			-						269,322
Loss before other expenses		(269,322	)		-						(269,322	)
Other expenses (income)
Interest expense		35,769			250			(e)			36,019
Accretion expense		-			122,723			(d)			122,723
Loss (gain) on change in derivative liability		-			6,504,334			(c)			6,504,334
Loss (gain) from extinguishment of debt		-			-						-
Total Other expenses (income)		35,769			6,627,307						6,663,076
Provision for income taxes		-			-						-
Net loss		(305,091	)		(6,627,307	)					(6,932,398	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		-			-						-
Net loss and comprehensive loss	$	(305,091	)	$	(6,627,307	)				$	(6,932,398	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.00	)							$	(0.03	)
Weighted average number of shares - basic and diluted		224,757,559									224,757,559

F-134

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED DECEMBER 31, 2002

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		December 31,			December 31,						December 31,
		2002			2002 - Net Change						2002
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(305,091	)	$	(6,627,307	)				$	(6,932,398	)
Adjustments to reconcile net income to net cash         used in operating activities:
Imputed interest		-			250			(e)			250
Accretion expense		-			122,723			(d)			122,723
Change in derivative liability		-			6,504,334			(c)			6,504,334
Changes in assets and liabilities:
(Increase) decrease in:
Account receivable		(174	)		-						(174	)
Inventory		(379	)		-						(379	)
Sales tax receivable		(7,706	)		-						(7,706	)
Research and experimental development tax credits receivable		43,448			-						43,448
Other assets		(429	)		-						(429	)
(Decrease) increase in :
Accounts payable and accrued liabilities		186,206			-						186,206
Accrued liabilities - related parties		9,997			-						9,997
Net cash used in operating activities		(74,128	)		-						(74,128	)
Cash flow from investing activities:
Increase in notes receivable		(112	)		-						(112	)
Net cash used in investing activities		(112	)		-						(112	)
Cash flow from financing activities:
Proceeds from loan payable		33,116			-						33,116
Proceeds from grants		44,711			-						44,711
Net cash provided by financing activities		77,827			-						77,827
Effect of Exchange rate changes on cash and cash equivalents		(3,587	)		-						(3,587	)
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-135

---

CONSOLIDATED BALANCE SHEET
SEPTEMBER 30, 2002

		September 30,									September 30,
		2002			Net Change						2002
		Original									Restated
ASSETS
Total Assets	$	687,676			-					$	687,676
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	1,545,405			217,937			(g)		$	1,763,342
Accrued liabilties - related parties		-			844,218			(g)			844,218
Current portion of long-term debt		37,246			144,717			(g)			181,963
Notes payable - related party		-			162,500			(g)			162,500
Convertible notes - non-related parties		-			804,626			(g),(b),(d)			804,626
Derivative liability		-			1,495,003			(a),(c)			1,495,003
Total Current Liabilities		1,582,651			3,669,001						5,251,652
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Long term debt (net of current)		144,717			(144,717	)		(g)			-
Convertible notes		932,240			(932,240	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		1,062,155			(1,062,155	)		(g)			-
Total Other Liabilities		2,542,168			(2,542,168	)					-
Total Liabilities		4,124,819			1,126,833						5,251,652
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding  224,757,559 shares		224,758			-						224,758
Additional paid-in capital		24,618,899			3,653			(e)			24,622,552
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
Deficit accumulated during the development stage		(28,114,811	)		(73,130	)		(c),(d)			(28,187,941	)
Unrealized loss on foreign exchange		(165,989	)		-						(165,989	)
		(3,437,143	)		(1,126,833	)					(4,563,976	)
Total Liabilities and Stockholders' Equity (Deficit)	$	687,676			-					$	687,676

F-136

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2002

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		September 30,			September 30,						September 30,
		2002			2002 - Net Change						2002
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		245,359			-						245,359
Depreciation and amortization		5,914			-						5,914
Research and development		450,000			-						450,000
Total Expense		701,273			-						701,273
Loss before other expenses		(701,273	)		-						(701,273	)
Other expenses (income)
Interest expense		23,865			250			(e)			24,115
Accretion expense		-			122,723			(d)			122,723
Loss (gain) on change in derivative liability		-			554,490			(c)			554,490
Loss (gain) from extinguishment of debt		-			-						-
Total Other expenses (income)		23,865			677,463						701,328
Provision for income taxes		-			-						-
Net loss		(725,138	)		(677,463	)					(1,402,601	)
Other comprehensive income (loss)
Loss on foreign exchange		-			-						-
Net loss and comprehensive loss	$	(725,138	)	$	(677,463	)				$	(1,402,601	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.00	)							$	(0.01	)
Weighted average number of shares - basic and diluted		224,757,559									224,757,559

F-137

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2002

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		September 30,			September 30,						September 30,
		2002			2002 - Net Change						2002
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(725,138	)	$	(677,463	)				$	(1,402,601	)
Adjustments to reconcile net income to net cash           used in operating activities:
Depreciation and amortization		5,914			-						5,914
Imputed interest		-			250			(e)			250
Accretion expense		-			122,723			(d)			122,723
Loss (gain) on disposal and abandonment of assets		530,651			-						530,651
Change in derivative liability		-			554,490			(c)			554,490
Changes in assets and liabilities:
(Increase) decrease in:
Account receivable		4,636			-						4,636
Inventory		2,915			-						2,915
Sales tax receivable		(7,308	)		-						(7,308	)
Research and experimental development tax credits receivable		77,094			-						77,094
Other assets		3,308			-						3,308
(Decrease) increase in :
Accounts payable and accrued liabilities		48,613			-						48,613
Accrued liabilities - related parties		11,026			-						11,026
Net cash used in operating activities		(48,289	)		-						(48,289	)
Cash flow from investing activities:
Reduction in notes receivable		863			-						863
Net cash used in investing activities		863			-						863
Cash flow from financing activities:
Payments on lease obligations		(53,815	)		-						(53,815	)
Proceeds from grants		67,061			-						67,061
Net cash provided by financing activities		13,246			-						13,246
Effect of Exchange rate changes on cash and cash equivalents		34,180			-						34,180
Net (decrease) increase in cash and cash equivalents		-			-						-
Cash and cash equivalents - beginning of period		-			-						-
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-138

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED JUNE 30, 2002

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		June 30,			June 30, 2002						June 30,
		2002			Net Change						2002
		Original									Restated
Revenues	$	27,091			-					$	27,091
Cost of Sales		12,127			-						12,127
Gross profit		14,964			-						14,964
Operations
General and administrative		412,693			-						412,693
Depreciation and amortization		11,885			-						11,885
Research and development		1,934,772			-						1,934,772
Total Expense		2,359,350			-						2,359,350
Loss before other expenses		(2,344,386	)		-						(2,344,386	)
Other expenses (income)
Interest expense		142,525			850			(e)			143,375
Accretion expense		-			46,631			(d)			46,631
Loss (gain) on change in derivative liability		-			(453,724	)		(c)			(453,724	)
Total Other expenses (income)		142,525			(406,243	)					(263,718	)
Provision for income taxes		-			-						-
Net income (loss)		(2,486,911	)		406,243						(2,080,668	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		(2,138	)		-						(2,138	)
Net income (loss) and comprehensive income (loss)	$	(2,484,773	)	$	406,243					$	(2,078,530	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.01	)							$	(0.01	)
Weighted average number of shares - basic and diluted		204,212,265									204,212,265

F-139

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED JUNE 30, 2002

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		June 30,			June 30, 2002						June 30,
		2002			Net Change						2002
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(2,484,773	)	$	406,243					$	(2,078,530	)
Adjustments to reconcile net income to net cash            used in operating activities:
Depreciation and amortization		11,885			-						11,885
Imputed interest		-			850			(e)			850
Accretion expense		-			46,631			(d)			46,631
Loss (gain) on disposal and abandonment of assets		1,500,000			-						1,500,000
Common stock issued in exchange for services and expenses		(33,947	)		-						(33,947	)
Change in derivative liability		-			(453,724	)		(c)			(453,724	)
Changes in assets and liabilities:
(Increase) decrease in:
Account receivable		(31,590	)		-						(31,590	)
Inventory		7,148			-						7,148
Sales tax receivable		(22,089	)		-						(22,089	)
Research and experimental development tax credits receivable		(76,525	)		-						(76,525	)
Other assets		38,756			-						38,756
(Decrease) increase in :
Accounts payable and accrued liabilities		128,246			-						128,246
Accrued liabilities - related parties		103,248			-						103,248
Net cash used in operating activities		(859,641	)		-						(859,641	)
Cash flow from investing activities:
Increase in notes receivable		(2,198	)		-						(2,198	)
Net cash used in investing activities		(2,198	)		-						(2,198	)
Cash flow from financing activities:
Loans from related parties		859,833									859,833
Deferred financing costs		34,375			-						34,375
Payments on lease obligations		(7,668	)		-						(7,668	)
Payments on loan payable		(49,985	)		-						(49,985	)
Proceeds from issuance of common stock		5,850			-						5,850
Proceeds from additional paid-in capital		61,897			-						61,897
Net cash provided by financing activities		904,302			-						904,302
Effect of Exchange rate changes on cash and cash equivalents		(41,120	)		-						(41,120	)
Net (decrease) increase in cash and cash equivalents		1,343			-						1,343
Cash and cash equivalents - beginning of period		(1,343	)		-						(1,343	)
Cash and cash equivalents - end of period	$	-		$	-					$	-

F-140

---

CONSOLIDATED BALANCE SHEET
MARCH 31, 2002

		March 31,									March 31,
		2002			Net Change						2002
		Original									Restated
ASSETS
Total Assets	$	2,727,001			-					$	2,727,001
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	1,254,272			136,103			(g)		$	1,390,375
Accrued liabilties - related parties					1,121,432			(g)			1,121,432
Current portion of long-term debt		22,447			196,751			(g)			219,198
Notes payable - related party					162,500			(g)			162,500
Convertible notes - non-related parties					453,032			(g),(b),(d)			453,032
Derivative liability					1,394,237			(a),(c)			1,394,237
Total Current Liabilities		1,276,719			3,464,055						4,740,774
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Long term debt (net of current)		196,751			(196,751	)		(g)			-
Convertible notes		750,000			(750,000	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		1,257,535			(1,257,535	)		(g)			-
Total Other Liabilities		2,607,342			(2,607,342	)					-
Total Liabilities		3,884,061			856,713						4,740,774
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorize  250,000,000 shares, issued and outstanding  197,363,834 shares		197,364			-						197,364
Additional paid-in capital		23,709,525			2,553			(e)			23,712,078
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
Deficit accumulated during the development stage		(24,904,900	)		198,090			(c),(d),(e),(j)			(24,706,810	)
Unrealized loss on foreign exchange		(159,049	)		-						(159,049	)
		(1,157,060	)		(856,713	)					(2,013,773	)
Total Liabilities and Stockholders' Equity (Deficit)	$	2,727,001			-					$	2,727,001

F-141

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED MARCH 31, 2002

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		March 31,			March 31, 2002						March 31,
		2002			Net Change						2002
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		198,665			-						198,665
Depreciation and amortization		13,627			-						13,627
Research and development		120,791			-						120,791
Total Expense		333,083			-						333,083
Loss before other expenses		(333,083	)		-						(333,083	)
Other expenses (income)
Interest expense		25,401			851			(e)			26,252
Accretion expense		-			46,631			(d)			46,631
Loss (gain) on change in derivative liability		-			278,054			(c)			278,054
Total Other expenses (income)		25,401			325,536						350,937
Provision for income taxes		-			-						-
Net loss		(358,484	)		(325,536	)					(684,020	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		175			-						175
Net loss and comprehensive loss	$	(358,659	)	$	(325,536	)				$	(684,195	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.00	)							$	(0.00	)
Weighted average number of shares - basic and diluted		192,114,478									192,114,478

F-142

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED MARCH 31, 2002

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		March 31,			March 31, 2002						March 31,
		2002			Net Change						2002
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(358,659	)	$	(325,536	)				$	(684,195	)
Adjustments to reconcile net income to net cash          used in operating activities:
Depreciation and amortization		13,627			-						13,627
Imputed interest		-			851			(e)			851
Accretion expense		-			46,631			(d)			46,631
Change in derivative liability		-			278,054			(c)			278,054
Changes in assets and liabilities:
(Increase) decrease in:
Account receivable		2			-						2
Inventory		64			-						64
Research and experimental development tax credits receivable		(27,447	)		-						(27,447	)
Other assets		24,365			-						24,365
(Decrease) increase in :
Accounts payable and accrued liabilities		100,788			-						100,788
Net cash used in operating activities		(247,260	)		-						(247,260	)
Cash flow from investing activities:
Decrease in notes receivable		15			-						15
Net cash used in investing activities		15			-						15
Cash flow from financing activities:
Loans from related parties		231,163			-						231,163
Deferred financing costs		12,303			-						12,303
Net cash provided by financing activities		243,466			-						243,466
Effect of Exchange rate changes on cash and cash equivalents		1,953			-						1,953
Net (decrease) increase in cash and cash equivalents		(1,826	)		-						(1,826	)
Cash and cash equivalents - beginning of period		483			-						483
Cash and cash equivalents - end of period	$	(1,343	)	$	-					$	(1,343	)

F-143

---

CONSOLIDATED BALANCE SHEET
DECEMBER 31, 2001

		December 31,									December 31,
		2001			Net Change						2001
		Original									Restated
ASSETS
Total Assets	$	2,739,452			-					$	2,739,452
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	1,153,485			73,708			(g)		$	1,227,193
Accrued liabilties - related parties		-			964,843			(g)			964,843
Current portion of long-term debt		25,538			196,751			(g)			222,289
Notes payable - related party		-			162,500			(g)			162,500
Convertible notes - non-related parties		-			406,401			(g),(b),(d)			406,401
Derivative liability		-			1,116,183			(a),(c)			1,116,183
Total Current Liabilities		1,179,023			2,920,386						4,099,409
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Long term debt (net of current)		196,751			(196,751	)		(g)			-
Convertible notes		750,000			(750,000	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		1,038,551			(1,038,551	)		(g)			-
Total Other Liabilities		2,388,358			(2,388,358	)					-
Total Liabilities		3,567,381			532,028						4,099,409
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding  197,363,834 shares		197,364			-						197,364
Additional paid-in capital		23,681,950			1,702			(e)			23,683,652
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
Deficit accumulated during the development stage		(24,546,241	)		523,626			(c),(d),(e)			(24,022,615	)
Unrealized loss on foreign exchange		(161,002	)		-						(161,002	)
		(827,929	)		(532,028	)					(1,359,957	)
Total Liabilities and Stockholders' Equity (Deficit)	$	2,739,452			-					$	2,739,452

F-144

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED DECEMBER 31, 2001

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		December 31,			December 31,						December 31,
		2001			2001 - Net Change						2001
		Original									Restated
Revenues	$	1,424			-					$	1,424
Cost of Sales		854			-						854
Gross profit		570			-						570
Operations
General and administrative		308,601			-						308,601
Depreciation and amortization		13,718			-						13,718
Research and development		154,175			-						154,175
Total Expense		476,494			-						476,494
Loss before other expenses		(475,924	)		-						(475,924	)
Other expenses (income)
Interest expense		28,185			851			(e)			29,036
Accretion expense		-			46,631			(d)			46,631
Loss (gain) on change in derivative liability		-			347,889			(c)			347,889
Total Other expenses (income)		28,185			395,371						423,556
Provision for income taxes		-			-						-
Net loss		(504,109	)		(395,371	)					(899,480	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		882			-						882
Net loss and comprehensive loss	$	(504,991	)	$	(395,371	)				$	(900,362	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.00	)							$	(0.00	)
Weighted average number of shares - basic and diluted		186,865,121									186,865,121

F-145

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED DECEMBER 31, 2001

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		December 31,			December 31,						December 31,
		2001			2001 - Net Change						2001
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(504,991	)	$	(395,371	)				$	(900,362	)
Adjustments to reconcile net income to net cash          used in operating activities:
Depreciation and amortization		13,718			-						13,718
Imputed interest		-			851			(e)			851
Accretion expense		-			46,631			(d)			46,631
Change in derivative liability		-			347,889			(c)			347,889
Changes in assets and liabilities:
(Increase) decrease in:
Account receivable		(1,625	)		-						(1,625	)
Inventory		654			-						654
Sales tax receivable		6,610			-						6,610
Research and experimental development tax credits receivable		185,675			-						185,675
Other assets		39,604			-						39,604
(Decrease) increase in :
Accounts payable and accrued liabilities		265,875			-						265,875
Net cash used in operating activities		5,520			-						5,520
Cash flow from investing activities:
Increase in notes receivable		(4,280	)		-						(4,280	)
Net cash used in investing activities		(4,280	)		-						(4,280	)
Cash flow from financing activities:
Deferred financing costs		26,968			-						26,968
Payments on notes payable		(256,940	)		-						(256,940	)
Proceeds from grants		236,988			-						236,988
Net cash provided by financing activities		7,016			-						7,016
Effect of Exchange rate changes on cash and cash equivalents		(4,931	)		-						(4,931	)
Net (decrease) increase in cash and cash equivalents		3,325			-						3,325
Cash and cash equivalents - beginning of period		(2,842	)		-						(2,842	)
Cash and cash equivalents - end of period	$	483		$	-					$	483

F-146

---

CONSOLIDATED BALANCE SHEET
SEPTEMBER 30, 2001

		September 30,									September 30,
		2001			Net Change						2001
		Original									Restated
ASSETS
Total Assets	$	2,976,484			-					$	2,976,484
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	977,321			48,435			(g)		$	1,025,756
Accrued liabilties - related parties		-			713,920			(g)			713,920
Current portion of long-term debt		363,963			107,460			(g)			471,423
Notes payable - related party		-			162,500			(g)			162,500
Convertible notes - non-related parties		-			359,770			(g),(b),(d)			359,770
Derivative liability		-			768,294			(a),(c)			768,294
Total Current Liabilities		1,341,284			2,160,379						3,501,663
Other liabilities
Long-term deposits and convertible notes		217,500			(217,500	)		(g)			-
Long term debt (net of current)		107,460			(107,460	)		(g)			-
Convertible notes		750,000			(750,000	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		762,355			(762,355	)		(g)			-
Total Other Liabilities		2,022,871			(2,022,871	)					-
Total Liabilities		3,364,155			137,508						3,501,663
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding  197,363,834 shares		197,364			-						197,364
Additional paid-in capital		23,612,286			851			(e)			23,613,137
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
Deficit accumulated during the development stage		(24,041,250	)		918,997			(c),(d)			(23,122,253	)
Unrealized loss on foreign exchange		(156,071	)		-						(156,071	)
		(387,671	)		(137,508	)					(525,179	)
Total Liabilities and Stockholders' Equity (Deficit)	$	2,976,484			-					$	2,976,484

F-147

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2001

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		September 30,			September 30,						September 30,
		2001			2001 - Net Change						2000
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		289,954			-						289,954
Depreciation and amortization		13,954			-						13,954
Research and development		87,839			-						87,839
Total Expense		391,747			-						391,747
Loss before other expenses		(391,747	)		-						(391,747	)
Other expenses (income)
Interest expense		26,093			851			(e)			26,944
Accretion expense		-			46,631			(d)			46,631
Loss (gain) on change in derivative liability		-			(39,557	)		(c)			(39,557	)
Total Other expenses (income)		26,093			7,925						34,018
Provision for income taxes		-			-						-
Net loss		(417,840	)		(7,925	)					(425,765	)
Other comprehensive income (loss)
Loss on foreign exchange		1,081			-						1,081
Net loss and comprehensive loss	$	(418,921	)	$	(7,925	)				$	(426,846	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.00	)							$	(0.00	)
Weighted average number of shares - basic and diluted		181,615,765									181,615,765

F-148

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2001

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		September 30,			September 30,						September 30,
		2001			2001 - Net Change						2000
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(418,921	)	$	(7,925	)				$	(426,846	)
Adjustments to reconcile net income to net cash         used in operating activities:
Depreciation and amortization		13,943			-						13,943
Imputed interest		-			851			(e)			851
Accretion expense		-			46,631			(d)			46,631
Stock options issued in exchange for services		367,273			-						367,273
Change in derivative liability		-			(39,557	)		(c)			(39,557	)
Changes in assets and liabilities:
(Increase) decrease in:
Account receivable		514			-						514
Inventory		2,928			-						2,928
Sales tax receivable		5,175			-						5,175
Research and experimental development tax credits receivable		32,356			-						32,356
Other assets		90,572			-						90,572
(Decrease) increase in :
Accounts payable and accrued liabilities		(269,751	)		-						(269,751	)
Accrued liabilities - related parties		(12,374	)		-						(12,374	)
Net cash used in operating activities		(188,285	)		-						(188,285	)
Cash flow from investing activities:
Investment		(89,500	)		-						(89,500	)
Net cash used in investing activities		(89,500	)		-						(89,500	)
Cash flow from financing activities:
Deferred financing costs		26,968			-						26,968
Payments on lease obligations		(17,148	)		-						(17,148	)
Proceeds from grants		239,609			-						239,609
Net cash provided by financing activities		249,429			-						249,429
Effect of Exchange rate changes on cash and cash equivalents		24,158			-						24,158
Net (decrease) increase in cash and cash equivalents		(4,198	)		-						(4,198	)
Cash and cash equivalents - beginning of period		1,356			-						1,356
Cash and cash equivalents - end of period	$	(2,842	)	$	-					$	(2,842	)

F-149

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED JUNE 30, 2001

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		June 30,			June 30, 2001						June 30,
		2001			Net Change						2001
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		407,022			-						407,022
Depreciation and amortization		47,182			-						47,182
Research and development		14,785			-						14,785
Total Expense		468,989			-						468,989
Loss before other expenses		(468,989	)		-						(468,989	)
Other expenses (income)
Interest expense		96,491			-						96,491
Accretion expense		-			66,179			(d)			66,179
Loss (gain) on change in derivative liability		-			(58,292	)		(c)			(58,292	)
Loss (gain) from extinguishment of debt		-			-						-
Total Other expenses (income)		96,491			7,887						104,378
Provision for income taxes		-			-						-
Net loss		(565,480	)		(7,887	)					(573,367	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		(7,130	)		-						(7,130	)
Net loss and comprehensive loss	$	(558,350	)		(7,887	)				$	(566,237	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.00	)							$	(0.00	)
Weighted average number of shares - basic and diluted		170,139,483									170,139,483

F-150

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED JUNE 30, 2001

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		June 30,			June 30, 2001						June 30,
		2001			Net Change						2001
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(558,350	)	$	(7,887	)				$	(566,237	)
Adjustments to reconcile net income to net cash         used in operating activities:
Depreciation and amortization		47,181			-						47,181
Accretion expense		-			66,179			(d)			66,179
Loss (gain) on disposal and abandonment of assets		(49,801	)		-						(49,801	)
Common stock issued in exchange for interest		4,200			-						4,200
Common stock issued in exchange for services and expenses		(1,009,142	)		-						(1,009,142	)
Stock options issued in exchange for services		496,411			-						496,411
Change in derivative liability		-			(58,292	)		(c)			(58,292	)
Changes in assets and liabilities:
(Increase) decrease in:
Inventory		24,695			-						24,695
Sales tax receivable		(24,905	)		-						(24,905	)
Research and experimental development tax credits receivable		279,213			-						279,213
Other assets		41,209			-						41,209
(Decrease) increase in :
Accounts payable and accrued liabilities		673,332			-						673,332
Accrued liabilities - related parties		(213,778	)		-						(213,778	)
Net cash used in operating activities		(289,735	)		-						(289,735	)
Cash flow from investing activities:
Increase in notes receivable		(112,789	)		-						(112,789	)
Reduction in notes receivable		116,089			-						116,089
Equipment		(60,769	)		-						(60,769	)
Net cash used in investing activities		(57,469	)		-						(57,469	)
Cash flow from financing activities:
Loans from related parties		880,417									880,417
Deferred financing costs		26,968			-						26,968
Proceeds from convertible notes		754,999			-						754,999
Payments on lease obligations		(39,217	)		-						(39,217	)
Proceeds from issuance of convertible subordinated debentures		(935,556	)		-						(935,556	)
Payments on loan payable		(75,147	)		-						(75,147	)
Proceeds from grants		(41,958	)		-						(41,958	)
Proceeds from issuance of common stock		733			-						733
Proceeds from additional paid-in capital		39,427			-						39,427
Net cash provided by financing activities		610,666			-						610,666
Effect of Exchange rate changes on cash and cash equivalents		(275,028	)		-						(275,028	)
Net (decrease) increase in cash and cash equivalents		(11,566	)		-						(11,566	)
Cash and cash equivalents - beginning of period		12,922			-						12,922
Cash and cash equivalents - end of period	$	1,356		$	-					$	1,356

F-151

---

CONSOLIDATED BALANCE SHEET
MARCH 31, 2001

		March 31,									March 31,
		2001			Net Change						2001
		Original									Restated
ASSETS
Total Assets	$	3,208,452			-					$	3,208,452
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued liabilties	$	799,893			35,762			(g)		$	835,655
Accrued liabilties - related parties		-			878,270			(g)			878,270
Current portion of long-term debt		137,653			403,002			(g)			540,655
Notes payable - related party		-			143,500			(g)			143,500
Convertible notes - non-related parties		-			246,960			(g),(b),(d)			246,960
Derivative liability		-			866,143			(a),(c)			866,143
Total Current Liabilities		937,546			2,573,637						3,511,183
Other liabilities
Long-term deposits and convertible notes		198,500			(198,500	)		(g)			-
Long term debt (net of current)		403,002			(403,002	)		(g)			-
Convertible notes		750,000			(750,000	)		(g)			-
Convertible notes		185,556			(185,556	)		(g)			-
Convertible loans		914,032			(914,032	)		(g)			-
Total Other Liabilities		2,451,090			(2,451,090	)					-
Total Liabilities		3,388,636			122,547						3,511,183
Stockholders' Equity (Deficit)
Common stock, $.001 par value, authorized  250,000,000 shares, issued and outstanding 175,756,295 shares		175,756			-						175,756
Additional paid-in capital		22,613,260			-						22,613,260
Deficit accumulated prior to entering development stage		-			(1,057,356	)		(r)			(1,057,356	)
Deficit accumulated during the development stage		(23,063,979	)		934,809			(c),(d),(e),(j)			(22,129,170	)
Unrealized loss on foreign exchange		94,779			-						94,779
		(180,184	)		(122,547	)					(302,731	)
Total Liabilities and Stockholders' Equity (Deficit)	$	3,208,452			-					$	3,208,452

F-152

---

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
FOR THE THREE MONTHS ENDED MARCH 31, 2001

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		March 31,			March 31, 2001						March 31,
		2001			Net Change						2001
		Original									Restated
Revenues	$	-			-					$	-
Cost of Sales		-			-						-
Gross profit		-			-						-
Operations
General and administrative		745,338			-						745,338
Depreciation and amortization		68,071			-						68,071
Research and development		359,282			-						359,282
Total Expense		1,172,691			-						1,172,691
Loss before other expenses		(1,172,691	)		-						(1,172,691	)
Other expenses (income)
Interest expense		21,623			-						21,623
Accretion expense		-			6,404			(d)			6,404
Loss (gain) on change in derivative liability		-			116,143			(c)			116,143
Loss (gain) from extinguishment of debt		-			-						-
Total Other expenses (income)		21,623			122,547						144,170
Provision for income taxes		-			-						-
Net income (loss)		(1,194,314	)		(122,547	)					(1,316,861	)
Other comprehensive income (loss)
Loss (gain) on foreign exchange		(67,773	)		-						(67,773	)
Net loss and comprehensive loss	$	(1,126,541	)	$	(122,547	)				$	(1,249,088	)
Net loss and comprehensive loss per share - basic and diluted	$	(0.01	)							$	(0.01	)
Weighted average number of shares - basic and diluted		168,063,841									168,063,841

 

F-153

---

CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED MARCH 31, 2001

		For the Three			For the Three						For the Three
		Months Ended			Months Ended						Months Ended
		March 31,			March 31, 2001						March 31,
		2001			Net Change						2001
		Original									Restated
Cash flows from operating activities:
Net income (loss)	$	(1,126,541	)	$	(122,547	)				$	(1,249,088	)
Adjustments to reconcile net income to net cash         used in operating activities:
Depreciation and amortization		68,071			-						68,071
Accretion expense		-			6,404			(d)			6,404
Stock options issued in exchange for services		2,801			-						2,801
Change in derivative liability		-			116,143			(c)			116,143
Changes in assets and liabilities:
(Increase) decrease in:
Account receivable		(5,144	)		-						(5,144	)
Inventory		4,455			-						4,455
Sales tax receivable		5,175			-						5,175
Research and experimental development tax credits receivable		239,674			-						239,674
Other assets		(27,015	)		-						(27,015	)
(Decrease) increase in :
Accounts payable and accrued liabilities		(255,027	)		-						(255,027	)
Net cash used in operating activities		(1,093,551	)		-						(1,093,551	)
Cash flow from investing activities:
Equipment		(2,433	)		-						(2,433	)
Equipment assembly costs		(139,582	)		-						(139,582	)
Net cash used in investing activities		(142,015	)		-						(142,015	)
Cash flow from financing activities:
Proceeds from convertible notes		935,556			-						935,556
Proceeds from notes payable		(744,490	)		-						(744,490	)
Proceeds from loan payable		(35,520	)		-						(35,520	)
Proceeds from issuance of common stock		10,764			-						10,764
Proceeds from additional paid-in capital		1,119,936			-						1,119,936
Net cash provided by financing activities		1,286,246			-						1,286,246
Effect of Exchange rate changes on cash and cash equivalents		(49,213	)		-						(49,213	)
Net (decrease) increase in cash and cash equivalents		1,467			-						1,467
Cash and cash equivalents - beginning of period		11,455			-						11,455
Cash and cash equivalents - end of period	$	12,922		$	-					$	12,922

F-154

---

ANNOTATIONS TO NET CHANGES IN RESTATED FINANCIAL STATEMENTS -

	(a)	Recognition of Derivative Liability associated with Convertible Notes (Derivative Financial Instrument).
	(b)	Recognition of Note Discount associated with Convertible Notes (Derivative Financial Instrument).
	(c)	Recognition of change in Derivative Liability associated with Convertible Notes (Derivative Financial Instrument).
	(d)	Recognition of Note Discount amortization associated with Convertible Notes (Derivative Financial Instrument).
	(e)	Recognition of interest expense associated with Convertible Notes (Derivative Financial Instrument).
	(f)	Recognition of preferred stock issuances at fair value.
	(g)	Reclassification of all liabilities which are due within one year or are in default.
	(h)	Correction to properly record fixed assets impairment charge from 2009 to 2008.
	(i)	Correction to amount of interest expense recorded in 2008.
	(j)	Correction to transfer write-off and settlement of certain balances relating to Convertible Notes - non-related parties from 2009 to 2003.
	(k)	Correction to record loss on issuance of common stock at fair value to settle outstanding debts.
	(l)	Correction to the amount recorded for professional fees on issuance of common stock at fair value for services rendered.
	(m)	Correction to record stock option expense.
	(n)	Correction to record imputed interest expense.
	(o)	Correction of the amount accrued for professional fees.
	(p)	Correction of the amount accrued for legal liabilities.
	(q)	Correction of amount of Convertible Notes outstanding at June 30, 2003.
	(r)	Presentation of portion of deficit accumulated prior to entering development stage.
	(s)	Correction of original financial statement classification and presentation.

F-155

---

Note 17      SUBSEQUENT EVENTS

On July 1, 2009, under executive employment agreements, the Company granted 6,000,000 stock options to its three executive officers relating to the 2010 Fiscal year. The nature and terms of these stock options are more fully described in Note 13. The Company will record compensation expense of $7,200 in Fiscal 2010 relating to the granting of the stock options.

On February 16, 2010, the Company’s Board of Directors approved an amended Certificate of Designation with respect to the authorization of up to 25,000,000 Series A Preferred shares, an increase from the 15,000,000 shares of Series A Preferred stock that were authorized to be issued. On December 6, 2010, the 10,000 additional authorized Series A Preferred shares were issued to two Directors and Officers of the Company. As at March 1, 2011, the Company had 25,000,000 Series A preferred shares issued and outstanding.

On February 17, 2010, the Company's Board of Directors approved an amendment to the Articles of Incorporation of the Company to increase the number of authorized shares of Common stock, par value $0.001, from 1,500,000,000 shares to 2,000,000,000 shares.

On December 6, 2010, the Company's Board of Directors approved an amendment to the Articles of Incorporation of the Company to increase the number of authorized shares of Common stock, par value $0.001, from 2,000,000,000 shares to 2,500,000,000 shares.

Subsequent to June 30, 2009 and up to February 16, 2011, the Company issued 1,114,007,540 common shares for services performed and in partial payment of a Settlement Agreement under Securities Act Regulation 10(a)3. As at March 1, 2011, the Company had 2,233,499,756 common shares issued and outstanding, versus its authorization of 2,500,000,000 shares.

Additional funding from private investors, referred to in Note 8, was received subsequent to June 30, 2009 and up to March 1, 2011 in the amount of $116,285 with conversion prices ranging from $.001 to $.005 and, when converted, would represent an additional issuance of 71,405,000 common shares.

F-156

---

Reports Filed on Form 8-K

• April 14, 2009.        Amend Articles of Incorporation
• May 12, 2009.         Amend Articles of Incorporation
• May 22, 2009          Notice of non-reliance on financial statements
• June 10, 2009.         Notice of non-reliance on financial statements
• August 11, 2009 (post-period) Change in certifying accountant
• September 15, 2009 (post-period amendment) Change in certifying accountant
• September 21, 2009 Change in certifying accountant

Financial Statement Schedules
None. Financial statements schedules have been omitted because they are not applicable or the required information is shown in the consolidated financial statements or the notes thereto.

Exhibits
The exhibits filed as a part of this Annual Report or incorporated herein by reference are as follows (Exhibits Incorporated Herein By Reference, Exhibit No. As Filed With Document Indicated):

(a)	Certificate of Incorporation filed August 19, 1987		3(a)
(b)	Certificate of Amendment filed June 20, 1989		3(b)
(c)	Certificate of Amendment filed March 10, 1993		3
(d)	Certificate of Amendment filed December 5, 1995		3(e)
(e)	By-Laws		3(b)
(f)	Certificate of Amendment filed August 11, 1997
(g)	Certificate of Amendment filed February 3, 1998		3
(h)	Certificate of Incorporation of Tirex Acquisition Corp., filed with the Secretary of State of Delaware on December 15, 1997		3(h)
(k)	Certificate of Amendment to the Certificate of Incorporation, filed with the Secretary of State of Delaware on July 10, 1998

F-157

---

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act, the registrant has duly caused this Annual Report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: March 1, 2011	THE TIREX CORPORATION
	/s/ John L. Threshie, Jr.
	John L. Threshie, Jr.
	Chairman of the Board of Directors and
	Chief Executive Officer

Pursuant to the requirements of the Exchange Act, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.

SIGNATURES		TITLE	DATE
Principal Executive Officer:
		Chairman of the Board	March 1, 2011
/s/ JOHN L. THRESHIE, JR.		of Directors and Chief
John L. Threshie, Jr.		Executive Officer
Principal Financial and Accounting Officer:
		Secretary, Treasurer,	March 1, 2011
/s/ MICHAEL D.A. ASH		and Chief Financial and
Michael D.A. Ash		Accounting Officer
A Majority of the Board of Directors:
		Chairman of the Board	March 1, 2011
/s/ JOHN L. THRESHIE, JR.		of Directors
John L. Threshie, Jr.
/s/ HENRY MEIER		Director	March 1, 2011
Henry Meier
/s/ LOUIS V. MURO		Director	March 1, 2011
Louis V. Muro

SUPPLEMENTAL INFORMATION TO BE FURNISHED WITH REPORTS FILED PURSUANT TO SECTION 15(D) OF THE EXCHANGE ACT BY NON-REPORTING ISSUERS

No annual report or proxy materials have been sent to security holders during the fiscal year ended June 30, 2009 or the subsequent interim periods. As at the date hereof, the Company plans to furnish proxy materials relating to its annual meeting, which is presently contemplated to be held during the current fiscal year. All such materials will be furnished to the Commission at the same time as they are sent to securities holders.

---